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ABSTRACT OF THE DISSERTATION
High Resolution Multi-parametric Diagnostics and Therapy of Atrial Fibrillation:
Chasing Arrhythmia Vulnerabilities in the Spatial Domain
by
Sarah Renee Gutbrod
Doctor of Philosophy in Biomedical Engineering
Washington University in St. Louis, 2015
Professor Igor Efimov, Chair

After a century of research, atrial fibrillation (AF) remains a challenging disease to study and
exceptionally resilient to treatment. Unfortunately, AF is becoming a massive burden on the
health care system with an increasing population of susceptible elderly patients and expensive unreliable treatment options. Pharmacological therapies continue to be disappointingly
ine↵ective or are hampered by side e↵ects due to the ubiquitous nature of ion channel targets
throughout the body. Ablative therapy for atrial tachyarrhythmias is growing in acceptance.
However, ablation procedures can be complex, leading to varying levels of recurrence, and
have a number of serious risks. The high recurrence rate could be due to the difficulty of
accurately predicting where to draw the ablation lines in order to target the pathophysiology
that initiates and maintains the arrhythmia or an inability to distinguish sub-populations of
patients who would respond well to such treatments.
There are electrical cardioversion options but there is not a practical implanted deployment
of this strategy. Under the current bioelectric therapy paradigm there is a trade-o↵ between
xii

efficacy and the pain and risk of myocardial damage, all of which are positively correlated
with shock strength. Contrary to ventricular fibrillation, pain becomes a significant concern
for electrical defibrillation of AF due to the fact that a patient is conscious when experiencing
the arrhythmia. Limiting the risk of myocardial injury is key for both forms of fibrillation.
In this project we aim to address the limitations of current electrotherapy by diverging from
traditional single shock protocols. We seek to further clarify the dynamics of arrhythmia
drivers in space and to target therapy in both the temporal and spatial domain; ultimately
culminating in the design of physiologically guided applied energy protocols.
In an e↵ort to provide further characterization of the organization of AF, we used transillumination optical mapping to evaluate the presence of three-dimensional electrical substrate
variations within the transmural wall during acutely induced episodes of AF. The results of
this study suggest that transmural propagation may play a role in AF maintenance mechanisms, with a demonstrated range of discordance between the epicardial and endocardial
dynamic propagation patterns. After confirming the presence of epi-endo dyssynchrony in
multiple animal models, we further investigated the anatomical structure to look for regional
trends in transmural fiber orientation that could help explain the spectrum of observed patterns. Simultaneously, we designed and optimized a multi-stage, multi-path defibrillation
paradigm that can be tailored to individual AF frequency content in the spatial and temporal
domain. These studies continue to drive down the defibrillation threshold of electrotherapies
in an attempt to achieve a pain-free AF defibrillation solution. Finally, we designed and characterized a novel platform of stretchable electronics that provide instrumented membranes
across the epicardial surface or implanted within the transmural wall to provide physiological
feedback during electrotherapy beyond just the electrical state of the tissue. By combining
a spatial analysis of the arrhythmia drivers, the energy delivered and the resulting damage, we hope to enhance the biophysical understanding of AF electrical cardioversion and
xiii

design an ideal targeted energy delivery protocol to improve upon all limitations of current
electrotherapy.

xiv

Chapter 1
Introduction
1.1

Atrial Fibrillation

“Close attention to the muscle surface at once reveals feverish activity; the whole surface is
alive with twitchings, or coarser undulatory movements. . . This is the full condition which
is properly termed fibrillation” —Sir Thomas Lewis [109]
Portions of this chapter appear in the following original publication:
Efimov IR and Gutbrod SR. Fibrillating Atrium: Rabbit Warren! Not Beehive! J
Cardiovasc Electrophysiol. 2013; 24: 336-337.

The heart is an eloquently designed organ with a simple purpose: to perform as an indefatigable pump and maintain constant blood flow to the body. Performance relies on the finely
tuned interplay of electricity, energy delivery, and the relentless generation of force. The sole
function of the sophisticated electrical propagation is to facilitate a reliable timing signal for
a synchronous beat with the greatest efficiency. Fibrillation is a pathological condition that
occurs when the integrity of the timing signal is disrupted. Chaotic electrical conduction
gives rise to quivering and ine↵ective contraction. In the ventricles the resulting mechanical
insufficiency is a hemodynamic emergency and, if sustained, it is incompatible with life. Alternatively, the lethality of fibrillation in the atria develops more slowly. The uncoordinated
motion promotes the formation of blood clots and the uncontrolled electrical propagation
leads to irregular conduction through the atrioventricular node, which can trigger compensatory reactions [25]. As a result, atrial fibrillation (AF) increases the risk of developing
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heart failure, dementia and stroke, and has a serious impact on quality of life and morbidity.
Although AF is immediately less fatal, it is a leading cause of hospitalization in the United
States, accounting for 3.2 million hospital-days per year and an annual healthcare burden
of $26 billion [99]. According to the Rotterdam study the lifetime risk of contracting AF is
22.2% for women and 23.8% for men of European ancestry [78]. Moreover, AF is a disease of
advancing age; prevalence doubles with every decade beyond 50 years of age. Consequently,
the most a↵ected population is growing in size and projection models calculate that as many
as 12 million Americans may su↵er from AF by 2050 [15].
Atrial Fibrillation Drivers
Unfortunately AF is a complex, heterogeneous, and metamorphic condition. In 1925 Thomas
Lewis described AF as being, “the absence of all signs of normal auricular [i.e. atrial]
contraction.” The most defining characteristic of AF (and sometimes the only similarity
between two individual episodes) is the fact that it doesn’t resemble normal atrial conduction.
The rate, morphology and stability of the abnormal electrocardiogram vary considerably
across patients and across time. AF is often defined by what it is not because it is the
simplest way to broadly describe such a diverse range of the electrical manifestations. For
over a century, there has been a significant e↵ort to quantitatively dissect the underlying
substrate and the biophysical mechanisms of AF initiation and perpetuation. This ongoing
e↵ort has led to several conflicting schools of thought that continue to shape the way that
AF is approached therapeutically. The controversy is well stated by Carl Wiggers:

As to the fundamental mechanism of fibrillation we have plenty of theories, but
none is universally accepted. . . . We may note in passing that [the di↵ering
hypotheses] all center around two ideas, viz. (a) that the impulses arise from
centers, or pacemakers, or (b) that the condition is caused by the re-entry of
impulses and the formation of circles of excitation [189].
Remarkably, both the focal and reentrant hypotheses of AF originated concurrently. Beginning in 1907 Rothberger and Winterberg postulated that AF could be sustained by multiple,
rapidly firing ectopic foci or pacemakers [200, 153]. The numerous foci-induced local contractions prevented coordinated contraction. The same year, Mayer presented an observation in
the jellyfish [124] that lead to the idea of reentrant mechanisms in the heart later formulated
2

by Mines [127] and Garrey [61, 62]. Most of this research was conducted by meticulously
observing or filming the mechanical oscillations of the fibrillating tissue. In the years to
come evidence accumulated on both sides of the argument. In 1920, Lewis demonstrated
electrocardiographic evidence in support of a reentrant basis of both atrial flutter (AFl) and
AF using 3 vectors to calculate the electrical axis of propagation [109]. The abnormal focal
activity theory also garnered empirical evidence with the use of monophasic action potential recordings in response to altering environmental conditions and pharmacological agents
[161], including a notable study on the focal application of aconitine that revitalized the argument for multiple centers of local activity in experimental fibrillation [156]. As each new
generation of scientists took a side in this debate, more sub-theories were spun o↵. Reentry
branched into theories of a single mother rotor vs. multiple persisting circuits. Based on a
computer model, Gordon Moe introduced the multiple wavelet hypothesis, characterized by
transient reentrant circuits that quickly die o↵ and are replaced by the generation of new
pathways instead of a stable rotor [131]. Although accepted for decades, the multiple wavelet
theory is losing favor to theories that focus on organizing centers with some degree of stability. Despite decades of research and substantial technological advancements to recording
systems that have greatly improved AF visualization, the general sentiment expressed in
1940 by Dr. Wiggers still stands valid: no theory of fibrillation is universally accepted.
The debate over competing theories is further complicated because AF is rarely seen in isolation of other co-morbidities or cardiomyopathies including: mitral valve disease, elevated
atrial pressure, or atrial extension. Additionally, the geometry of the atria introduces structural complexities that obscure the mechanism of perpetuation. Unlike the ventricles, there
are abundant anatomical discontinuities for a wavefront to anchor to. It is possible that the
wavefront dynamically transitions between functional and anatomical reentry.
Likely there is no overarching answer to what sustains fibrillation in the atria. Instead
individual AF episodes may lie along a spectrum between the various theories. If that is the
case, the field needs to focus our e↵orts on ways to identify sub-populations of AF in order to
direct therapy appropriately. Carl Wiggers provides guidance for how to proceed,“Although
we are not yet in a position to suggest any hypotheses which satisfactorily explain either the
inception or the evolution of the fibrillation process, we may profitably examine the clues
which recent work o↵ers” [189]. It is my hope that this dissertation adds to the discussion.

3

Evolution of Atrial Fibrillation Therapy
Due to the diversity and the metamorphic nature of the disease population and the lack
of clarity behind the biophysical mechanisms of the disease, AF lacks a robust therapeutic
approach. The competing concepts of AF perpetuation have implications for developing
therapeutic approaches. Reentry requires a substrate, whether it is anatomic or functionally
based on intrinsic spatial heterogeneities in the myocardial tissue. Therefore the goal would
be to extend the refractory period or create linear lines of block to disrupt the circuit. For AF
driven by multiple pathways, extensive ablation functionally divides the tissue and isolates
small regions incapable of maintaining a circuit. Alternatively, if AF is maintained by ectopic
foci, the primary goal of a therapy is to suppress automatic impulse generation.
Pharmacologic targets for heart rhythm disorders are particularly challenging (even if the primary goal of therapy was easily identifiable) because of the ubiquitous nature of ion channels
throughout the body and the delicate balance of electrophysiological parameters that allow
for proper conduction in the heart [148]. For those agents with cardiac or even atrial specificity, the titration of the drug is difficult. Anti-arrhythmic agents are often pro-arrhythmic
under di↵erent conditions and AF is associated with severe ionic remodeling that progressively shifts the ionic balance [79]. Therefore temporal evolution of AF further convolutes
the therapy decision tree. Many of the possible agents that have shown preclinical promise
have not made a widespread clinical impact or worse have had an adverse e↵ect. There are
still many groups looking to improve the atrial selectivity and e↵ectiveness of novel drug
targets. Some options include taking advantage of drugs with frequency dependent activity.
Ideally these agents would not intervene when the heart is in the natural sinus rhythm but
would disrupt fast fibrillatory conduction [68]. However, for now the best pharmacological
option remains a prophylactic anticoagulation therapy protocol. This approach falls short of
reversing the pathophysiology underlying AF, instead simply reduces the thromboembolic
risk.
Electrotherapeutic approaches, including electrical cardioversion by high voltage shocks or
radio frequency (RF) ablation, o↵er an alternative methodology but these applications are
not without limitations. High voltage shock therapy is a well-developed technique for ventricular fibrillation and when applied across the atria, it is e↵ective at terminating the fibrillatory
conduction. However, the physical and psychological pain associated with shocks prevented
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the adaption of this therapy in an implantable form. Ablation began as a surgical procedure
and is still performed that way today. However, many clinicians opt to use endovascular
catheters to transmitter RF energy to burn focal points or lines across the surface of the
atrial tissue. As suggested previously, the goal is to disrupt the generating source or the
driving circuit of the arrhythmia. There is a substantial push to create feedback or alternative energy sources to provide clean and controlled transmural lesions with non-surgical
ablation. The results of these procedures vary widely and it is not yet clear how to identify
those patients who have the greatest chance of benefiting from such a procedure.
An ablation procedure or an electrical cardioversion is deemed successful if sinus rhythm is
restored; however neither approach has a long-term guarantee. AF was reported to recur
in up to 71% of paroxysmal AF patients within 5-years following an RF ablation [186].
This high recurrence rate could be due to the difficultly of accurately predicting where
to draw the ablation lines in order to target the pathophysiology. Electrical cardioversion
is a one-time restorative therapy but without an accepted implantable option it is not a
viable method to prevent sustained AF at every occurrence. Under the current bioelectric
therapy paradigm there is a trade-o↵ between efficacy and perceived pain, both of which are
positively correlated with shock strength. Contrary to ventricular fibrillation, pain becomes a
significant concern in the treatment of AF due to the fact that a patient is generally conscious
when experiencing the arrhythmia. To improve the efficacy of both ablation and electrical
cardioversion the field may need to shift from a one-size-fits-all approach to mechanism-based
personalized therapeutic modalities.

1.2

History of Defibrillation

“Scientists often study the past as obsessively as historians because few other professions
depend so acutely on it. Every experiment is a conversation with a prior experiment, every
new theory a refutation of the old.” —Siddhartha Mukherjee [136]
Portions of this chapter appear in the following original publications:
Gutbrod SR and Efimov IR. A Shocking Past: A Walk Through Generations of
Defibrillation Development.IEEE Trans Biomed Eng. 2014; 61(5): 1466-1473.
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Boukens B, Gutbrod SR, and Efimov IR. Imaging of Ventricular Fibrillation and
Defibrillation: The Virtual Electrode Hypothesis. Membrane Potential Imaging in the
Nervous System and Heart. Eds: Marco Canepari, Dejan Zecevic, Olivier Bernus. Springer
International Publishing. Series vol. 859 July 2015. Ahead of Publication.

In order to move towards a mechanism-based approach to electrical cardioversion, it is critical
to first review the historical evolution of electrotherapy. The road to the first successful
application in a patient is tied to the plasticity of the mechanistic theory behind why a
high-voltage shock restores sinus rhythm. Hidden within the theoretical understanding of
defibrillation is the ability to target the applied electric field in an individualized manner and
thus reduce the energy requirement for success. A mechanism-based approach bolsters the
campaign for the development of a painless and harmless electrical cardioversion strategy
that could be successfully implanted in AF patients. As the use of electrotherapy on AF
followed the application on VF, this history refers to the use of defibrillation in general
without a distinction between heart chambers.
The goal of defibrillation is to restore a synchronized rhythm to the entire myocardium. A
large electrical shock has been known to successfully achieve this objective for over a century with a long circuitous history of clinical use [59]. Over several centuries the evolution
of cardiac electrotherapy has traversed long geographical distances, circumvented political
and cultural roadblocks, and faced bold scientific and public opposition. Despite the many
external setbacks, new advances in technology have persistently driven defibrillation from
the naive application of newfound electricity by amateurs in the 18th century to the powerful, life-saving, clinical tool it is today. The historical narrative navigates many seemingly
unrelated fields of science and technology, including zoology, physics, power and circuitry
engineering, physiology, cardiology, and computer modeling. Tenacious key individuals, who
dedicated their careers to reversing sudden cardiac death and understanding the biophysical
interaction between the heart and applied electric fields, propelled the study of defibrillation
across generations and continents. The story of electrotherapy o↵ers a unique perspective
on the role engineering has played in shaping the optimization of delivery, the reduction in
shock strength, and the ever evolving, working hypothesis of the mechanism of a successful
defibrillation attempt.
Early Naive Applications of Electrotherapy
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The therapeutic potential of applying electricity directly to the human body was recognized
long before the language of physics and physiology caught up to explain the observed phenomena. In ancient times, electric fish were used in both South American and Greek societies
for remedial purposes [194, 203]. These antiquated societies observed that a discharge from
these fish had the ability to numb tissue. In fact the ancient Greek name for the electric fish
is the root word for narcotics. The therapeutic use of the fish’s natural abilities is shrouded
in myth and the efficacy of shocks delivered in such an uncontrolled manner is no longer
known but there is evidence of prescribed use of the fish in the treatment of chronic pain diseases ranging from headaches to arthritis and gout from as far back as the first century [56].
Remedies involving live electric fish can be traced from antiquity to the middle ages, carried
across civilizations within medical texts. However, the connection between these fish and
electricity was not immediately made after the discovery of electricity in the 18th century.
The first knowing medicinal application of electricity followed the invention of instrumentation that could produce electricity at will by storing the charge. The evolution of these
early capacitors are shown in Figure 1.1 from the fish to Otto von Guericke’s sphere and the
Leyden jar [177, 77, 176]. One simply had to charge such a device as the Leyden jar with a
static generator like the sphere and then connect the circuit through the patient to deliver a
large electrical shock. Although not designed with the intention of medical applications, the
prospect of therapeutic electricity arose from researchers who experimented on the e↵ects of
electricity when applied to themselves. There was no physiological foundation for the use of
electrotherapy, only a simple fascination with the new discovery of electricity.
(a)

(b)

(c)

(d)

Figure 1.1: Historical Evolution of Electrotherapy Instrumentation. a) Electrical fish provided the first source of current for electrotherapy [56], b) Otto von Guericke’s sphere to
create charge statically [177], c) the Leyden jar used to store charge [77], d) Alessandro
Volta’s depiction of a voltaic pile, which would lead to modern batteries in implantable
devices [176]
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The first reports of electrical stimulators in hospital settings date back to 1767 and 1777 at
London St. Bartholomew and King’s hospitals, respectively [37]. Electric shocks of up to
50,000V were naively applied, with a wide range of electrode placements and materials, to
any number of disease states under the assumption that electricity was a cure-all. By the
late 18th century there were multiple reports detailing the application of external shocks as
a form of resuscitation; the first of which was a 1788 human resuscitation case reported by
Dr. Charles Kite [103]. The Lancashire Society for Recovery of Apparently Dead published
guidelines for attempting to revive a drowning victim stating, “let the powerful stimulus
of electricity be applied by passing a shock through the heat, the balls of the electrometer
being no more than a third or half and inch from each other” [1] By 1802 the use of electrical
resuscitation was endorsed by the Royal Humane Society [2].
Unfortunately, theoretical support for the use of electrical stimulation lagged behind anecdotal evidence of success and there was widespread unregulated use of electrotherapy by both
amateurs and hospitals alike. Empirical animal testing conducted during this time period
did not add much enlightenment to when and why electrical stimulation worked [4]. The
combined lack of an understanding of electrical conduction within the cardiac tissue and the
lack of an existing method for monitoring the electrical activity of the heart significantly
limited these experiments. Important mechanistic strides were made in the related field of
animal electricity and muscle contraction, led by Galvani and his dancing frog legs [60],
but anecdotal success appeared sufficient justification for non-standardized electrotherapy in
humans.
Electricity was still a new technology, whose power was only beginning to be harnessed. The
next advance in electricity would come from the realization that the fish of antiquity were
discharging electrical shocks without constantly shocking themselves and must therefore have
a unique way of storing charge. Alessandro Volta, using John Hunter’s elegant dissections of
the electric organ of the fish [56], cleverly developed the voltaic battery [176] (Figure 1.1).
Volta’s invention, which he referred to as an “artificial electrical organ,” converts chemical
energy into electrical energy to provide a practical continuous power source. Volta opened
the door for new paradigms of electrotherapy that were not limited to a single explosive
discharge. Providing an adequate and compact power source to the discharge device remains
a significant aspect of the design of all defibrillators, including those used today. With the
first reliable steady source of current, electrotherapists could now travel easily with their
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device and carrying such a device (e.g. in a cane) became increasingly popular among
amateurs and physicians in the early 1800s.
Dark Days for Electrotherapy
Within a century, electrotherapy would drastically fall in public opinion to such a degree that
all interest in researching defibrillation would be wiped out from both lay and scientific communities. The new negative outlook on electrotherapy emerged following the widespread
uneducated application of electricity to all manners of disease with outrageous claims of
miraculous results. The credibility of defibrillation su↵ered greatly because of the implications that it could raise the dead and restore life. Such claims acquired widespread notoriety
through popular literature. The public easily misunderstood and misappropriated defibrillation to sorcery and quackery. John Shoemaker wrote the following on electrotherapy:

No remedy of equal value has been so misused; so much exaggerated as to intrinsic
worth; or so greatly decried as worthless. . . the mechanism for operating electric
force has improved much more rapidly than the intelligent use of it [163].

Ostentatious experiments such as John Aldini’s, whose studies on hanged or guillotined criminals in England and France were deemed grotesque by many, further damaged the public
opinion of electrotherapy [8]. When defibrillation came back into favor in the next century it
would be confined to the AC wall outlets of research laboratories without direct therapeutic
intentions. Electrotherapy did not return to a public access therapy until Automated External Defibrillators were distributed in the late 1990s and early 2000s. In 1999 the American
Red Cross included defibrillator training as part of the standard CPR training course to increase awareness on how to use the publicly accessible devices. Learning from past mistakes,
these devices are tightly controlled with little interaction required. The success of these
devices relies on sophisticated detection algorithms that do not require medical training to
identify fibrillation and deliver shocks only when safe and appropriate.
Although the appeal of electrotherapy declined, research investigating the condition underlying cardiac death continued. In the second half of the 19th century, several key European
physiologists including Carl Ludwig (Germany) [82], John MacWilliam (Great Britain) [126]
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and Edmé Vulpian (France) [178] published fundamental observations on the onset and progression of arrhythmias, including electrically induced ventricular fibrillation (VF) and AF.
In 1899, physiologists Prevost and Batelli at the University of Geneva reported the first application of experimental defibrillation in a footnote of a paper on VF initiation by faradization.
Prevost and Batelli used a capacitor discharge in the range of 2,400-4,800 V, delivered along
a vector from the small intestine to the mouth, to defibrillate a canine [146]. Regrettably
this important observation went largely unnoticed for a number of years because it remained
unlinked to a clinical need. Defibrillation gained relevance only when electricity companies
like Consolidated Edison and Bell Telephone Laboratories o↵ered funding for research on
electrocution to protect their workers [20], and doctors, whose patients were accidentally
overdosed on anesthetics, began looking for ways to revive them [3].
Geographical Divides
At this point in history the development of defibrillation diverges geographically. For many
years there are simultaneous, isolated experiments conducted in the Western world and the
Soviet Union, both of which contribute to the current state of defibrillation.
In America, William Kouwenhoven and physicians at Johns Hopkins University conducted
experiments delivering alternating current (AC) to electrodes in direct contact with the
canine myocardium to induce fibrillation. An accidental second shock arrested the fibrillation
and reproduced Prevost and Batelli’s successful defibrillation results. The American group
then systematically investigated the e↵ects of the strength (2,200V, 0.4-8A) and duration
(0.1-5s) of applying 60Hz AC to canine hearts in fibrillation [85]. These experiments were
conducted with transthoracic and epicardial electrodes, and concluded that transthoracic
defibrillation required 5 times the current as epicardial defibrillation. They also tested the
e↵ects of the size of the electrodes on defibrillation success. Another American group, Ferris,
King, Spence, and Williams, compared 60Hz AC, 25Hz AC and direct current (DC) and
found that 60HZ required the least current [55]. However, they were testing long duration
shocks of >1s. They hypothesized that there was no di↵erence in defibrillation threshold
(DFT) for shorter shocks, without performing the study. This oversight may be why AC
shocks persisted much longer in the West. In the 1930s, defibrillation failed to restore sinus
rhythm in 40-50% of the animal experiments in which it was performed. Carl Wiggers from
Western Reserve University investigated the causes behind this high rate of defibrillation
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failure. He meticulously described the compounding e↵ects of VF-induced ischemia on the
ability to defibrillate successfully, emphasizing the importance of early delivery. Wiggers
also observed that a very brief and strong countershock was most successful and introduced
an idea he called serial defibrillation, which delivered a series of 3-7 weaker AC shocks with
a 1-2s interval between shocks [190].
In Russia the two critical players are Lina Shtern and her graduate student Naum Gurvich.
In 1939, Gurvich published results on the superiority of monophasic DC shocks over the
traditional AC, delivering shocks in a range from 2,000 to 6,000V [72, 71]. DC provided
safety advantages as well as a decreased risk of re-induction. The Russian group found
more pronounced shock-induced mechanical stunning after exposure to AC compared to
DC [69]. Gurvich also increased the complexity of the capacitor circuit used to deliver the
transthoracic shock by adding an in-line inductor. The circuit, waveforms, and the device
that Gurvich used are shown in Figure 1.2 [72, 71]. This design was the first significant step in
waveform optimization to reduce the DFT and cardiac damage associated with strong electric
shocks. Improving the circuit in this way dispersed the energy better in time, decreasing the
peak current and lengthening the duration.
(c)

(a)

(b)

Figure 1.2: Naum Gurvich’s Impulse Defibrillator. a) Capacitor-inductor circuit implemented to create a biphasic dc discharge, b) the various waveforms used in animal experiments, and c) the transthoracic biphasic defibrillator built in 1962. All panels adapted from
[69].
Claude Beck and his team from Western Reserve University were the first to successfully
apply defibrillation in a patient in 1946 [20]. When conducting a thoracic surgical procedure
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on a 14-year-old boy, the patient’s heart began to fibrillate. Since Beck already had direct
access to the heart, he borrowed a system from the research lab down the hall and applied
110V, 1.5A AC shock, after using an ECG to confirm VF. He did not include the duration
of the shock in his case report. Upon delivery of the second shock, the heart returned to a
fast but regular rhythm and the patient made a full recovery. In 1956, Paul Zoll expanded
the successful clinical use of defibrillation to include transthoracic application on humans
with 710V, 15A AC for 0.15s [211]. The widespread use of electrocardiography provided
a method to confirm VF as well as a way to confirm successful defibrillation. The data
associated with repeated successes would promote the public perception of defibrillation as
a viable therapeutic option instead of repeating the earlier 18th and 19th century failed
attempts for legitimacy and acceptance.
With a proven clinical application, the question began to change from “can we defibrillate?”
to “how can we defibrillate better?” Defibrillation research entered an era of incremental
optimizations of the shock waveform. American researchers finally caught up to the Soviet
research, confirming that DC was superior to AC shock. Bernard Lown led the investigations
in the United States reaching the same conclusion that using an inductor to attenuate the
capacitor discharge was necessary to limit myocardial damage [118]. He proposed the Lown
waveform, an underdamped impulse with duration of 2.5ms for clinical use to reduce rise time
and pulse duration. Lown also published his ideal circuit components: a capacitance of 16µF
and an inductance of 100mH to allow for widespread replication of his results [117]. Bohumil
Peleska (Czechoslovakia) conducted rigorous instrumentation evaluations to minimize peak
voltage and current as well as minimize total energy [143]. These two goals remain the
principle aim of current defibrillation development. John Schuder from the University of
Missouri at Columbia introduced the idea of short-circuiting the capacitor after a time delay
to remove the low voltage decreasing exponential tail after observing that it could re-induce
fibrillation [159]. The truncated exponential pulse waveform gained popularity because the
relatively simple circuit lent itself to implementation of a fully implantable, automated,
catheter-based defibrillator conceived independently by both Schuder [158] and Mirowski
[128] in 1970 and successfully implanted in the first human patient by Mirowski in 1980
[129].
Theory Shapes Therapy
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Defibrillation is not a therapy that was born out of a strong biophysical foundation. The
mechanistic studies trailed far behind the empirical clinical use of the tool. Investigations
into the interaction between tissue and applied electrical shocks were hindered by limitations
in available recording instrumentation. Consequently, the precise physiological mechanism
of the electrical requirements for successful defibrillation proved to be a complex problem
to answer. Across decades the principle hypotheses have been shifting and sometimes even
contradictory.
The original motivation behind applying a shock across the heart, based solely on observing
mechanical contractions, was to incapacitate or stun the tissue. The temporary stunning
hypothetically allowed the heart time to “reset”. Gurvich was the first to propose that
the shock actually stimulated the heart [69] but even this description did not o↵er a lot of
guidance for designing an optimal shock delivery system. Traditionally, defibrillator design
has been driven by the need to simplify and minimize the circuitry necessary to provide
a relatively safe shock that can achieve high shock strength above the DFT. Investigating
factors that influence the DFT or proposing hypotheses to improve defibrillation efficacy
based on biophysical mechanisms is a relatively new endeavor in the field [70].
The main premise of the early electrophysiological theories was that the electric field produced by the shock needed to be strong enough to stimulate the entire myocardium, including
regions in various states of repolarization and refractoriness. This theory of total extinction
states that only a homogenous depolarization interrupted the fibrillatory patterns and reset
the tissue [85]. Some researchers amended this theory asserting that it was sufficient to capture enough tissue to halt all activation fronts, which did not necessarily include the entire
excitable myocardium [190]. From this idea the critical mass (CM) hypothesis was formed.
The CM hypothesis began as an investigation into the mechanism of maintaining continuous
fibrillation but was quickly applied to achieving successful defibrillation as well. Early 20th
century experiments at Washington University in Saint Louis led Garrey to postulate that
the inducibility and continuation of VF was related to the mass of myocardium [62]. In 1975,
Douglas Zipes presented experimental evidence in support for this theory as it applied to
chemical defibrillation mechanisms. By selectively depolarizing regions of tissue chemically,
Zipes demonstrated that a CM of myocardium could maintain VF and lead to defibrillation failure [210]. Correspondingly, a shock could succeed if it interrupted enough activation

13

fronts to isolate the patterns to small regions below the CM. Any remaining activation fronts
would then self-terminate, leading to successful restoration of sinus rhythm.
Another theory born of the same early concept is the extension of refractoriness. This idea
suggested that an applied shock uniformly extended the refractory period of the captured
tissue. Extending action potential durations across the tissue resulted in simultaneous recovery, which wipes away the “memory” of the fibrillatory waves maintaining the arrhythmia
[169]. Alternatively, the theory of upper limit of vulnerability [53, 34] supported the idea that
regions of weak potential gradient were critical to providing a source for maintaining a large
enough area for early activation and the continuation of fibrillation. Although these theories
are not necessarily mutually exclusive, they did lead to di↵erent ideas of how to optimize
defibrillation. Several groups designed defibrillation schemes and new lead configurations to
target areas of low potential gradient after shock delivery or to reach the CM necessary for
success [91, 187, 38]. Both of these theories supported the claim that high voltage shocks
were necessary for success. However, as evidence emerged to support a delicate balance
between defibrillation and myocardial damage, scientists began to look for new ways to decrease the energy required for success. Shock strength is also positively correlated with the
perception of pain, which can be severe for shocks of defibrillation strength. The potential
risk of myocardial damage and the pain, both physical and psychological, associated with
implantable devices has driven research for lower energy defibrillation schemes.
In the 1980s and 1990s, empirical studies began to emerge, supporting the idea that Gurvich’s biphasic damped sine waveform and other biphasic waveforms were superior over
monophasic pulses [87, 179, 199]. As high-power amplifier designs improved, new waveform shapes could be easily implemented in research environments; rectilinear, triangular,
trapezoidal, and triphasic waveforms were tested [87, 179, 193, 86, 154]. Scientists began to
probe the response to applied shocks at various scales, especially with computational studies.
Using resistor-capacitor simulations to model the cardiac cell membrane’s response to applied shocks, several groups demonstrated a shape dependence on efficient delivery of energy
[88, 135, 147], which was supported by empirical observations. Based on these predictions
the truncated biphasic exponential waveform delivers energy inefficiently due to the time
constant of the cell and an ascending trapezoidal waveform has the lowest theoretical DFT.
Years later, the ascending waveform would also be shown to cause less damage independently
of the decrease in efficacy [88].
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Still, further advances required a more in-depth understanding of the mechanism of defibrillation failure. Fortunately, two new scientific research methodologies were introduced that
revolutionized the field’s ability to study cardiac stimulation mechanistically and with high
resolution. The first was a computational approach called the bidomain model [173]; the
second was an experimental technique using fluorescent voltage-sensitive dyes embedded in
the membrane called optical mapping [134]. Optical mapping (which will be discussed in
detail in Chapter 2) allows for the uninterrupted exclusive visualization of the electrical activity of the tissue before, during, and immediately after the shock application. The path
of current from an externally applied field flows through the extracellular and intracellular
subdomains of the myocardium di↵erently, creating voltage gradients that result in changes
in transmembrane potentials. The transmembrane changes are the driving forces of the
shock-induced restoration of sinus rhythm through initiated wavefronts. Membrane potential dyes measure the electrical activity with specificity for the signal that is mechanistically
determining a successful defibrillation that cannot be achieved with extracellular electrodes.
Optical mapping and bidomain models target both root causes of the failure of defibrillation:
1) the persistence of pre-shock fibrillatory waves and 2) successful defibrillation followed by
re-initiation of new shock-induced wavefronts.
Both these concepts are integral in supporting a new hypothesis that emerged describing
the transmembrane response to applied stimulation. This new theoretical hypothesis, called
the virtual electrode polarization (VEP) theory, transformed the direction of defibrillation
research [149, 48]. The theory states: the external application of an electric field induces
regional polarizations known as the virtual cathodes and virtual anodes, often opposing
the regions of structural or functional heterogeneity. As a secondary e↵ect, new wavefronts
and phase singularities can be initiated from these regions that can lead to defibrillation
failure [49]. The theoretical foundation of this idea was formulated by Sobie et al., which
was termed the “generalized activating function” [166]. The generalized activating function
shows mathematically how a combination of field gradients, underlying heterogeneities in
refractoriness and anatomical discontinuities in conduction properties can create neighboring
regions of virtual anodes and cathodes, which simultaneously hyperpolarize and depolarize
di↵erent regions of tissue. This shock-induced di↵erence in the excitability of the tissue can
form secondary sources and induce new fibrillatory wavefronts. The landmark implication of
this new theory was that defibrillation efficacy was not only dependent on the properties of
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the electric field but also on the intrinsic properties of the tissue structure and conductivity
in a predictable fashion.
A critical computational study discovered that unequal anisotropy in tissue conduction results in a complex spatial dependence of potential distribution in response to large currents,
which influences the location and the shape of the virtual electrodes [162]. Using cellular
monolayers with patterned regions of discontinuity in the conduction properties, researchers
were able to demonstrate how virtual electrode shapes and positions were predictably dependent on shock polarity [188]. The spatial regions of hyperpolarization and depolarization
mirrored each other with reversed polarity.
(a)

(b)

Figure 1.3: Schematic of Virtual Electrode Polarization Theory of Anodal vs. Cathodal
Shocks. a) Post-shock activation of an anodal shock. b) Post-shock activation of a cathodal
shock, which is more likely to sustain reentry. Modified from [207]
Additional studies showed that the chirality of the VEP-induced reentrant path could be
predicted from the postshock VEP pattern as the wavefront moves into the de-excited region
[35]. Combining the research of polarity dependent spatial patterns of secondary sources
and the reentry chirality dependence, optical mapping experiments were used to explain the
mechanism for monophasic anodal shock superiority compared to cathodal shocks [207]. The
VEP distribution after anodal shocks behaves like a sink; with the induced pathways traveling
inward and colliding with each other to self terminate any shock-induced wavefronts. The
VEP distribution of cathodal shocks behaves more like a source, leaving more spatial room
to develop into a sustainable reentrant wave. In Figure 1.3 [207], panel a illustrates the
sink phenomenon of anodal shocks with a schematic drawing showing a simple VEP pattern
and the crowded inward propagation that is more difficult for a reentrant path to escape.
Alternatively panel b shows the source behavior of cathodal shocks, illustrating the space
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that the virtual anodes provide for a reentrant path to thrive and direct propagation outward
to the excitable regions. The pattern in the schematic also shows how phase singularities
(represented by solid black circles) can arise at the transition between the virtual electrodes
with opposing polarity. In this hypothetical case, the cathodal shock induces quatrefoil
reentry. The conduction velocity of the induced reentry is also dependent on the degree of
polarization in the virtual anode; a more negative polarization increases conduction velocity.
If the conduction is fast enough, the propagating wave will hit a line of conduction block
before this tissue can recovery and an induced wavefront with self- terminate.
Furthermore, optical mapping helped reveal the mechanism behind the empirical observation
that biphasic shocks were superior compared to monophasic shocks. Biphasic shocks immediately reverse the polarity and distribution of the virtual electrodes, greatly decreasing the
heterogeneity in the post-shock tissue response. The mirrored VEP pattern also removes
the excitable de-excited tissue, reducing the risk of VEP-induced phase singularities [49].
Empirical studies have demonstrated a low DFT for ascending waveforms. Mechanistically
this is because the ascending VEP pattern achieves a greater degree of polarization, leading to a faster conduction velocity and an induced wavefront that is more susceptible to
self-termination.
VEP is the most comprehensive theory describing the cardiac response to applied electric
fields. It has successfully predicted a wide range of observable phenomena. Due to the diversity of arrhythmia properties, and the clear indication that DFT is dependent on intrinsic
tissue conditions, it may be time for a shift in the energy delivery paradigm. The clinical
field has not been quick to adopt new defibrillation strategies. Even small but powerful
increments such as switching to a biphasic waveform, faced opposition to incorporation into
clinical devices [198]. New methodologies that require a substantial shift in strategy also
require significant redesigns of circuitry and therefore, the reduction in voltage and energy
must be equally considerable without loss of safety to merit redesigns.
That is not to say that there has been no progression in implantable devices since the switch
to biphasic waveforms. Clinical improvements have focused on sensing algorithms, programmability, battery miniaturization, and lead development with great success [74]. Shock
delivery in both internal and external defibrillation has recently been improved by incorporating impedance compensation into the shape algorithm [94, 113]. Although simple in
17

concept, the idea of altering the waveform to provide more consistent current delivery was
the first step in patient-tailored defibrillation strategies. By exploiting the shock-induced
heterogeneities predicted by the VEP theory, we may be able to design patient-specific
electrotherapies that are gentler than the gold standard approach. Continuous new advancements in monitoring and data acquisition techniques have shaped and will continue to shape
the resolution and scale at which scientists can probe the state of cardiac tissue. These advances will continue to drive the mechanistic understanding of defibrillation to new depths
and propel new innovations in the implementation of defibrillation. In the words of VicePresident Hubert Humphrey, who was responsible for eventually bridging the geopolitical
divide between Soviet and American defibrillation groups, research on defibrillation can be
described as “at least a partial conquest of death. . . [it is] the oldest category in the worldbut one which commands our newest e↵orts” [89].

1.3

Shift to Low Voltage Defibrillation for Atrial Fibrillation

After the success of implanted devices for VF, researchers applied similar devices to the
treatment of AF with shocks of similar magnitude. These devices, known as implanted
atrial cardioverters (IAC), overlooked an important design consideration that di↵ers from
VF. Patients in AF are hemodynamically stable and therefore conscious when an implanted
device responds with a high voltage shock. Initial clinical trials of early IAC devices indicated
that they had high specificity and sensitivity to AF detection and delivered e↵ective shock
therapy [157]. However, they did not gain patient acceptance, primarily due to the fact that
the energy level needed to achieve cardioversion by a single biphasic intracardiac shock was 13 J, which exceeded the pain threshold [130]. Murgatroyd and Camm reported that patients
required sedation for shocks >1.1J [137]. The fear, anxiety, and psychiatric complications
associated with the painful shocks severely a↵ected patient quality of life [58].
A retrospective study conducted on 119 patients with IACs found severe descriptions of the
perception of a shock including “a knife to the heart”, “being hit by a truck,” or “being kicked
by a mule.” In this study 23% constantly dreaded the shock, and 5% admitted that they
would rather take their chances with the IAC removed [5]. Moreover, current electrotherapies
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are not entirely innocuous; many studies have demonstrated evidence of myocardial damage
as a direct result of the application of high-energy shocks including the generation of free
radicals, morphological destruction, and functional impairment [50, 32, 17]. In all of these
studies the degree of damage was positively correlated with shock strength [205]. Several
clinical trials have shown that patients with an implanted cardiac defibrillator who received
either appropriate or inappropriate shocks have an increased risk of mortality compared to
those that received no shock [145, 155]. This risk has also been shown to increase with the
number of shocks received.
Since the biphasic capacitor discharge waveform has been incrementally optimized since
its establishment in the field, it is unlikely that significant further DFT reduction can be
achieved if the waveform is constrained to this traditional single shock premise. Thus,
there is an acute need to explore novel physiological mechanisms, biophysical methods and
engineering approaches for low energy internal atrial defibrillation to transition away from a
one-size-fits-all approach [44]. Some reports suggest that high peak energy is more harmful
than high cumulative energy [167]; therefore dispersing energy across a sequence of shocks
may be the best option for reaching towards a tolerable pain and damage-free therapy.
For over a decade, a primary initiative of the Efimov lab has been to explore a physiological
basis for a painless defibrillation strategy. The work in this dissertation builds upon previous
work and continues to use the VEP hypothesis to shape shock delivery. Initial studies were
based on highly organized arrhythmias (i.e. substrate based ventricular tachycardia or AFl)
and the concepts gleaned have been applied to increasingly more chaotic arrhythmias. The
first pivotal study observed that the shock-induced VEP pattern has a phase dependence
[150, 112]. When properly timed with respect to the activation wavefront, the heterogeneous
response can be taken advantage of to dramatically lower DFT [112, 12]. Since it was not
straightforward to predict the ideal phase, the therapy was adapted to include multiple low
voltage pulses across 1 cycle of ventricular tachycardia. Additional studies demonstrated
that multiple closely timed shocks (within 1-2 cycles of arrhythmia) terminate AFl/AF with
significantly lower energy than a single shock in an ex vivo rabbit model of Acetylcholineinduced AF [12]. This idea advanced from multiple shocks to a multiple-stage electrotherapy
(MSE), which had a markedly decreased DFT compared to a single biphasic shock in an acute
model of AF in an open-chest canine model. The feasibility of delivering the MSE from a
traditional lead based approach was confirmed in a closed chest model of self-sustaining AF
19

in a canine model [90]. Figure 1.4 summarizes the results from the in vivo delivery of the
MSE compared to a single biphasic shock (BPS). MSE significantly reduced the total energy
(0.16 ±0.16 J vs. 1.48 ±0.91 J) and the peak shock voltage (31.1 ±19.3 V vs. 165 ± 34 V).
More details on MSE and this study will be discussed in Chapter 5.

Peak Voltage (V)

(a)

Peak Voltage (V)

(b)

Figure 1.4: Summary of Multi-Stage Electrotherapy Results in Chronic Canine Model. Summary of in vivo atrial DFTs (n = 8) for BPS versus MSE. The peak shock voltage represents
the maximum leading-edge voltage required for cardioversion by BPS or Stage 1 of MSE.
The total energy represents the sum of the energy of all stages of each therapy. Values are
mean +/- SE in a) and median +/- quartiles in b). Modified from [90]
The lab has primarily focused on creating a sequence based on the temporal frequency of
electrical stimulation. However, the spatial dispersion of applied energy has also been known
to have a significant impact on defibrillation efficacy for nearly 40 years when Tsukerman
et al. first described a rotating current field [172]. Then in the late 1980s and early 1990s
there was a large push in the field to investigate new lead configurations for both atrial
[38] and ventricular arrhythmias [95, 187]. Many of these studies focused on an orthogonal
dual current path designed to target areas with low potential gradients after the first shock
was applied, in order to achieve near uniform dispersion of applied current densities. These
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studies achieved remarkable DFT reductions; however, it was still not enough to restore
sinus rhythm painlessly. We believe there is room to further the understanding of how the
direction of the electric field interacts with the anatomical and functional geometry of the
heart. Studies have shown a clear directional sensitivity to applied electric fields on isolated
single cells, where an electric field parallel to the cellular axis was superior to an electric field
applied perpendicularly [174]. The organization of fibers and gap junctions on the tissue level
complicates this correlation but it still supports the claim that di↵erent vectors may engage
di↵erent tissue layers/regions. The increased disorder of AF and dispersion of functional
and structural heterogeneities in the tissue might require several “optimal” vectors in order
to target the applied electric field to the sources.

1.4

Scope of Dissertation

In this dissertation I aim to address the limitations of current AF electrotherapy by diverging
from the traditional circuits driven approach. My central objective is to work towards the
design of physiologically directed applied energy protocols for AF termination that are gentle
on the heart. Such an approach relies on extracting detailed spatiotemporal organization of
AF drivers from the chaotic electrical activity and exploiting the physiological tissue response
to applied electrical shocks described by the virtual electrode hypothesis. In this dissertation
I use novel optical imaging techniques and implement signal processing algorithms on a
diverse array of AF animal models to characterize the spatiotemporal dynamics of AF before,
during, and immediately following high voltage shock delivery. I designed and tested the
efficacy of strategies targeting arrhythmias in both the temporal and spatial domain. I also
developed a platform of novel instrumentation to address the lack of feedback information
available to assess the immediate tissue damage incurred from a shock to further guide future
therapy development. In Chapter 2, I present the disease models, experimental techniques
and processing algorithms used to conduct the studies included in this dissertation. Chapter
3 follows with a study characterizing the discordance of AF dynamics across the transmural
wall in an acute model of AF. In Chapter 4, I apply the same techniques to compare the
transmural AF dynamics in another animal model and investigate the presence of structural
discontinuities that can harbor 3D substrates in the atria. In Chapter 5, I present the
evolution of the multi-stage electrotherapy including the incorporation of spatial rotation
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patterns. I explore empirical reductions in DFT in two models. Finally in Chapter 6, I
introduce the design and application of a stretchable electronics platform that conforms to
the heart with a unique array of sensors that can assess local markers of tissue damage.
Each sensor used to investigate the interplay of electrical, mechanical and energetic shock
responses is accompanied with a feasibility study in an appropriate model.
It is my hope that these studies will help lead to the convergence of a successful defibrillation
threshold and the pain threshold so that IAC can become a viable option to treat AF and
prevent advanced remodeling. I also hope to enhance our understanding of the dynamic
interaction of wavefronts that leads to termination and continue transforming the field of
defibrillation into one driven by biophysics. The novel stretchable electronics platform developed and validated as part of this project revolutionizes the amount of spatial information
we can gather on the e↵ects of defibrillation shocks on tissue. By combining a spatial analysis
of the arrhythmia drivers, the energy delivered and the resulting damage I hope to enhance
the biophysical understanding of AF electrical cardioversion and design an ideal targeted
energy delivery protocol to improve upon all limitations of current electrotherapy.
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Chapter 2
Methods
Portions of this chapter appear in the following original publications:
Meyers J, Gutbrod SR, and Efimov IR. ”Tachycardia Termination by Shocks and Pacing.”
Clinical Cardiac Pacing, Defibrillation, and Resynchronization Therapy. 5th Edition.
Editors; Ellenbogen KA, Wilko↵ BL, Lau CP, Auricchio A, Neal Kay G. Elsevier Health
Sciences, 2015. Ahead of Print

There are many studies that speak to the diversity of clinical arrhythmias and it is a difficult
task to replicate the pathological substrate of AF in an experimental model. Clinically, AF is
delineated by its longevity, ranging from paroxysmal to long-standing persistent. However,
a new study implies a level of uncertainty in the traditional view of the AF burden [122].
Additionally, new discordance has arisen in the field about whether all AF is a progressive
disease, continually remodeling to better preserve the arrhythmogenic substrate or if the
concept of “AF begets AF” represents only a subset of clinical episodes [191]. Where AF
is progressive, the remodeling a↵ects many facets of atrial function including electrical and
structural changes. Moreover, the changes occur along di↵erent time scales. Electrically,
there are changes in the ionic balance and the inter-cell connectivity, manifesting in APD
reduction, loss of rate adaptation and conduction slowing. Structurally, atrial tissue in AF
is marked by increased cell size, myolysis, glycogen accumulation, increased fibrosis and
a heterogeneous distribution of gap junctions. Some researchers have speculated that the
structural remodeling is an adverse e↵ect of high metabolic stress from sustained rapid
contraction but the full mechanism remains unknown [9]. Consequently, it is difficult to
recapitulate the spectrum of clinical AF conditions in a single model.
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2.1

Animal Models
1.5μM Acetylcholine
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Figure 2.1: E↵ect of Acetylcholine on Action Potential Duration in Ovine Model. The
reduction in APD increases the vulnerability to arrhythmia induction.
The experiments presented in this dissertation were conducted on a variety of di↵erent
animal models of AF including rabbit, canine, and sheep. The rabbit is the best choice
for feasibility investigations, and technology development because the cost is low, the size
is ideal for whole heart optical imaging and the atrial tissue can more appropriately be
approximated as 2D due to smaller tissue thickness. In parallel, the large animal models are
used to test efficacy of our novel electrotherapy paradigms and signal processing techniques
because these models are more accurate representations of human anatomy and physiology.
Some of the models are acute, using pharmacological agents or elevated pressures to acutely
decrease the action potential duration (APD) and artificially provide room for a sustained
arrhythmia in otherwise healthy tissue (see Figure 2.1 for example APD after Acetylcholine).
In contrast, some of the studies are conducted on chronic models that incorporate time for
progressive pathological remodeling and spontaneous AF initiation. All animal experiments
presented within this dissertation have been approved by one of two institutional boards,
depending on where the experiments were conducted. Those that were conducted in St Louis
were approved by the Washington University Animal Studies Committee and those that were
conducted in Bordeaux were approved by the Université de Bordeaux ethical committee.
Acute Animal Models
The acute AF rabbit model is a whole heart Langendor↵ perfused model with pressure-loaded
atria, originally developed by the Allessie group [50]. The pulmonary artery is cannulated
and connected to a pressure column of 10-15 cm H2 O. The pulmonary and caval veins are
ligated and the interatrial septum is perforated to create a single pressurized atrial chamber.
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Theoretically the elevated pressure activates stretch-sensitive receptors to provide transient
electrical alternations to the APD. A shortened APD combined with the obvious dilation of
the atria in this model (shown in Figure 2.2) provides more “elbow-room” for a sustained
arrhythmia. AF is induced using programmed stimulation of an extra beat or 100 cycles of
50 Hz burst pacing. We have used this model to empirically test the temporal parameters
of the first generation MSET, the e↵ects of cycle length on efficacy of AF defibrillation, and
optimize the hardware necessary for spatial patterns. Based on the LA bipolar electrogram
recordings, this model had a dominant frequency (DF) that ranged from 11.96 to 20.75 Hz
with a sample mean of 15.54 Hz.
Aorta
Pulmonary
Artery

Loaded 10-15 cm H2O atria

Unloaded atria
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Figure 2.2: Acute Rabbit Model of Atrial Fibrillation. The left panel displays the unloaded
atria. The right panel shows the increase in surface area of the inflated atria. An example
electrogram from an induced AF episode is also displayed.
The acute AF ovine model is based on artificially increasing the vagal tone in an isolated
left atrial preparation. The whole heart is explanted and retrogradely perfused with cold
cardioplegia. The left coronary artery is cannulated for perfusion. Under constant perfusion
of cold cardioplegia the right atria and the ventricles below the main branch of the circumflex
artery are removed by gross dissection. All vessel branches leading to the ventricles and right
atrium were ligated. The preparation is flattened by opening the right superior pulmonary
vein. Figure 2.3 shows a representative example of the preparation and the distribution of
frequency content for 75 episodes in this model. AF is induced by adding 0.2µM -10µM
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Acetylcholine to the perfusate and using 1 second of 50Hz burst pacing delivered to either
the epicardium or the exposed endocardium. Acetylcholine suppresses automaticity and
shortens the APD by binding to muscarinic receptors and acetylcholine activated potassium
channels. Many studies have suggested that this model induces reentrant AF. The transient
substrate is formed by Acetylcholine-induced spatial heterogeneity in repolarization. The
burst pacing provides the trigger. AF episodes induced in this model had a DF ranging from
3.897 ± 0.48 to 10.03 ± 2.88 Hz with a sample mean of 7.21 Hz. AF was maintained by
1-10 transient rotors, with at least 1 rotor present an average of 70% of the time signals were
recorded.
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Figure 2.3: Acute Ovine Model of Atrial Fibrillation. The epicardial and endocardial field
of view is displayed once the preparation is isolated and stretched on the frame. The distribution of frequency contact displays the range of AF episodes that can be induced by tuning
the amount of Acetylcholine.
The canine acute AF model is similar to the sheep except that this preparation includes
both atria. After explant the ventricles are removed and all vessel branches leading to the
ventricles are tied o↵. The tissue is dual perfused through cannulas in the left and right
coronary arteries. The right atrium is flattened by an incision along the vena cava and
the left atrium is opened along the right superior pulmonary vein. Figure 2.4 shows a
representative example of the preparation. The distribution of frequency content from 34
episodes is also included in the figure. AF is induced by adding 0.5µM -1.0µM Acetylcholine
to the perfusate and using 1 second of 50Hz burst pacing. AF episodes induced in this model
had a DF ranging from 5.13 Hz - 10.28 Hz and an RI ranging from 0.11 - 0.71.
Chronic Animal Models
The chronic model of AF in this dissertation is a canine tachy-paced model first described
in the goat by Allessie [191]. The animals are implanted with commercial devices with the
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Figure 2.4: Acute Canine Model of Atrial Fibrillation. The distribution of frequency content
highlights the range of AF episodes that can be tuned by the amount of Acetylcholine.
ability to pace continuously at a high pacing rate. We used Medtronic CRT Maximo devices
with the addition of a custom software high rate pacing option. The pacing lead (Medtronic
5096) is placed through the right external jugular vein in the right atrial appendage. The
animal is allowed to recover for at least 1 week before continuous atrial pacing at 400 bpm is
initiated for 6-8 weeks. E↵ective refractory period remodeling was observed a couple of weeks
before spontaneous AF. Weekly interrogations are performed until AF is sustained for >30
mins. Digoxin is administered (0.25 mg/kg-0.5 mg/kg) if the ventricular rate exceeds 130
bpm with high rate pacing (HRP). This model is used for both in vivo DFT experiments as
well as ex vivo optical mapping experiments. The tissue preparation for the optical mapping
is the same as the acute canine model without the addition of Acetylcholine. The chronic
nature of this model promotes increased heterogeneity of the electrophysiological properties
over time, and in turn, alters the AF circuits. Previous studies have demonstrated that
rapid-pacing induced AF has reduced L-type calcium current and intracellular Ca+2 overload, which manifest as a shortened APD and a loss of rate adaptation. The potassium
channel function is also altered, with spontaneous Ik,ach opening and reduced Ito current.
Structurally, rapid-pacing induced AF leads to an accumulation of glycogen, and a redistribution of gap junction connexins. Interstitial fibrosis development is a major architectural
change in clinical AF and although some studies have suggested a mild increase in fibrosis
with this model, it does not replicate the clinical level of fibrosis [141].
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2.2

Optical Mapping

Optical mapping is a critical experimental technique used to study electrophysiology and the
biophysical mechanisms of electrotherapy. Membrane bound potentiometric dyes translate
the intrinsic electrical signal carried by ions into an optical signal that can be collected with
photodetectors. Dye molecules embedded within the membrane of cardiomyocytes emit a
fluorescent signal with an emission profile that is dependent on the membrane potential.
When the membrane potential changes (i.e. during an action potential), the dynamic wavelength of the emitted light can be recorded as a loss in fluorescence with appropriate filter
settings on the acquisition hardware. Filters are specific for particular dyes (e.g. excitation 520 ± 20nm and emission >650 nm for di-4-ANEPPS). The change in emitted light is
linearly related to the membrane potential, which enables the recording of “optical action
potentials”. The mechanism is illustrated in Figure 2.5. The number of myocytes that give
rise to an optical action potential signal depends on the dye, the optical magnification, the
focal plane and the pixel size of the sensor that is used for recording. Based on the interaction of these parameters an optical action potential is a representation of a depth-averaged
transmembrane potential.
Before the development of this technique, investigators were hindered by limitations in available recording instrumentation. No other technique o↵ers large spatial coverage and fine resolution in both the spatial and temporal domain. Additionally, electrical shocks of defibrillation strength produce large artifacts in signals recorded with extracellular and intracellular
electrodes. These artifacts overwhelm all intrinsic electrical activity in the presence of the
applied electric field and blind investigators to the immediate post-shock tissue interactions.
The polarization of the electrodes delays the recovery of the recording integrity even after
the shock is completely delivered. Some researchers developed creative attempts to minimize
the time that the electrical signal is overloaded, including using a non-polarizable reference
electrode (only useful if both the tissue and the field are uniform) or by switching amplifier
gains or connectivity on the acquisition systems during shock delivery [33]. These techniques
decreased the recovery lapse in recording time down to as low as 20ms. Unfortunately, this is
still too long to observe the immediate tissue response to the shock. The translated optical
signal is isolated from the applied electric field but reflects the tissue’s response.
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Figure 2.5: Mechanism of Voltage Sensitive Dyes. The fractional fluorescence that is measured by the CMOS camera is a function of a conformational change in the dye in response
to a change in membrane potential that shifts the emission spectrum.
Optical mapping allows for the uninterrupted visualization of the electrical activity of the
tissue before, during, and immediately after the shock application. Figure 2.6 shows an
example of this phenomenon from an ex vivo rabbit heart study. The optical and electrical
signals are recorded simultaneously when the shock is delivered at the lightning bolt. Both
the local bipolar electrogram in contact with the tissue and the far field bath electrode require >1000ms to recover with this instrumentation amplifier. Meanwhile the immediate
shock-induced depolarization is visible in the optical signal morphology as well as the quiescent delay until the arrhythmia resumes. With advances in optical sensors and custom dye
properties, optical mapping has become a dominant driving force of cardiac electrophysiology
research and was used in every stage of this dissertation.
A Micam ULTIMA single or dual system with 100 x 100 pixel CMOS sensors was used for
voltage-sensitive mapping in all experiments. Optical signals are recorded for 1-8 seconds
at a sampling frequency of 1kHz. Two di↵erent voltage sensitive dyes and filter settings
were used depending on the experimental objectives. For deep penetration experiments di4ANBDQBS was used with 660nm excitation. For superficial surface mapping experiments
di-4ANEPPS was chosen with 520nm excitation. Muscle contractions can lead to changes
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Figure 2.6: Simultaneous Optical and Electrical Recordings during an Applied Shock. This
example highlights the advantage of optical mapping during defibrillation delivery as the
integrity of the signal is not compromised like the electrograms.
in emission intensity unrelated to electrical activity. To remove motion artifacts the tissue is pharmacologically uncoupled prior to acquisition. We used Blebbistatin to uncouple
the mechanical contractions. Blebbistatin is a cell membrane permeable myosin II ATPase
inhibitor. Myosin is an essential component in the cardiac contraction machinery, which
crosslinks with actin to generate force. Once bound, blebbistatin inhibits myosin binding to
actin by preventing the phosphate release and keeping the myosin in a state with low affinity for actin [104]. It is important to note that while necessary for the acquisition of clean
optical signals, adding Blebbistatin does alter the energetic state of the myocardium. This
is an important limitation to all optical mapping that must be acknowledged. Adaptations
of the technique that are specific to each project and the details of the methodology will
be addressed in each individual chapter. A detailed protocol for rabbit optical mapping is
included in Appendix C.
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2.3

Signal Processing of Arrhythmias

Optical mapping provides excellent signal quality and spatial coverage. However, the complex and polymorphic nature of arrhythmias makes a quantitative analysis of the spatial
map of signals remarkably challenging. The goal of signal processing algorithms is to extract
underlying organization out of seemingly chaotic propagation and expose spatiotemporal
patterns in the recorded potential signals. If the behavior is organized on some level then it
may be possible to identify zones critical to fibrillation perpetuation that can serve as targets
for intervention. It is important to note that recorded signals provide a short glimpse into an
arrhythmia that may persist for months (e.g. persistent AF). The algorithm must have high
sensitivity to any degree of spatiotemporal organization captured within the brief recording interval. Although this dissertation focuses primarily on optical signals, this chapter
considers the challenges of algorithms for both electrical and optical recordings.
The most direct approach to quantifying the primary propagation pattern is to examine
a spatial map of activation times. Activation maps identify the origin of a beat as well as
regions of concurrent activation, which illustrate the spread of propagation. Activation is defined as the maximum negative derivative in a unipolar electrogram or the maximum derivative of an optical upstroke. Although easily applied to paced rhythms or simple tachycardias,
identifying activation time is a difficult task during AF when there are multiple simultaneous
wavefronts dynamically colliding and altering the local signal morphology, along with other
variables including structural interference and signal artifacts. Several algorithms implement
interpolation or data fit techniques to compensate for the diversity in signal morphology and
improve the accuracy of extracting activation time [24]. Even though these algorithms were
tested in the best-case scenario (i.e. healthy tissue) it was still computationally intensive to
di↵erentiate the local deflections from distant activity in an automated fashion and they did
not o↵er a method to quantify the stability of such patterns. Healthy tissue is a rare occurrence clinically and fractionated electrograms further complicate the performance of such
algorithms. Bipolar electrograms remove most of the far field signal contributions but introduce a dependence on the orientation of the propagating wavefront. Due to the difficulties
associated with defining activation time and assessing the reproducibility of these patterns
over time, researchers began to look for alternative approaches to identifying spatiotemporal
patterns.
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Spectral analysis is performed in an attempt to discretize regions by the rate of excitation
[21, 165]. This approach decomposes the time series into discrete frequency bands. The
dominant frequency for each time series is ascertained from the power spectrum in the
P
frequency domain: !max s.t|X(!)|2 = n1 | nt=1 e i!t x(t)|2 = maximum. This approach is
appealing because it is less dependent on the peak signal amplitude and therefore less prone to
signal artifacts. However, since each recorded time series is represented by a single parameter,
dominant frequency is a stationary measure of organization. The regularity and organization
index [18, 51] are additional parameters that can be extracted from the power spectrum
to quantify the dominance of a frequency band and attempt to capture the variability of
frequency within the arrhythmia. These two measures quantify how well the signal can be
approximated with a sinusoid of frequency equal to the identified dominant frequency. The
di↵erence between the two parameters is the inclusion or exclusion of harmonic peaks. These
parameters provide a single stationary parameter in time to describe the excitation rate and
the stability of the cycle length and looks for the spatial distribution of those parameters.
There are time scales of organization, many of which are important to understanding the
global architecture of fibrillation. Therefore a steady-state measure of the frequency content
may contain some valuable information about organization but it is not a full representation
of the dynamic nature. The ideal parameter would represent the behavior of the propagating
wavefronts in both the temporal and spatial domain. Some researchers are working on
implementing robust time-frequency analysis methods to look for temporal variations in
dominant frequency [121]. Conduction velocity vector fields are another option to combine
spatiotemporal dynamics. We use these approach throughout this dissertation. However, an
alternative approach exists that has the capacity to look at both the temporal and spatial
domains simultaneously: phase analysis.
Phase analysis was first introduced to the cardiac field through analytical models. Art
Winfree drew an analogy to the way Alan Turing’s theoretical model preceded and guided
the observation of how patterns develop in biology, a theoretical approach to excitable media
directed the interpretation of rotating propagation in fibrillation. In fact, the details on how
to apply this technique directly to experimental observations in a standard manner are still
being worked out. In the 1970s analytical models began to address how to replicate the
spatiotemporal dynamics of chemical waves [195, 196]. This led to developing conditions in
the reaction-di↵usion models that would manifest in stable propagating rotors in excitable
media. The language used to describe this propagation varies within the field including:
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Figure 2.7: Example Atrial Fibrillation Signal Translated to Phase Space. This example
from a canine model of AF highlights the closed loop trajectories in the phase plane that
correlate to each optical action potential.
vortex, critical point, rotor, spiral wave, centers of self-organization, and pivot points of
reentrant circuits. However regardless of the name it is given, the behavior resembles vortices
in optics, fluid dynamics, and magnetic waves.
Due to the observed similarities, researchers turned to phase analysis, a non-linear dynamic
systems analysis technique often used in physics and applied mathematics to quantify oscillating behavior and turbulence stability [23]. This approach is used to di↵erentiate deterministic behaviors in chaotic oscillators from random noise. Along the frequency spectrum,
chaotic signals sit between sinusoids and noise [175]. The behavior is aperiodic, but the signal is not random so a signal processing technique that filters out the dynamic fluctuations
is not appropriate. Phase analysis involves a translation from the temporal domain into the
phase plane, where organized quasi-periodic signals become closed loop trajectories and the
angle along the trajectory with respect to a known origin is defined as the phase. Figure 2.7
illustrates this translation using a signal obtained optically from AF in a canine model. Cardiac fibrillation is a superposition of periodic and aperiodic signals. If the signal is arbitrarily
random in time, the trajectory in the phase plane is equally random, whereas the trajectory
in the phase plane has a definite shape if the system is deterministic. Reconstructing the
signal in the phase plane di↵erentiates chaos from random noise where frequency analysis
cannot. Figure 2.8 compares a sinusoidal signal, a signal from a chaotic oscillator circuit
known as Chua’s circuits [164], and a uniform random noise signal in the time domain, the
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frequency domain, and phase plane, highlighting the advantages of using phase to di↵erentiate the signals. The definitive shape of the chaotic oscillator in the phase domain clearly
distinguishes it from noise. The chaotic signal has many qualitative similarities with potential signals during fibrillation, which is why phase was considered as a method for identifying
underlying organization in arrhythmias.
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Figure 2.8: Comparison of Sinusoid, Chaotic and Random Signal. A representative sinusoid
with a single frequency (blue), a Chua’s chaotic oscillator (black), and a Gaussian white
noise (red) time series are displayed along with the corresponding frequency analysis and the
conversion to the phase plane to illustrate how these parameters can be used to distinguish
chaos from noise. Note the spread of the frequency bands and the clear trajectory in the
phase plane that are characteristic of both chaotic signals and fibrillation recordings.
In order to perform the conversion into the new coordinate system there must be two parameters that oscillate in time and are out of phase with one another. The simplest models of
cardiac excitability define two parameters to characterize physiologically observed behaviors:
excitability and refractoriness. Therefore the models lend themselves to be easily converted
into the phase plane. A unique value now defines each point in time within the period of an
oscillating signal. Critically, with this method the period is a dynamic length of time instead
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of a fixed value to adjust for beat to beat variability. A topological analysis of the phase can
be used to extract patterns of organization and assess the stability of these patterns in time
and space. In a stable two variable system the critical points are mathematically defined as
the intersection of the nullclines in space[105]. This point is defined as a “phase singularity”
(PS). In stable spiral waves this is also the point in space where the spatial gradient of phase
diverges. It is possible to dynamically track the core of the spatial rotation through time
using the mathematical definition to identify the location in each frame. PS trajectories
can be used to provide insight into the substrate that is facilitating self-sustaining arrhythmias. More recently, PS tracking has become a method of identifying targets for ablation
[138, 114]. Additionally, the appearance or disappearance of PS during defibrillating shocks
can be used to assess the mechanism of a successful shock.
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Figure 2.9: Definition of Phase Singularity in Experimental Data. a) Phase map at an instance of time of an experimentally recorded AF from an ovine model with a single sustained
rotor. b)A map displaying the gradient of phase with the red inset at the point of divergence. c) A plot of the topological charge in 3D and 2D to identify the location of the phase
singularity, where the topological charge equals +1 or -1.
Unfortunately, the application of phase analysis to experimental data is less straightforward.
A singularity is not as rigorously defined in physiological terms. In clinical and most research
cases only one variable is recorded from each electrode, the potential. New techniques were
required in order to create a second state variable and track the phase transitions and
singularities in a reconstructed phase plane [13]. Additionally, algorithms were introduced
to identify PS that can no longer be defined as the intersection of the nullclines from the
state variables. Instead a phase singularity is defined as a point around which all phases of
a cycle are present [26, 151, 49]. This is calculated using the equation for topological charge,
1 H
which evaluates a contour integral of the spatial gradient of phase: nt = 2⇡
C r · dl. A PS
has a topological charge of ±1 depending on the chirality of the rotation. All other locations
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will have a topological charge of 0. This definition of PS is illustrated in Figure 2.9. Panel
A displays a phase map from an optical mapping experiment on an ovine model of AF that
is maintained by one rotor at a single instance of time. Panel B maps the gradient of phase
with an inset at the point of divergence. The spatial map of the topological charge identifies
the PS at the point of divergence in Panel C.
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Figure 2.10: Phase Conversion using Various Second State Variable Definitions. In experimental data, only one variable is recorded (i.e. potential). Therefore a second variable
must be created in order to convert the signal to the phase domain. A representative pixel
from optical recording of acute AF in an ovine model is used to highlight the di↵erences in
the phase signal between three definitions of the second state variable: Hilbert transform
(green), a time delayed potential signal where tau is defined at 25% of the fibrillation cycle
length (purple) and a time delayed potential signal where tau is defined as the first zero
crossing of the autocorrelation of the potential signal (black).
One approach to create a second state variable is to use the potential signal o↵set by a time
delay (V (t + ⌧ )). The phase results are dependent on the selection of ⌧ . Several groups
have suggested di↵erent definitions of ⌧ including a fraction of the global cycle length or the
lag at the first zero-crossing of the autocorrelation of V (t) [13, 26]. The rationale behind
using the zero crossing was to create a second variable that is linearly independent from the
potential time series, whereas a ⌧ that is based on the cycle length ensures that the two
state variables are out of phase. Numerical studies have shown that the choice of ⌧ can
influence the number and stability of PS from the same dataset [27]. The Hilbert Transform
provides a more robust way to create a phase-shifted signal and has gained favor because it
creates a linear transition through the cycle and removes the variability of an arbitrary time
delay. This technique converts a real signal to a complex signal where the imaginary portion
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(a)

Time delayed potential

is instantaneously shifted by - ⇡2 . Figure 2.10 shows how the definition of the second state
variable influences the phase with respect to time ( (t)) for an individual optical recording in
an ovine model of AF. Simultaneously plotting the phase from a single pixel calculated using
two time embedding approaches and the Hilbert Transform emphasizes the morphological
variability in the phase transition, especially during the second action potential.

0

(b)
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Figure 2.11: Complications of Applying Phase Analysis to Electrograms.The conversion to
phase is challenging when the state variable is multiphasic as seen in a unipolar electrogram
from an intracardiac catheter during human AF. Two second state variables were used
a) a time delayed potential signal and b) the Hilbert transform. The Hilbert transform
applied directly to the unipolar signal has many false positive phase transitions that do not
correspond to activation on the electrogram.
Another challenge to overcome is the e↵ect of the signal morphology and the signal to noise
ratio of the recorded data. The Hilbert Transform performs best for monophasic zero-mean
signals. When the signal morphology deviates from this shape it becomes less appropriate
to directly apply this transform. When the signal that represents activation is multiphasic
in nature the phase signal will transition through a cycle inappropriately with respect to
the physiology. The Hilbert Transform is also sensitive to noise fluctuations in the same
way. This is very easily observed by applying the transform to raw electrograms as is shown
in Figure 2.11. In this figure signals from an intracardiac signal from human AF (MITBIH database) [66, 132] demonstrate how the direct application of phase analysis to raw
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electrograms is inappropriate. Striking di↵erences can be observed between the trajectories
in the phase domain depending of which definition of second state variable is used. However,
the most significant observation is the large number of false positive deflections in phase
when the Hilbert is applied to the human unipolar deflections. The phase transition does
not correspond to the physiological cycle when the signals are multiphasic. Various levels of
signal conditioning can be applied to the acquired signals. For example, the DC components
of a signal must be removed before a Hilbert Transform can be applied, which has resulted
in the introduction of empirical mode decomposition in the pipeline of signal conditioning.
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Figure 2.12: Matrix of Signal Conditioning Parameters. a) The columns represent degrees
of signal processing and the rows represent definitions of the second state variable. b) Traces
from a single pixel of atrial fibrillation in an ovine model highlight the e↵ects of processing
on the phase trajectories using the Hilbert Transform.
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Furthermore, phase analysis can be sensitive to spatial interpolation between recording sites.
Since a singularity is defined based on the spatial pattern of phase it is important to choose
an interpolation technique that does not artificially introduce rotation, especially along lines
of conduction block. Some techniques have been introduced to limit the false positive identification of singularity points including a constraint that the phase singularity must lie along
an isophase wavefront defined along ⇡2 with a minimum length [151]. Also groups have tried
to classify PS as stable based on the wavefront rotation around the point in order to separate
meaningful PS from transient points or signal processing artifacts.
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Figure 2.13: Fractional Di↵erences in Phase Maps by Definition. a)Example calculation
of fractional di↵erence between baseline conditioning and temporal smoothing. b) A heat
map that shows the average fractional di↵erence compared to the baseline processing for all
second state variable definitions. c) A heat map that shows the average fractional di↵erence
compared to the Hilbert Transform.
Phase analysis is a powerful technique that can be applied to cardiac fibrillation signals to
look for underlying organization and determinism. In many cases the spatial pattern of phase
is a cleaner representation of the potential pattern. However, there are many parameters
within the application of phase algorithms that must be standardized within the field. Phase
should be used in conjunction with the potential signal rather than as a replacement to be
viewed in isolation. However, it is critically important to be aware that processing influences
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the phase analysis results and it is difficult to perform a rigorous analysis of the accuracy of
one technique over another in experimental data without a gold standard definition.
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Figure 2.14: Inter-item Correlation of Wavefront Count. a) Example wavefront count traces
for a single AF episode for all processing and second definition pairs. b) Measure of reliability
for wavefront count. c) Heat maps for inter-item correlation for summary of all hearts tested.

To support this claim and to determine the optimal algorithm for the data in this dissertation, I developed a study to quantitatively compare di↵erent definitions of phase and look
for internal consistency within methods. Using optical action potentials from a pharmacologically induced ovine model of AF, I investigated the variability of phase singularity
location, stability, and trajectory when subject to increasing degrees of processing in the
temporal and spatial domain and various definitions of phase variables. Once acquired, all
signals were spatially filtered with a uniform 3 x 3 bin, temporally filtered with a low pass
FIR digital filter with a cuto↵ frequency of 100Hz, normalized and detrended for baseline
conditioning. Additional degrees of processing were applied to the data including: 1) a tight
temporal bandpass filter from 2-10 Hz, 2) a larger spatial filter with a Gaussian 5 x 5 bin, 3)
a Savitzky-Golay smoothing filter in time with a 200 ms window or 4) an aggressive combination of 1-3. Additionally, 3 definitions of the second state variable were used to calculate
the phase: a) Hilbert Transform, b) a time embedded signal with a ⌧ defined as 25% of
the global dominant frequency, and c) a time embedded signal with ⌧ defined as the first
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zero crossing of the autocorrelation. The matrix of varied parameters is displayed in Figure
2.12. Phase trajectories from a single pixel with each level of processing highlight the e↵ects
of processing in the phase plane. Each 2⇡ rotation represents a cycle of AF. The phase
dynamics from 5 hearts with a total of 10 AF episodes were then quantified using each pair
of variables from the matrix. PS were defined using the topological charge algorithm and
considered stable when they persisted for 2 full rotations. Wavefronts were defined along the
⇡
isophase line. Inter-item correlation tests were calculated for outcomes including, phase
2
distribution, wavefront count, PS trajectory duration and PS spatial meandering area to
assess the reliability of di↵erent tests and the internal coefficient of consistency for each
parameter.
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Figure 2.15: Frequency Relationship to Inter-item Correlation. a) Dominant Frequency b)
Regularity Index.
The spatial phase maps were compared by calculating the fraction of the field of view that
di↵ered by greater than 5% of the phase cycle compared to the baseline condition for all 10
episodes. A representative example is shown in Figure 2.13. The autocorrelation definition
was most sensitive to signal conditioning. The temporal filter and temporal smoothing were
least sensitive to di↵ering second variable definitions. Unfortunately the regions near the
phase singularities were the most variable between definitions and processing conditions. The
number of wavefronts were calculated at a frequency of 20 Hz for each condition based on the
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isophase lines. The inter-item correlation was calculated based on the temporal wavefront
count traces. All tested condition pairs failed to reach a threshold of reliability (chronbach’s
alpha value of 0.8), although they were trending close to acceptable values (Figure 2.14). On
the right the variability of wavefront traces are shown for each pair in the processing matrix
for a single AF episode. The inter-item correlation heat maps highlight the pairs that are
most correlated using the Hilbert Transform. Panel b provides a summary of the chornbach’s
alpha for each definition of second state variable across all 10 AF episodes. This indicates
that phase analysis outcomes are sensitive to the amount of processing applied to the data
and may lead to either an overestimate or an underestimate of the number and location of
critical regions contributing to the organization of AF. Figure 2.15 compares the inter-item
correlation and the dominant frequency and regularity index of individual AF episodes for
all 10 episodes. There was no trend between the frequency content of the arrhythmia and
the sensitivity to di↵erent algorithms.
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AF.
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The e↵ect on temporal and spatial stability was quantified by calculating the dynamics of
all identified phase singularities. The results from each episode are shown in Figure 2.16
to highlight the variability in outcome due to arrhythmia di↵erences using only the Hilbert
Transform. Baseline filtering led to the greatest number of identified PS, the greatest spatial
ratio, a hight time ratio, and the lowest number of consecutive rotations per stable rotor.
By investigating individual episodes, this is due to a high rate of false positive identification
in the noisy boundary region even when selecting for only stable rotors. The spatial filter
had the lowest PS count and the lowest time stability ratio. This pattern is because the
spatial filter results in a greater percentage of time frames when no wavefront is present
compared to all other levels of processing. The example with 26 consecutive rotations is
parceled into discrete rotations separated into several windows of rotation when the spatial
filter is applied. Time frequency and temporal smoothing allow the most variation within
the cohort of AF episodes tested. The time frequency filter was still sensitive to boundary
noise but to less of a degree compared to the baseline filter. When applied to a negative
control (known focal pattern) the temporal smoothing filter was the only processing group
that identified the pattern incorrectly as rotation (data not shown).
Researchers and clinicians who apply phase analysis to guide patient therapies must be
conscious of these e↵ects when interpreting the results and chose appropriate filters. Perhaps
for now the most appropriate answer is to use multiple algorithms and create a weighted
map of the results of rotational activity (example Figure 2.17) where 2-3 regions could be
identified by looking at the entire gamut of PS incidence maps). Based on the results of this
pilot study we chose to condition our data with the tight temporal filter with an additional
threshold map based on a signal to noise ratio (SNR) threshold to remove some of the false
positive regions that were associated with low SNR.
Due to di↵erences in morphology of unipolar electrograms, these results will not directly
extend to electrical recordings, but a similar assessment of internal consistency must be done
to systemically illustrate the importance of transparent and standardized preconditioning in
any therapeutic phase algorithm. One approach involved using a model fit to the clinical
recordings instead of a processed signal for electrogram data. For example we explored
one statistical approach to the problem using a matching pursuit algorithm to compute a
nonlinear approximation of the signal based on symlet wavelets. For the study in Chapter
4, we need to compare the isophase wavefronts between paced rhythms as a control and
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Figure 2.17: Phase Singularity Incidence Maps. Matrix of incidence maps for all processing
conditions. Processing pairs highlight di↵erent regions for rotors.
induced AF. Paced rhythms are not as sinusoidal in shape as the AF signals and therefore
they are more sensitive to noise if using the Hilbert Transform. Details of this approach are
discussed in Chapter 4.
It is important to remember that while a PS is rigorously defined in mathematics, the
techniques applied to experimental data and the physiological definition of such a point are
less rigorous. It is not yet clear if a non-excited but excitable core exists in the physical
manifestation of rotational propagation in cardiac applications. As the field becomes more
familiar with tracking PS in space and time, it will help clarify the stability definitions in
both domains and elucidate how this technique can be used to guide therapy most e↵ectively.
PS identification is also an important technique for determining the mechanism of successful
applications of electrotherapy. In order to terminate an arrhythmia a therapy must disrupt
the circuits that are immediately sustaining the arrhythmia as well as avoid inducing new
rotating waves as a result of the tissue response to a shock. Tracking the dynamics of
new PS immediately following the shock is a good indication of whether the shock-induced
wavefronts are at risk of re-inducing an arrhythmia.
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Chapter 3
Quantification of the Transmural
Dynamics of Atrial Fibrillation by
Simultaneous Endocardial and
Epicardial Optical Mapping in an
Acute Sheep Model
Large portions of this chapter appear in the following original publication:
Gutbrod, Sarah R, Walton R, Gilbert S, Meillet V, Jaı̈s P, Hocini M, Haı̈ssaguerre M,
Dubois R, Bernus O, and Efimov IR. Quantification of the Transmural Dynamics of Atrial
Fibrillation by Simultaneous Endocardial and Epicardial Optical Mapping in an Acute
Sheep Model. Circulation: Arrhythmia and Electrophysiology. 2015; CIRCEP.114.
published online ahead of print.

3.1

Introduction

Establishing a comprehensive description of AF substrates that sustain arrhythmias remains
a formidable task. Unfortunately, guided treatment approaches require advancements in the
way we categorize arrhythmias beyond the classical approach to di↵erentiate cases by only
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the duration of the arrhythmia. Animal models of AF o↵er a platform from which to investigate the relevancy of new methods of characterizing AF organization. Historically, most
investigators have assumed atrial tissue is a functionally two-dimensional (2D) structure.
Simulations and mapping modalities have largely ignored the role of transmural conduction
during AF, emphasizing in-plane epicardial or endocardial propagation patterns as the driver
circuits for the arrhythmia. In a 2D projection, transmural breakthrough can easily be misattributed to focal activity, further complicating the interplay between the multiple substrate
hypotheses. However, the field is beginning to recognize that tissue thickness should not be
completely ignored. Several recent animal studies have suggested that epicardial-endocardial
dissociation may play an important and dynamic role in the progression of the AF substrate
and the stability of the arrhythmia [46, 47, 52, 208, 22]. Although the wide diversity of
the disease plays a crucial role in the mechanism controversy, it is also possible that threedimensional (3D) conduction may account for some of the discrepancies in AF maintenance
hypotheses. By taking advantage of optical tissue penetration properties, we used transillumination optical mapping to quantitatively assess the association between propagation on
the epicardial and endocardial surfaces in an acute AF model compared to paced rhythms.
We used these patterns to infer the 3D heterogeneity of the substrate. Using this approach
we evaluated degrees of discordance in the spatiotemporal organization of individual induced
AF episodes.
Traditional optical mapping is a 2D imaging technique, transducing the electrical activity
of the superficial layers of cells into optical signals that linearly depend on transmembrane
potential changes [28]. However, the depth of penetration is largely based on the absorption
and scattering properties of the excitation and emission light and can be tuned by wavelength
and camera orientations. Simultaneous imaging at two depths within the tissue is achieved
by detecting fluorescence on the ipsilateral and contralateral tissue surface relative to the
illumination source [19, 29]. Figure 3.1 provides for a visual schematic of the theory behind
the transillumination approach [19]. Two planes of data (a reflected and transmitted plane)
are collected with each illumination direction. Optical signals collected in the reflected and
trans-illuminated modes are averaged signals from across depth subdivisions. Biophotonic
simulations have predicted that the average depth of contribution to the reflected signal with
red light is 1.5 mm, while the average depth of the contralateral signal is 4 mm from the
illuminated surface. Simulations excited by green light have an average depth of 0.5 mm in
the reflected configuration and 2.5 mm in the transmitted configuration [180]. Several studies
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have used this technique to characterize propagation patterns in ventricular tissue [181, 182].
One additional study used the same principle to look at a small window of atrial tissue [208].
However, to our knowledge transillumination had not been applied to a large field of view of
atrial tissue prior to this study. In order to optimize the methodology for this application we
used a novel voltage sensitive dye [123] that is excited by a range of excitation wavelengths
and a combination of emission filters to achieve the best signal quality. The flexibility of this
experimental set-up allowed us to assess the feasibility of achieving two planes of data in
the significantly thinner and contoured atrial tissue. We applied this technique to correlate
the simultaneous propagation patterns at two di↵erent depths within the atrial wall with
high spatial resolution and without having to physically expose the transmural tissue, which
may disrupt the integrity of fibrillatory circuits. For paced data we were able to look at four
planes by aligning two files taken with opposing illumination directions. For AF data the
two configurations cannot be temporally aligned.
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Figure 3.1: Schematic of Transillumination Mechanism. Distributions showing contribution
to total signal in endocardial, endo-transilluminated, epi-transilluminated, and epicardial
and a schematic of how those distributions cut virtual planes through a left atrial preparation.
Modified from [19]
In this study we used an acute acetylcholine-induced model of AF in the isolated sheep left
atrium (LA) to test the hypothesis that inherent local heterogeneities in electrophysiological
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properties and anatomical discontinuities can support dyssynchronous electrical propagation in AF across the transmural wall independently of AF-induced structural remodeling.
We used parameters that are commonly used for clinical characterization of AF including:
dominant frequency (DF), regularity index (RI) , and phase singularity (PS) analysis. As
personalized therapy strategies based on high density mapping gain favor, it is increasingly
important to understand the limitations of 2D mapping techniques and the subsequent e↵ects
on the efficacy of therapy paradigms. There is no clinical technique yet available to assess
transmural propagation. Basket and plaque arrays only measure local surface signals. This
leaves clinicians with a 2D projection of a potentially 3D substrate. It is unclear whether
a 2D view is sufficient to guide directed therapeutic approaches such as Focal Impulse and
Rotor Modulation [138] or rotor-guided ablation [114]. Transillumination optical mapping
provides an experimental platform to investigate the spatiotemporal dynamics and infer the
3D transmural propagation patterns.

3.2

Methods

Experimental Preparation
Optical mapping experiments were conducted in isolated LA preparations from Texel crossbred sheep (N=13 total preparations, N=5 to characterize the technique and N=8 to quantify
AF dynamics) weighing 40-55 kg. The animals were treated in accordance with the guidelines from Directive 2010/63/EU of the European Parliament on the protection of animals
used for scientific purposes and the local Université de Bordeaux ethical committee. The
sheep were pre-medicated with 20mg/kg ketamine and 0.02mL/kg acepromazine (Calmivet,
France). Surgical plane anesthesia was induced with 10mg/kg sodium pentobarbital and
maintained under isofluorane, 2% in 100% O2 . The chest was opened to provide access to
the heart and the animal was euthanized by sodium pentobarbital (2000mg). The heart
was rapidly excised and perfused with 200 mL of cardioplegia and heparin through an aortic
cannula. The left coronary artery was isolated for cannulation. Under constant perfusion
of cold cardioplegia the ventricles were removed below the main branch of the circumflex
artery. All ventricular vessel branches were tied o↵ and LA was flattened by opening the
right superior pulmonary vein. The right atrium was removed via an incision down the atrial
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septum and the remaining pulmonary vein ostia were inverted to maximize the exposed surface area. The LA preparation was stretched across a frame and secured to pull it flat as
shown in Chapter 2. The LA preparation was perfused with methylene blue to ensure adequate perfusion and transferred to warm oxygenated Tyrode’s solution for optical mapping.
Perfusion was maintained for the duration of the experiment at 20 mL/min. The tissue was
suspended vertically in a bath to allow optical access to both the endocardial and epicardial
surface as seen in schematic form in Figure 3.2. Two stainless steel electrodes were clipped
to the endocardial surface to record a bath electrocardiogram.
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Figure 3.2: Schematic of Experimental Set-up. a) Endocardial illumination b) Epicardial
illumination.
Optical Mapping Acquisition
The tissue was electromechanically uncoupled with 15 µM Blebbistatin and stained with a
50 µM bolus injection of di-4 ANBDQBS or a 15 µM bolus injection of di-4 ANEPPS. Two
illumination LEDs were tested to titrate the depth of signal contribution. The LEDs were
either two 660 nm or two 530 nm LEDs (Cairn Research Ltd, Kent, UK). Fluorescence was
filtered through a 715 nm long pass filter or a 585 ± 35 nm bandpass filter respectively
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and acquired using two CMOS cameras (MICAM Ultima, SciMedia) with 5cm x 5cm fields
of view (spatial resolution 500 µM). The atria were paced at 1-5Hz from various locations
with a bipolar electrode on either the epicardial and endocardial surface at twice the pacing
threshold. Four-second recordings were captured at 1,000 frames per second. Acetylcholine
(Sigma-Aldrich, MO) was added to the perfusate in increasing concentrations from 0.1 µM
to 5 µM until AF could be induced by 50 Hz burst pacing. An AF episode was recorded if
it was self-sustaining for >30 seconds.
Magnetic Resonance Imaging (MRI)
Limited by equipment availability, the atria from 5 hearts were imaged with MRI after optical
mapping to obtain the complex anatomical geometry of the preparations. Immediately
after the completion of the optical mapping, the perfusate was removed from the imaging
chamber and replaced with YL VAC 14/6 Fomblin perfluoropolyether (Ausimont, Milan,
Italy), an organofluorine with no 1H MRI signal. The sealed chamber was placed in a
Siemens Magnetom Avanto 1.5T MRI scanner (Erlangen, Germany) with the axis of optical
imaging aligned to the b0 direction. Imaging was carried out using a Siemens cardiac MRI
sequence with a simulated ECG (cycle length 700ms), echo time 2.98ms, repetition time
399.19ms, flip angle 90°, matrix size of 512 x 512 x 192, spatial resolution of 0.62 x 0.62
x 0.31 mm3 , for a total field of view of 316 x 316 x 60 mm3 , and an acquisition time of
32 minutes. The images were segmented from the background signal using Seg3D2- 2.1.5
(Scientific Computing and Imaging Institute, University of Utah, USA). The segmentation
mask was generated using a median filter and thresholding to exclude non-tissue voxels
with a binary erode then dilate. The resulting segmented slices were reconstructed into
a volume and further processed in Paraview using additional threshold filters and manual
volume extraction to remove the ventricular tissue from the edges of the tissue preparation.
Transmural thickness was estimated along a normal line through the tissue perpendicular to
the CMOS camera focal plane using a custom C++ program.
Arrhythmia Processing
All optical signals were processed with custom MATLAB software, some of which was developed by previous students and is described in detail elsewhere [108]. Briefly, each pixel
was spatially filtered with a 3 x 3 uniform average bin, every temporal sequence was low
pass filtered by an FIR filter with a cuto↵ frequency of 100 Hz, drift in the baseline was
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removed with a polynomial fit subtraction, and the magnitude of the fluorescent change was
normalized to a range of [0,1]. DF was evaluated for each pixel as the frequency band with
maximal power on a periodogram calculated with a Fast-Fourier transform (resolution 0.24
Hz). RI was defined as the ratio of the power within a 1 Hz band centered on the DF and
the total power spectrum from 0 to 100 Hz. A perfect sine wave with a single frequency
yields an RI of 1. Single parameter spatial maps were aligned using MATLAB’s intensity
based image registration to account for any small translation or scaling di↵erences in camera
orientation between fields of view before statistical comparisons.
Wavefront and Phase Dynamics
Prior to transforming the optical signals into the phase domain, additional levels of preconditioning were applied to both paced and arrhythmia data as described in detail in Chapter
2. The epicardial-endocardial correlation during paced data was used as a control in these
studies to account for confounding e↵ects of optical acquisition. The signals were temporally
filtered with a narrow [2,10] Hz band pass filter and were spatially masked to keep only those
pixels with SNR of at least half the maximal SNR in the field of view. SNR was calculated
during a 2 Hz pacing trace for each preparation and illumination direction as the ratio of
the baseline amplitude to the amplitude of an optical action potential after normalization.
To convert the optical signal into the phase space we applied the Hilbert Transform on the
detrended processed optical signals. Wavefronts were defined as the isophase lines along
(t) = ⇡2 . The number of discrete wavefronts was calculated for each field of view with a
sampling frequency of 50Hz. Conduction velocity vectors were estimated from the direction
of vectors normal to the curvature of the isophase wavefronts [93]. Conduction velocity maps
were calculated with a 0.5s resolution. PS were calculated as non-zero topological charges
constrained to the isophase wavefronts in each time frame. Static PS incidence maps were
calculated by summing binary PS location maps across time. PS were considered distinct if
they were >5 pixels apart in a single frame. The minimum Euclidean distance between PS
on the two imaging planes was calculated using MATLAB’s nearest neighbor search algorithm. Dynamic PS stability was calculated in terms of full wavefront rotations around the
PS. Stable PS were arbitrarily defined by 2 full rotations. The spatial PS ratio is defined as
the fraction of the field of view through which all stable PS track. The temporal PS ratio is
the fraction of the total sequence where at least one stable PS is present.

51

Statistical Analysis
All means that characterize the spatial average of a single AF episode are represented as
sample mean ± standard deviation. All means that characterize average Epi-Endo trends
across the cohort of hearts are reported as sample mean ± standard error of the mean. When
comparing transilluminated vs. reflected or paced vs. AF, the data points are pooled and
averaged for each heart. A statistical comparison between groups is applied to the cohort
of hearts with an unpaired two-tailed t-test. When the comparison was across multiple
variables, i.e both fields of view and rhythm type, a multivariate analysis of variance was
used. Significance was defined as p <0.05. When testing whether the absolute value of the
di↵erence between the endocardial and epicardial parameter is equal to 0, a one-tailed t-test
is used on the average di↵erences per heart. Mean conduction velocity vectors and angular
variance are calculated from the circular distribution of individual conduction velocity vectors
from each wavefront in time [209]. The mean propagation vector is compared to the mean
from the contralateral field of view for each episode. The di↵erence in angle is averaged for
each heart before a two-tailed t-test is applied between the paced and AF conditions. For
comparing the wavefront count, a Pearson’s linear correlation coefficient is calculated for
each episode (AF and paced). The correlation coefficients are pooled and averaged within
each heart, before the two groups are compared. An average 2D correlation coefficient from
MATLAB is used to compare the DF and RI intensity images from each field of view in a
similar manner.

3.3

Results

Two-plane Imaging Feasibility
To characterize the application of the transillumination technique to atrial tissue, we compared the signal quality and basic electrophysiological parameters acquired for both light and
filter combinations. Figure 3.3 displays representative optical action potential traces using
green excitation and red excitation. The transilluminated signal is averaged across a greater
depth, this manifests as an increase in upstroke duration. There is also a clear distinction
between the distributions of the upstroke duration with each mode and light combination.
The green reflected signal is more superficial than the red reflected signal, resulting in a shift
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to shorter upstroke durations. We quantified the average signal to noise ratio and the fraction of signals with dual components in the upstroke to compare the two acquisition modes.
The mean reflected SNR was 17.73 ±0.82 (s.e.m) and the transilluminated SNR was 17.47
± 0.84 for N=5 hearts with red excitation. There was no statistical di↵erence between the
mean SNR with endocardial illumination or epicardial illumination with red light (p=0.84).
The mean reflected SNR was 11.96 ± 0.69 (s.e.m) and the transilluminated SNR was 8.82
± 0.63 for N=5 hearts with green excitation. For green light 26% of the signals contained
dual components in the upstroke morphology compared to 28.8% for red light. Additionally,
action potential durations (APD) values were assessed at a range of pacing frequencies from
both imaging planes and the observed di↵erences are displayed in Figure 3.4.The red light
configuration resulted in longer APD for all acquisition planes.
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Figure 3.3: Characterization of Green Excitation vs Red Excitation. a) Representative
optical action potentials with both excitation wavelengths. b) Distributions of upstroke
durations with both excitation wavelengths, with a kernel distribution fit.
The transilluminated plane with red excitation light has a better signal to noise ratio. To
maximize the spatial coverage of the transilluminated plane, red excitation was chosen for
the cohort of AF dynamics (N=8 hearts, 20 AF episodes). To verify that the dual sided
imaging technique was capturing information at two distinct depths within the tissue we
calculated the breakthrough delay on the field of view contralateral to the pacing electrode
at various locations, relative to the pacing spike. When the tissue was paced epicardially at
2Hz, the delay until breakthrough on the endocardial plane was 11.63± 1.1ms (s.e.m) across
all hearts (N=8 animals). Conversely, the delay for endocardial pacing until breakthrough
on the epicardial plane was 9.6± 2.52ms. The breakthrough delays confirm that there is a
propagation delay between the two planes.
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Figure 3.4: Action Potential Duration Di↵erences across Acquisition Modes. In all modes
and across all pacing cycle lengths red excitation leads to longer action potentials.
Transmural Heterogeneties
From the MRI volumes we extracted local thickness parameters. A representative volume
colored by thickness is displayed in Figure 3.5 to highlight the complex geometric contours
of the atrial tissue in this preparation. Additionally, the tissue thickness distributions from
five volumes show a wide range of variability with each preparations and across the cohort
of imaging anatomies. Although the distributions are shifted within each heart, thickness
ranges from <1 mm to >1 cm after excluding the ventricular edges
Acetylcholine was added in increasing doses to each preparation, ranging from 0.1µM to 5
µM, until a sustained AF was induced. The APD after the necessary final dose of acetylcholine was givenranged from 129.73±17.3 to 188.19±18.51ms on the endocardial surface
(µ ± ) and the epicardial range was 125.14±16.46 to 164.46±13.51ms (µ ± ) during 2Hz
pacing for all 8 preparations. For paced data the imaging acquisition protocol can create 4
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Figure 3.5: MRI Volume Reconstructions from Sheep Left Atria. a) Example volume reconstructed from MR images colored by thickness. b) Distribution of thicknesses for each heart.

distinct planes through the tissue, a reflected and trans-illuminated plane for each illumination direction that have been temporally aligned. We defined the local gradient of APD
as the di↵erence from the reflected signals during endocardial illumination, to the reflected
signals from epicardial illumination. The average transmural gradient in APD from endocardium to epicardium was 24.13±6.34ms. Finally, we registered the thickness map to the
transmural APD gradient plane. Although both the thickness and the APD transmural
di↵erences were heterogeneously dispersed across the field of view there was no correlation
between these two parameters (data not shown).
Arrhythmia Static Parameters
A total of 10 epicardially illuminated episodes and 10 endocardially illuminated episodes
were included in the analysis of AF transmural discordance. The DF and spatial standard
deviation, including both the endocardial and epicardial field of view, ranged from 3.90±0.48
to 10.03±2.88 Hz. The di↵erence between epicardial and endocardial global DF was not
significantly di↵erent from zero when assessed by a two-tailed t-test (p=0.3516, N=8 hearts).
The global RI and spatial standard deviation ranged from 0.12±0.065 to 0.704 ± 0.079, with
an Epi-Endo di↵erence that was not significantly greater than zero (p=0.42, N=8 hearts).
The distributions in the Epi-Endo di↵erence of these global parameters across all hearts
are shown in Figure 3.6. Two representative examples from opposite sides of the spectrum
are also displayed, highlighting the spatial congruency across both the imaging planes. The
spatial distribution of DF across the transmural wall had an average 2D correlation across
all hearts of 0.79±0.06 (s.e.m). Likewise, the spatial distribution of the RI had an average
correlation of 0.930±0.009, with no statistical di↵erence between illumination configurations.
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PS incidence maps were created as a static characterization of each arrhythmia. The mean
distance between the static PS locations and the nearest PS on the contralateral side was
5.24±0.3mm (N=8).
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Figure 3.6: Static Atrial Fibrillation Frequency Characterization. a) Di↵erences in global
dominant frequency and regularity index across all hearts. b) Representative spatial maps
of dominant frequency and regularity index for a two episodes of AF. c) Summary of spatial
correlation between imaging plane for both parameters. Error bars represent s.e.m. [73]
Arrhythmia Dynamics
All dynamic parameters are presented in comparison to paced data as a control to account for
the e↵ect of anatomical complexities on the optical planes and SNR edge e↵ects on the fields
on view. The dynamic number of propagation wavefronts was quantified in a time series
and correlated with the opposing side. Figure 3.7 illustrates the wavefront identification and
displays representative wavefront count traces for a paced rhythm and an AF episode. The
mean correlation between epicardial and endocardial wavefront count was 0.69±0.035 for
pacing versus 0.47±0.048 for AF (p=0.0028, two-tailed t-test, N=8 hearts).
The average direction of propagation was calculated for each episode with a resolution of
0.5s with a random starting time. A representative propagation angle calculation from both
the paced and AF groups is shown in Figure 3.8 along with the angular distribution. The
statistically significant (p=0.044, N=8 hearts) di↵erence in angle between the two planes
was 20.37±3.04°during pacing and 61.43±12.37°during AF. A one-way multivariate analysis
of variance confirmed that the angular variance did not di↵er between rhythms or fields of
view.
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Figure 3.7: Transmural Correlation of Wavefront Count. Representative example of wavefront identification with optical mapping traces and corresponding temporal sequences of
wavefront count for a paced rhythm (a) and a fibrillatory rhythm (b). c) Summary of the
transmural correlation of the wavefront count across imaging planes. Error bars represent
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The PS dynamics are specific to each heart and even vary between separate AF episodes
within a single preparation. Therefore, we report the detailed observations of two AF
episodes and the summary of phase tracking for the remainder of the episodes (Figure 3.12).
Table 3.1 quantitatively describes two individual episodes, representing the range of observed
dynamics: the first is less complex but has discordant phase dynamics across the two imaging planes while the second is more complex but displays more conserved dynamics across
the transmural wall. Sample optical traces from corresponding pixels in both fields of view
and electrical bath traces for each example AF episode are displayed in Figure 3.9. These
highlight the temporal regions when the endocardial and epicardial propagation patterns
diverge.
AF episode 1 shows a temporally stable epicardial rotor with minimal spatial meandering,
while the dynamics at the endocardium are less stable in both the temporal and spatial
domain. The pattern can be visualized in the sequential phase maps (Figure 3.10). The
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dynamic phase and potential movies are also available in the original publication (Video 12) There are observable spatial di↵erences in wavefront propagation patterns at each instance
of time.
This dyssynchrony manifests in an increase in the PS count with less rotations on the endocardium. The constant driver is veiled in this imaging plane (Figure 3.12). In contrast,
in AF episode 2, the spatial and temporal trajectories of one imaging plane nearly trace
the trajectories from the opposing plane (Figure 3.12), which is reflected in similar spatial
and temporal ratios. The dynamic conservation of the propagation pattern is emulated in
the small di↵erence observed between propagation vectors (Table 3.1) and visualized in the
sequence of phase maps in Figure 3.11 or dynamically in Videos 3-4 in the original publication. Despite the increase in the number of wavefronts present at each instance of time, all
wavefronts track well together across the transmural wall in almost all instances of time.
Figure 3.12 extends these observations to all hearts in the cohort. The correlation coefficient
between the number of PS on the endocardial imaging plane and the PS count on the
epicardial plane is 0.879. The average number of stable PS was 4.04±0.66 (s.e.m, N=8 hearts)
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Table 3.1 Detailed Dynamics for Two AF Episodes
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Figure 3.9: Corresponding Endocardial and Epicardial Optical Action Potentials for AF
Episode 1 and 2. Normalized optical signals from corresponding pixels on the endocardial
(blue) and epicardial (red) imaging plane and ECG bath (black) for the two detailed AF
episodes. The simultaneous potential traces highlight moments of dyssynchrony across the
transmural wall. [73]
and 3.3±0.59 for the endocardial and epicardial plane respectively. The absolute value of the
di↵erence in PS count between the epicardial and endocardial plane was significantly greater
than 0 with a median di↵erence of 1.0 PS (p=1.01x10-5 , 1 tailed t-test). The correlation
coefficient across all hearts for the spatial stability ratio is 0.795. The average area across all
hearts through which stable PS trajectories traversed was 4.63±1.05 cm2 (endo) and 3.56±1.0
cm2 (epi). The absolute value of the di↵erence between the epicardial and endocardial
plane was significantly greater than 0 with a median di↵erence of 9.27% of the field of view
(p=5.87x10-4 , N=8 hearts). The correlation coefficient for the ratio of time that has at least
one stable PS present between the imaging planes is 0.111 across all hearts. The absolute
value of the di↵erence between the epicardial and endocardial plane was significantly greater
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Figure 3.10: Sequential Phase Map of AF Episode 1
than 0 with a median di↵erence of 19.75% of the total recorded sequence (p=2.78x10-4 , N=8
hearts).

3.4

Discussion

Modern clinical mapping techniques are confined to observing only the surface manifestations
of 3D propagation patterns. In a manuscript describing the 3D organizing centers of chemical
waves Art Winfree recognized that although a pattern could be discerned within a 2D plane,
it would be nearly impossible to identify the organizing center without the complete 3D
perspective [197]. Several reports have suggested that AF organizing centers may also be
more completely described as 3D structures. A substantial 3D component to the drivers of
AF could contribute to the complexity of personalized therapy approaches. In simulations
of 3D reentry, Winfree predicted that a critical thickness exists which must be surpassed
before reentry in the z-dimension is observed. This critical value was suggested and later
confirmed by additional groups to be estimated by ⇡1 times the distance a wave propagates
in 1 rotation. It is important to note that the distance can be dynamic and therefore the z
component of propagation may also be dynamic. Gray and Jalife eloquently articulated the
role of thickness in reentry in the ventricles:
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As the thickness was increased, the activity on the top and bottom surfaces near
the center of rotation became discordant resulting from a curved filament whose
ends remained attached to the top and bottom surfaces. As the thickness was
increased further the filament first curved and then as reentry developed in the
third dimension, the filament broke into two pieces. . . increasing the number of
filaments and hence “sources of activity” [67].

However, this describes the destabilization of reentry in a uniform slab and refers to ventricular arrhythmias. The architecture of the atria is complex with structural discontinuities
and sharp gradients in thickness. It is unclear how much the atrial geometry contributes to
a divergence from 2D propagation patterns during AF.
Dyssynchronous transmural activation was documented with simultaneous endocardial and
epicardial recordings as early as 1993 [160]. Using unipolar electrode recordings, Schuessler
et al. correlated discordant activation activity with anatomic heterogeneities of the canine right atrium in acute AF. Importantly, neither surface was preferentially faster during
tachyarrhythmia propagation. A recent in vivo electical mapping study by Eckstein et al.
quantified the percentage of fibrillation waves that were preceded by electrical activity on
the contralateral surface [47]. The authors reported a marked increase in the incidence of
breakthrough with an increase in the degree of epi-endo dissociation, suggesting that what
may appear to be a focal source is actually due to 3D transmural propagation. Yamazaki
et al. used simultaneous epicardial and localized endoscopically-guided endocardial optical
mapping to predict the virtual transmural architecture of rotors [208]. The presented results
show some rotors in phase on both planes and some with a filament twist or non-identical
activation patterns. In their study the rotors were often associated with sharp transitions in
tissue thickness near the thinnest regions. Computationally, a dual layer simulation by Gharaviri et al suggested that epi-endo dyssynchrony increased AF stability compared to single
layer simulations [63]. The model was only a proof of principle simulation with arbitrarily
placed discrete transmural connections. Even so, the incorporation of a third dimension
for propagation increased the number of wavefronts at any given time and the lifespan of
phase singularities without e↵ecting the frequency content of the simulated arrhythmia, in
agreement with the data observed in our study.
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Figure 3.11: Sequential Phase Map of AF Episode 2
Our study continues the line of work towards 3D AF substrate characterization by charting
the dynamic dissociation between layers and probing the transmural uniformity of potential drivers with expanded spatial coverage and resolution. The global DF and the spatial
distribution of DF are both well conserved across the transmural wall. The RI is also well
conserved as a global mean and a spatial pattern. However, the frequency content does
not represent a complete characterization of the dynamic AF substrate. In order to further
assess the transmural uniformity of the substrate we investigated individual wavefront dynamics. Compared to the paced rhythms, the number of wavefronts is less correlated during
an arrhythmia. The observed correlation for paced rhythms is not 1 as might be expected.
The observed value may be due to the SNR spatial mask partitioning a single wavefront
into multiple segments on one imaging plane as seen in Figure 3.7. It may also be the result
of breakthrough delay on the side contralateral to the pacing electrode. This unexpected
outcome illustrates why we used the pacing data as a control instead of analyzing the AF
episodes in isolation. We also evaluated the di↵erence in shape of the propagating wavefront
from each imaging plane, through propagation vector angles. The pacing wavefronts move
in unison across the tissue, except immediately following the pacing spike (not shown in
figure). However, the propagation during the arrhythmia is significantly less uniform across
the transmural wall with a significantly larger di↵erence in mean propagation angle. Figure
3.8 shows a representative example of an endocardial wavefront that is trailing behind the
simultaneous epicardial pattern. The mean di↵erence in angle shows that the organizing
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centers of the AF substrate have 3D components, resulting in a di↵erence in the propagation
vector direction.
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Figure 3.12: Phase Singularity Dynamics across the Wall. a) AF Episode 1, b) AF Episode 2:
I) Representative phase maps with wavefronts highlighted in white. II) Spatial trajectories
of all PS superimposed on the optical field of view images for endo (blue) and epi (red)
imaging planes. III) Simultaneous PS trajectories in spatiotemporal domain for endo (blue)
and epi (red) imaging planes. c) Summary of PS correlation data across all 20 AF episodes
including PS count, spatial ratio, and temporal ratio. AF Episode 1 (green). AF Episode 2
(pink). [73]
Phase plane analysis is a technique derived from the physics of vortices (e.g. spiral waves,
rotors, scrolls, etc.) and applied as a popular method to map the organizing centers of the
AF substrates (See Chapter 2). Although the algorithms employed vary between institutions with various degrees of clinical efficacy, the theory behind PS tracking is sound and
well established. The conversion from potential space into phase space assigns a unique
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value to each instant of time within one period of a signal, which can be dynamic in fibrillation. Spatially, a PS forms at the wavebreak of reentry or wavefronts collisions. These
singularity points can be localized and tracked through time as a dynamic indicator of the
spatiotemporal organization and stability of an AF episode. In this study we investigated
the contralateral activity at the site of stable PS to assess the transmural uniformity of the
dynamic AF substrate. PS incidence maps show that the distance to the nearest neighboring
PS on the contralateral surface is relatively small suggesting that PS are macroscopically
localized to similar regions of the LA. In fact the distance seems to be similar in size to an
ablation catheter tip, which may explain why driver ablation has been successful in some
cases. However, due to tissue curvature, this observation does not allow direct inference to
the transmurality of the rotor. For example, if tissue is curved and the rotor filament is perpendicular to the tissue surface (no transmural variations in rotor properties) then the PS on
epicardium and endocardium will appear displaced with respect to each other in the imaging
planes. Conversely, a more complex intramural filament may give rise to what would seem
like perfectly aligned PS on epicardial and endocardial imaging planes. Additionally, the
locations with the highest relative frequency of a PS assume each time frame is independent,
which puts greater emphasis on the PS with less spatial meandering that repeatedly pass
through the same pixel often. Therefore the PS trajectories may be a more important spatial
measure of the transmural synchrony of organizing centers than the PS incidence maps.
Consequently, we simultaneously mapped the PS trajectories of stable PS, defined as when
the wavefront passes 2 full rotations or 4⇡ around the singularity, in both the epicardial and
the endocardial imaging planes. We used the spatial ratio and the time ratio as measures of
the colocalization across the transmural wall in the spatial and temporal domains. Although
all three parameters we tested showed di↵erences across the wall significantly greater than
zero, the greatest measure of discordance was observed in the temporal stability of PS across
surfaces. The spatial meandering and PS count are more conserved on average, although
Episode 1 does display a greater degree of meandering preferential to the endocardial plane.
AF Episode 1 demonstrates how non-uniform transmural propagation leads to breakthrough
that disrupts the stable organized propagation pattern. The propagation videos show that
the endocardial wavebreak does not occur on every pass of the stable rotation but does repeat
several times within the sequence. The traces in Figure 3.9 also show propagation in the
endocardial plane that is near-continuously out of phase with the epicardial trace. Detailed
Episode 2 is an example of an AF substrate that is more uniform across the transmural
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wall. Although not always completely synchronous, the PS track together through time and
space. The video displays an obviously synchronous collective pattern. The traces in Figure
3.9 echo this pattern; there are short bursts of out of phase propagation (e.g. 1000-1500ms)
but the traces track in sync for the majority of the measured sequence. The cohort of
AF episodes included in this study lies along a spectrum of transmural uniformity outlined
by these two examples. However, there was no correlation between frequency content and
degree of dissociation that could help predict which episodes are likely to exhibit transmural
di↵erences (data not shown). There were fast and slow, disorganized and regular, single
rotor and many PS arrhythmias that had varying levels of functional dissociation. A single
surface manifestation of these episodes would not have captured the complete view of the
dynamic 3D substrates in this study.
The acute model of AF does not incorporate pathophysiological structural remodeling, which
could conceivably compound the degree of dyssynchrony observed across the transmural wall.
In this model the likely sources of transmural dyssynchrony are abrupt changes in geometrical thickness due to complex contours of the atrium including the pulmonary vein ostia,
trabeculations and appendage and a heterogeneous response to acetylcholine. Each heart did
display regional di↵erences in APD after acetylcholine, creating transmural dissimilarities.
However, there was no correlation between the transmural repolarization gradient and thickness, nor was there a correlation with the APD di↵erences across the wall and the spatial
pattern of the frequency content. It is possible that dyssynchrony locates at the interface
between these two factors, where there is substantial space anatomically and a considerable
gap between repolarization to harbor transmural conduction. This study does not rigorously
identify the tissue conditions that are favorable to discordant propagation patterns, instead
focusing on chronicling the spatiotemporal prevalence of dissociated patterns. Future work
would require transmural discontinuities to be assessed histologically to obtain further insight
into the source of dyssynchrony.

3.5

Limitations and Future Directions

AF is an exceptionally diverse disease. We used a range of acetylcholine doses to encompass
the variability of clinical AF with respect to frequency content and organization with the
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selection of AF episodes analyzed in this study. Still, there are some limitations to extending this model to the clinical population of AF. Most notably, this is not a model that is
favorable to automaticity. The depression of focal discharges by acetylcholine [42] creates a
substrate that fosters re-entry and rotor drivers. Additionally, although the image acquisition technique allows for multiple planes to be imaged simultaneously, it is still not possible
to fully capture out of plane rotation. The biophotonic simulations provide an estimate for
the depth of the contributing signal for each illumination/optical configuration; however, in
practice there are many variables that could a↵ect this parameter including: the angle of
incidence of light, the focal plane of the cameras, and the complex contours of the anatomy.
We used the pacing data as a control to account for some of these e↵ects that vary from
experiment to experiment.
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Chapter 4
Investigating the 3D Substrate of
Atrial Fibrillation in a Canine Model
4.1

Introduction

The atria are complex heterogeneous structures. The twists and turns of the anatomical
architecture are far more complicated than a two-dimensional sheet or a shell with uniform
thickness. Intuitively, such an intricate geometry should have ensuing e↵ects on the conduction through the volume of the atrial tissue, even disregarding any functional di↵erence
across the wall. Depth dependent distributions of electrophysiological parameters have been
well studied in the ventricular tissue [65, 115, 64]; however the 3D nature of the atrial tissue
has been largely ignored. Our previous study on an acute ovine model captured a range of
transmural discordance in the phase dynamics of AF evaluated simultaneously on the epicardial and endocardial surface with transillumination optical mapping [73]. In addition to the
functional mapping, we looked at reconstructed volumes from Magnetic Resonance Imaging
as a preliminary investigation into atrial tissue structural variation. With a crude estimate of
wall thickness we saw wide variety from <1 mm to >1 cm. Another study in sheep suggested
that the abrupt changes in thickness, particularly the transition from thick to thin regions
harbor AF drivers [208]. Although thickness alone could foster a three-dimensional substrate, we conducted a thorough investigation of structural and functional di↵erences across
the transmural atrial wall to characterize the 3D substrate in a canine model. The present
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study compares the transmural electrical patterns and structural di↵erences in an acute canine model of AF. The acute AF substrate is created by Acetylcholine-induced changes in
action potential duration (APD) and induced by 50 Hz burst pacing.
Ex vivo preparations with both the left and right atria intact were optically mapped from the
endocardial and epicardial surface. Two di↵erent light configurations, constant epicardial
illumination and alternating epicardial and endocardial illumination, were applied to probe
various planes within the depth of the tissue. The optical mapping studies were used to
confirm dyssynchrony in an additional animal model and investigate electrophysiological
gradients across the atrial wall. Functional studies were followed by histological analysis
to quantify the pattern of structural transmural connections that could support electrical
dissociation across the wall.

4.2

Methods

Experimental Preparation
All animal procedures were performed in accordance with the ethical guidelines of the National Institutes of Health and were approved by the Washington University in St Louis
Animal Studies Committee. Optical mapping experiments were conducted in isolated atrial
preparations from Mongrel canines (N=5) weighing 25-30 kg. Animals were initially sedated
with 5-7 mg/kg propofol via the cephalic vein, intubated and mechanically ventilated. A
surgical plane of anesthesia was maintained with 1-3% isoflurane. A median sternotomy
was performed and the pericardium opened. The heart was arrested with cold Cardioplegia
and explanted from the chest. While submerged in cold cardioplegia, both the right and
left coronary arteries were isolated and cannulated. The ventricles were removed below the
circumflex artery and all ventricular-descending branches were ligated. The right atrium
was opened along the caval veins and the left atrium was opened along the right superior
pulmonary vein, leaving most of the atrial septum and the atrial roof intact. The dual atria
preparation was stretched across a frame to flatten the tissue surfaces and expose the endocardial surface (see Figure 4.1. The tissue was transferred to oxygenated Tyrode’s solution
(37 °C, pH 7.4) and perfused at 60 ± 5 mm Hg pressure for the duration of the experiment. A
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bath electrocardiogram was continuously monitored between 3 suspended needle electrodes,
recorded with a Powerlab 26T (AD Instruments).
(c)

(a)

pacing electrode
sensing electrode

RA

LA

Endo Camera

(b)
Epi Camera
LA

RA

Figure 4.1: Experimental Preparation for Canine Transillumination Protocol. a) Endocardial
field of view. b) Epicardial field of view. c) Experimental set-up.
When spontaneous contractions resumed, 15 µM Blebbistatin was delivered in a bolus injection over 10 minutes through both coronaries, followed by a 50 µM bolus injection of Di -4
ANBDQBS. Optical mapping files were recorded for 2 or 4 seconds at 1000 Hz simultaneously from both the endocardial and epicardial cameras with a field of view of 4 cm by 4 cm.
The tissue was excited by 630 nm LEDs from either the endocardial side, the epicardial side
or alternating with each frame. When the light orientation alternates the e↵ective sampling
frequency is reduced to 500 Hz for each plane. The signals were processed with the custom
MATLAB software described in Chapter 3. One change was made to the previous analysis
for the identification of isophase wavefronts in the paced data. In this model, the Hilbert
Transform was sensitive to noise and resulted in a high rate of false positive wavefronts for
the paced rhythms. We added an additional layer of processing using a matching pursuit
algorithm to statistically model the deflections from the paced rhythms before applying the
Hilbert Transform. Figure 4.2 displays an example before and after this processing, highlighting the removal of false positive wavefronts and the conservation of the true positive
wavefronts. Basic EP parameters were extracted for each plane during paced rhythms and
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AF. To induce AF, 0.5-1.0 µM Acetylcholine was added to the perfusate followed by 100
cycles of 50 Hz AC burst pacing. AF was imaged if it sustained for >30seconds. Measures of
dyssynchrony including dominant frequency, regularity index, wavefront count, and primary
propagation vectors were assessed using the same parameters outlined in Chapter 3. Although both atria remained intact to conserve fibrillatory patterns that involved the whole
surface area, we mapped only one atria at a time due to field of view limitations.
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Figure 4.2: Example of Matching Pursuit Algorithm Processing for Isophase Identification.
a) Example potential before and after matching pursuit is applied. b) Phase before and
after matching pursuit is applied. c) Wavefront identified in spatial map before and after
matching pursuit for false wavefront. d) Wavefront identified in spatial map before and after
matching pursuit for true wavefront.
Histological Staining
After the optical mapping protocol was completed the tissue was removed from the perfusate and fixed for 36 hours in 4% PFA solution followed by serial dehydration in ethanol
(N=5 hearts). Small blocks (4cm2 ) were removed from the pulmonary veins, left appendage,
left free wall, and atrial roof for paraffin embedded sectioning along the transmural axis
(Histology Core, Washington University Medical Center). Transmural sections from each
block, 5 µm thick, were stained with Masson’s Trichrome (IMEB, Inc), or Hematoxylin and
Eosin (H & E). All slides (N=5 hearts) were imaged under brightfield illumination using a
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Olympus NanoZoomer 2.0-HT System (Hope Center, Washington University in St Louis).
Fiber orientation was estimated using a custom MATLAB program based on a previously
described method [11]. Images captured at 5X magnification were divided into 100 x 100
pixel non-overlapping panels. The horizontal and vertical gradients were calculated to estimate the fiber orientation. Panels with a majority of fibers oriented between 45°and 135°were
identified as containing primarily transmural connection paths. Figure 4.3 demonstrates this
method on an example slide from the pulmonary vein region. The red and green boxes highlight representative panels that were identified as having a transmural orientation while the
blue box shows an example distribution for a non-transmural orientation. For each slide the
fraction of panels that were identified as containing transmural fibers was quantified. Both
Masson’s Trichrome and H & E slides were used to estimate primary fiber orientations. In
addition to traditional histology we reconstructed the volume of a 5 cm by 5cm section of
the pulmonary vein region using cryo-imaging technology (BioInvision, OH) to inspect the
transmural transitions in fiber orientation in a region critical to AF substrates.
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Figure 4.3: Fiber Orientation Estimation Algorithm. Example slice stained with H & E.
Red and green panels highlight transmural orientations. Blue highlights nontransmural distribution.
Statistical Methods Dyssynchrony parameters were compared using the methods outlined
in Chapter 3. Briefly, all parameters were averaged per heart before statistical comparison
to account for repeated measures in the same anatomy. Unpaired t-tests were applied to
make paced vs. AF comparisons. Significance was defined as p <0.05. Wavefront counts
were compared with a Pearson’s linear correlation coefficient. The correlation coefficients are
pooled and averaged within each heart, before the two groups are compared. 2D correlation
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coefficients from MATLAB were used to compare the DF and RI intensity images from each
field of view. The percentage of transmural fibers were compared with a two-way multivariate
analysis of variance across both the location and the type of stain used to identify the fibers.

4.3

Results

AF Dyssynchrony
A total of 23 induced AF episodes were included in this experimental cohort, 15 were acquired
with epicardial illumination and an additional 8 episodes were acquired with alternating illumination. The episodes had an average DF of 6.93 ± 0.69Hz with a mean di↵erence across
the transmural wall of 1.06 ± 0.28 Hz, which is significantly greater than 0 (p=0.0465). Additionally, the episodes had an average RI of 0.40 ± 0.07 with a mean di↵erence of 0.11 ± 0.02
across the wall, which is significantly greater than 0 (p=0.0175). The spatial distributions
of the static frequency parameters were correlated across the wall for individual episodes.
Figure 4.4 shows a representative example highlighting the regional similarities across the
endocardial and epicardial imaging planes for DF and RI. The average 2D correlation for
DF was 0.81 ± 0.06 and the 2D correlation for RI was 0.80 ± 0.06.
Contrary to the previous sheep model, AF in this model was driven by transient rotation
patterns (<2 rotations) instead of persisting rotors. Therefore, we compared the temporal
wavefront count and the primary propagation vectors to characterize the dynamic substrate
but did not look at detailed phase singularity dynamics. For dynamic parameters, paced
rhythms were used as controls. When multiple wavefronts were present simultaneously, the
angular average propagation vector of each wavefront was used as the primary angle on both
surfaces. Figure 4.5 shows a representative phase map in an instance of time from an AF
episode with clear di↵erences in the propagation pattern across both imaging surfaces. In
this example a transient rotor is observable on the epicardial surface, while the propagation
appears as a focal breakthrough on the endocardial surface. The average correlation in
wavefront count was 0.57 ± 0.027 for AF compared to a control correlation of 0.80 ± 0.047,
a significant reduction in correlation (p=0.0160). The average di↵erence in the angle of the
propagation vectors across the epicardial and endocardial surface was significantly increased
72

Dominant Frequency (Hz)
Endo

10 Hz

9
8

Regularity Index

Endo

0.5

0.4

7
0.3

6
5
4

0.2

3
2

0.1

1 Epi

Epi

0

0

Summary of Static Epi-Endo Concordance (N=15 episodes)
Parameter

Abs(Epi-Endo)

2D Correlation

Dominant Frequency (Hz)

1.06 ± 0.28

0.81 ± 0.06

Regularity Index

0.11 ± 0.02

0.80 ± 0.06

Figure 4.4: Simultaneously Acquired Static Parameters for Two-plane Imaging. Representative examples of dominant frequency and regularity index and a table summary of
experimental cohort..
for AF rhythms with a control di↵erence of 16.34 ± 4.89°and a di↵erence of 43.91 ± 1.60°for
the AF condition (p=0.0365).
Functional Gradients
Before AF was induced, we looked for transmural gradients in EP parameters. We assessed
average APD across both reflected imaging planes in the 4 plane acquisition. The average
restitution curves from the reflected signals are displayed in Figure 4.6. The APD is relatively
flat across both planes until the pacing cycle length dips below 250ms. However, the average
epicardial APD is consistently shorter than the endocardial APD when the tissue is paced
from the appendage, suggesting that there may be a repolarization gradient across the wall
in the canine atria.
Using alternating light we extended the dyssynchrony analysis across 4 imaging planes for
N=8 AF episodes. Figure 4.7 highlights the regional transitions across the transmural wall
for DF and RI. The average RI and DF values were flat across the transmural wall for all
episodes with no average trend between the epicardial and endocardial imaging plane.
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Figure 4.5: Simultaneously Acquired Dynamic Parameters for Two-plane Imaging. a) Representative example of phase wave with dynamics that di↵er across the transmural wall. b)
Example wavefront counts from paced and AF cases. c) Table summary of experimental
cohort.
Structure
Looking at 4 distinct locations within the atrial geometry we found evidence of fiber bundles
that seem to provide discrete fast connections between the epicardial and endocardial surface
instead of a transition of fibers that all run parallel to the epicardial surface. These fibers
did not make up the majority of the orientations observed in the histological sections and
they were not observed at a consistent fraction across the regions sectioned. There was not
a significant di↵erence between fiber orientation measured from Masson Trichrome or H & E
stains. Figure 4.8 displays example Masson Trichrome stains from each region as well as the
summary data for the average fraction of transmural-orienting fibers. The two regions with
the most fibers oriented through the wall were the left atrial appendage and the pulmonary
vein region. Both areas had 20-25% of fibers running in a non-parallel orientation. The
atrial roof and the left free-wall had <5% of fibers running through the wall to connect the
epicardial and endocardial surfaces. There was no significant di↵erence between the two
stains however, there was a significant di↵erence between the appendage and the free wall
or the atrial roof, as well as a significant di↵erence between the pulmonary vein and the
74

130

Action Potential Duration (ms)

125
120
115
110
105
100
Endocardium
Epicardium

95
90

0.2

0.25

0.3

0.35

0.4

0.45

0.5

0.55

Pacing Cycle Length (s)

Figure 4.6: Simultaneous Endocardial and Epicardial Restitution Curves. Errorbars represent s.e.m of experimental cohort.
free wall or the atrial roof. There was no significant di↵erence between the appendage and
the pulmonary vein region.The reconstruction of the pulmonary vein region imaged with
Bioinvision’s cryo-imaging technology can be seen in Figure 4.9 along with a 10 µM sample
transmural slice to highlight the fine microstructure of the fiber orientation.

4.4

Discussion

The results of this study extend those of the previous study in an ovine model, confirming
that transmural dyssynchrony is observed in multiple acute models of AF compared to paced
rhythms in the same geometry. There are many di↵erences across animal models including
crude shape di↵erences in the atria of canine and sheep. With this study, we confirmed that
AF dyssynchrony was not specific to the ovine model and could be replicated in a geometry
that more closely resembles human anatomy. Here, we showed that there were statistically
significant di↵erences across 2 plane and 4 plane propagation patterns during AF and paced
rhythms in the canine model. Additionally, the results confirm that dynamic analysis is required to tease out spatiotemporal dissociation patterns. Histological staining of transmural
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Figure 4.7: Simultaneously Acquired Static Parameters for Four-plane Imaging. a) Dominant
frequency b) Regularity index. c) Trends across the transmural wall for all AF episodes.
sections revealed discrete transmural pathways instead of a structured continuum between
the epicardial and endocardial surfaces in the canine atrial wall that may facilitate electrical
discordance across the wall and provide structural discontinuities that could harbor a 3D
substrate of AF. The geometry of the atria is seemingly much more disorganized than the
continual rotating fiber orientation observed across the wall in the ventricle. This may be
due to mechanical di↵erences during development. The atria are not required to generate
the same degree of force and therefore tight control of the wall structure is less crucial to
function. However, the resulting nonuniform distribution of transmurally-running fibers may
contribute ti the spectrum of functional dyssynchrony. Due to the significant longitudinal
and traverse conduction velocity di↵erences across individual cells, these fibers may serve
as short circuits, rapidly connecting the epicardial and endocardial plane. Depending on
the colocalization of the fibers and rotor cores, the short circuit may synchronize the functional pattern or disrupt the synchronization with rapid breakthrough. The structure alone
is not enough to harbor transmural discordance because it is not observed during paced
rhythms but the spatial relationship between these fibers and the AF drivers may create the
discordance in abnormal patterns. In addition to non-uniform structural paths that could
contribute to the spectrum of dyssynchrony, we also observed transmural di↵erences in APD.
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Functional gradients may also play an important role in the 3D substrate that perpetuates
stable AF. The transmural distribution of vagal innervation and receptors may provide an
additional factor that amplifies the dissociation across the wall in these models that was not
studied here.

1 cm

Figure 4.9: Representative Reconstructed Canine Pulmonary Vein.

4.5

Future Directions

A major limitation of both this study and the previous study described in Chapter 3 is the
fact that these studies were conducted on healthy tissue. The arrhythmias analyzed ignore
77

the temporal progression of AF in the clinical setting. There is a great deal of evidence
that functional and structural alterations across di↵erent scales within the heart develop
to favor AF perpetuation with increased duration [79, 9]. Several studies have begun to
investigate more sustained e↵ects of transmural di↵erences on the progression of AF. One
such study, conducted by Everett et al., performed endocardial non-contact mapping and
epicardial plaque electrode mapping in 5 di↵erent models of AF in canines to assess the
e↵ect of structural remodeling on the dimensionality of the AF substrate [52]. The authors
found that models with only electrical remodeling showed more dissimilarity between the
endocardial and epicardial surface activation patterns than models that also incorporated
structural remodeling. Conversely, Eckstein et al. charted the time course of epi-endo dissociation during pacing induced AF in goats. Their data suggests that progressive uncoupling
in both the longitudinal and the transmural dimension promote stability of AF and increase
the duration of AF [45]. The study also proposes that greater degrees of dissociation occur
in the thicker atrial tissue. Due to this discrepancy it is critical to expand this study to
include additional models of AF that develop stable substrates with some degree of pathophysiological remodeling. Infiltration of fibrosis and the redistribution of connexins have
the potential to severely disrupt the epicardial to endocardial relationship observed in these
models. Therefore, we have begun a preliminary study on a model of self-sustaining AF in
the canine to compare directly to the results of the acute model. The chronic substrate is
created by 6-8 weeks of high rate pacing-induced electrical remodeling. The chronic model,
which has been used extensively by many groups including our own, results in spontaneous
and self-sustaining AF. These animals were implanted with an ICD (Maximo, Medtronic)
and a right atrial appendage pacing lead. After at least 1 week of recovery, high rate pacing (400 bpm) was turned on using a custom software extension. If the ventricular rate was
greater than 130 bpm, 0.25-0.375 mg of digoxin was administered. The animals were checked
weekly for spontaneous AF and for ventricular rate control. After AF that sustained for >24
hours the hearts underwent an unrelated defibrillation experiment and were explanted for
optical mapping following the same procedure outlined above.
To clarify the structure-function relationship of the transmural fiber orientations, the anatomical architecture needs to be registered to the functional data. Analyzing both in the same
coordinate system may clarify the mechanism between di↵erent levels of dyssynchrony. Due
to the non-uniform distribution of these fibers, we may be able to use this analysis to identify
anatomical regions that are more likely to require dual sided analysis. If we do not have
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to map the complete surface area of both the epicardial and endocardial planes but instead
focus on regions that are more prone to dyssynchrony we may be able to acquire this data
clinically without requiring new technological advances in sensing.
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Chapter 5
Iterative Advancements Towards Low
Voltage Defibrillation Delivery
Strategies for Atrial Fibrillation
“ . . .When fibrillation stopped it was an accident and that [with therapy] one merely set up
the conditions to permit this accident to occur more readily” - Gordon Moe [120]
Portions of this chapter appear in the following original publication:
Janardhan A, Gutbrod SR, Li W, Lang D, Schuessler RB, Efimov IR. Multistage
electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation
with lower energy than a single biphasic shock. J Am Coll Cardiol. 2014; 63: 40-48.

5.1

Introduction

Electrical cardioversion of AF is e↵ective at restoring sinus rhythm but in its current form
it is not a practical continuous therapy. As long as the defibrillation threshold (DFT) exceeds the pain threshold, patients will not tolerate an implanted cardioverter. In an e↵ort
to drive down the DFT we previously developed an electrotherapy approach that shifts from
a single universal waveform to an adaptable sequence tailored to the frequency of each individual episode of AF. This therapy is rooted in the initial discovery that there is a shock
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strength phase dependence for successful unpinning of atrial and ventricular tachyarrhythmias [111, 150] and the notion that multiple pulses increase the probability of delivering a
low-voltage shock during the optimal temporal window [12, 112]. From these initial studies,
we hypothesized that a further decrease in peak voltage could be achieved if the multiple
pulses were followed by anti-repinning phases to prevent the reinitiation of AF. Our novel
electrotherapy consists of 3 stages of successively decreasing energy levels, which we refer to
as multi-stage electrotherapy (MSE) delievered in a frequency-dependent manner as shown in
Figure 5.1. We prospectively compared MSE with the gold standard single biphasic shocks
(BPS) to establish the DFT in an in vivo canine model of self-sustaining AF, delivered
through chronically-implanted transvenous leads. The chronic model of AF is described in
2. Briefly, a pacing lead (model number 5096; Medtronic, Inc.) was implanted into the right
atrial appendage (RAA), and defibrillation leads were implanted into the RAA (model number 6935; Medtronic, Inc.), left pulmonary artery (LPA), and coronary sinus (CS) (model
number 6937A; Medtronic, Inc.). The CS of canine hearts often tapers abruptly, preventing
implantation of a lead in the distal CS. The inferior branch of the LPA runs adjacent to the
lateral CS and was therefore used to anatomically approximate the clinical distal CS implantation. The pacing lead was connected to an implanted high-rate pacing (HRP) device
(Medtronic, Inc.) programmed with custom software. The HRP at 400 beats/min began
1 week after implantation from the RAA pacing lead at twice the atrial capture threshold.
For this study, AF was defined as self-sustained AF lasting >30 min during interrogation.
Once this arrhythmia was observed, the animal was rechecked 1 week later to determine if
AF persisted for >1 week. If AF was present defibrillation studies were performed.
A total of 32 in vivo defibrillation studies were performed in 8 dogs; 123 episodes of sustained
AF were successfully converted to sinus rhythm, yielding an average of 3.8 cardioversions
per study. The mean DFT of MSE was significantly lower compared with that of BPS in
terms of total energy (0.16 ± 0.16 J vs. 1.48± 0.91 J, respectively; p <0.001) and peak shock
voltage (31.1 ± 19.3 V vs. 165 ± 34 V, respectively; p <0.001). Importantly, these results
demonstrate that atrial DFT can be e↵ectively lowered by using commercially available
transvenous implantable leads placed in RA and CS.
Subsequently, we investigated the mechanism by which MSE terminates AF by using optical
mapping. The hearts of 7 dogs with self-sustaining AF induced by HRP were explanted for
mechanistic studies. Due to denervation, some hearts required the perfusion of low doses of
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Stage 1

Stage 3

Stage 2

Figure 5.1: Multistage Electrotherapy Waveform
acetylcholine to induce sustained AF ex vivo. A representative AF episode is shown in Figure
5.2. Sample optical recordings are shown from the highest dominant frequency locations. To
illustrate a possible mechanism MSE, the spatial evolution of the tissue response after the
application of MSE was contrasted between an example of successful MSE application (with
a peak voltage of 7 V/cm) and an unsuccessful application (5 V/cm) from the same animal.
Phase maps from these two example sequences are displayed in Figure 5.3. MSE succeeds
when Stage 1 can homogenize the tissue, which allows the Stage 2 shocks to prevent any
critical points that may result from the virtual electrode polarization (VEP) of the initial
shocks or the original drivers to reinitiate the arrhythmia. Stage 2 works by continually
capturing an increasing amount of tissue with each shock. This action thus prepares the
atria for the pacing spikes of Stage 3 to reset the repolarization pathway. In the unsuccessful
case, the therapy fails during Stage 2. Due to the results of this biophysical investigation we
designed several studies to optimize the timing of Stage 2 delivery and test the efficacy of
incorporating spatial sensitivity to drive the DFT down further. The goal of these studies
is to design an electrical cardioversion protocol that exploits both temporal and spatial
vulnerabilities. Following a similar pattern used in earlier development we used a rabbit
model to establish sensitivity and optimize parameters before implementing the therapeutic
protocol in a canine model to test the feasibility of exploiting it.
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Figure 5.2: Example Frequency Content of ex vivo Canine Atria. a) Optical field of view.
b) Spatial dominant frequency. c) Spatial regularity index [90]

5.2

Methods

All animal procedures were performed in accordance with the ethical guidelines of the National Institutes of Health and were approved by the Washington University in St Louis Animal Studies Committee. Acute AF was induced in Langendor↵-perfused, pressure-loaded
rabbit hearts (N=5 per experimental condition, N=15 total). The animals were anesthetized
with 80mg/kg Sodium Pentobarbitol and 400 U/kg of heparin IV through the ear vein
catheter. When unresponsive to pain, the heart was removed via gross dissection and a cannula was placed in the aorta to allow retrograde perfusion of oxygenated Tyrode’s solution.
Epicardial fat was removed from the atria to provide a clean field of view. The interatrial
septum was perforated with access gained through the pulmonary veins, taking care not to
damage the sinus node. The pulmonary and caval veins were tied o↵, while the pulmonary
artery was cannulated and loaded with a constant elevated pressure of 10-15 cm H2 O. The
expanded atria could then support an arrhythmia that was induced with programmed stimulation (100 cycles of 50 Hz AC pacing). A bipolar sensing electrode was placed on the
left atria to estimate the frequency with Labchart’s real-time cycling algorithm (AD Instruments). The voltage delivered was recorded with a di↵erential voltage probe (Yokagawa)
and the current was recorded with a AC/DC current probe (A622, Tektronix, Inc., Beaverton, Oregon) for each defibrillation strategy. For multi-path therapies these measurements
were made upstream of the digital relay gates. A CMOS camera was suspended above the
preparation to view the superior aspects of the inflated atria. Blebbistatin and di-4ANEPPS
were perfused to prepare the tissue for optical mapping using a 520nm excitation LED and
a >650nm long pass emission filter. Due to the transparency of the inflated atrial tissue
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Figure 5.3: Comparison of Successful and Unsuccessful Multistage Electrotherapy Application. a) Successful termination with a peak shock strength of 7 V/cm displayed with
representative optical trace from middle of the field of view (orange trace). The panels show
the evolution of phase during therapy application, beginning with an AF example, then proceeding to Stage 1 shocks 1 and 2; Stage 2 shocks 2, 4, and 6; and first stimulus of Stage 3.
The middle left panel in A shows a representative optical action potential with the definition
of phase. b) Unsuccessful termination with a peak shock strength of 5 V/cm displayed with
representative optical trace from the middle of the field of view (blue trace). Panels show
evolution of failed response to therapy, starting from an AF example, then progressing to
Stage 1 shocks 1 and 2; Stage 2 shocks 2 and 4 through 6; and first stimulus of Stage 3. [90]
the optical recordings from this perspective are a superposition of the atrial and ventricular
signals. It is important to maintain sinus rhythm in the ventricles while the atria are in AF
so that the signals can be separated digitally by frequency content using wavelet analysis.
Therefore, the defibrillation shocks were triggered by the R-wave to prevent inducing ventricular arrhythmias. If a ventricular arrhythmia was induced, it was immediately terminated
before continuing with the protocol.
Defibrillation efficacy
Three separate experimental protocols were used to test 12 di↵erent therapies. Each experiment included a control condition (BPS) to account for di↵erences across animals. . For
the first study (Experiment I) the timing parameters for coupling stage 2 and stage 3 were
altered. The interstage delay and the intra-stage frequency were varied compared to the AF
cycle length (CL) to create the following 5 experimental conditions: 1) 50% AF CL delay
+ 100 % AF CL frequency, 2) 80% AF CL delay + 100% AF CL frequency, 3) 100% AF
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CL delay + 100% AF CL frequency, 4) 50% AF CL delay + 90% AF CL frequency, and 5)
50% AF CL delay + 70% AF CL frequency. All therapies were delivered across a single pair
of mesh electrodes. For the second study (Experiment II), we tested delivery of only Stage
1 across varied shock vectors to create the following 4 experimental conditions: 1) 2 shocks
delivered anterior-posterior, 2) 2 shocks delivered across lateral vector, 3) 1 shock delivered
anterior-posterior followed by 1 shock lateral vector, and 4) 1 shock delivered across lateral
vector followed by 1 shock delivered anterior posterior. All pairs of shocks were delivered
within 1 AF CL. For the third study (Experiment III) we added more electrodes to test the
following conditions: 1) 2 shocks delivered with an angle shift of 60°, 2) 2 shocks delivered
with an angle shift of 120°, and 3) 3 shocks delivered with two angle shift of 60°.
a)

Sensing Electrode

Camera Rail

Defib
Meshes

LED
Pacing Electrode

0

LA EG

EKG

Voltage (V)

b)
40

Time (ms)

Figure 5.4: a) Experimental Set-up for Rabbit Atria Defibrillation Efficacy Studies. b)
Representative successful cardioversion with 2 Stage 1 shocks at 30 V each, rotated by 270°.

Custom devices with 6 cm x 1 cm stainless steel mesh electrodes were placed in the bath
surrounding the whole heart. Two di↵erent devices containing 4 electrodes 90°apart or 6
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electrodes 60°apart were used in these experiments. All shocks were delivered via a custom Labview based defibrillation platform developed by Cardialen, Inc that is on loan to
Washington University in St Louis. Additional digital relay gates were added to the front
of the system to provide the timed vector switches. The relay gates were constructed with
ST1-DC5V relays (Panasonic) controlled by custom Labview code and example of which is
included in Appendix C. The complete experimental set-up is displayed in Figure 5.4.
Once sustained AF (>1 min without self-terminating) was achieved, the therapies were
delivered in a randomized order. Each therapy was delivered, starting at 10V and increased
in increments of 10V until successful termination was achieved. Every therapy was tested
at least 5 times per animal per experiment. Ten seconds were allowed to pass after a failed
defibrillation attempt before another shock was delivered to prevent coupling. Five minutes
passed before re-inducing AF after each successful cardioversion.
A probability of success curve with a Weibull distribution was created from the compiled
series of successful defibrillations for each condition. From these distributions, the shock
strength for 50% success (p50) and 80% success (p80) was determined. Figure 5.5 illustrates the process. Statistically, the Weibull distribution curves were compared within each
experiment using a log-rank test for multiple conditions.
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Figure 5.5: Weibull Distribution Fit to Defibrillation Threshold Data. a) Distribution of
successful BPS shocks. b) Weibull Fit to DFT data. c) Quantiles show linear trend which
means that the Weibull Distribution is a good fit to the DFT data.
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5.3

Results

Experiment I
In this study we used the ex vivo rabbit model of AF to address the e↵ects of the timing of
the multiple components in each stage of MSE on defibrillation efficacy. The probability of
success curves for all 5 conditions are displayed in Figure 5.6. Since the Weibull distribution
is based on a model fit through the data, the 5% and 95% confidence intervals are also
displayed for each condition. The long-rank test determined that the curves are statistically
di↵erent (chi-squared 25.5, p <0.005). The p50 and p80 values display similar trends between
therapies. The minimum p50 was achieved with an inter-stage delay of 50% AF cycle length
(CL) and a stimulus frequency of 100% AF CL. The mean p50 shock strength for this
therapy was 2.73 V/cm (CI 2.73- 3.64 V/cm). The mean p50 shock strength for BPS was
5.45 V/cm (CI 4.55-6.36 V/cm). Elongating the inter-stage delay was detrimental to the
DFT for both tested conditions. This seems to hold with the results observed optically in the
chronic canine study. AF episodes in this model have a mean frequency of 15.54Hz, which is
comparatively fast. We looked for a correlation between AF CL and DFT. These therapies
are all dependent of frequency and it is possible that the pacing spikes in Stage 3 begin to
approach the frequencies with which we induce AF in healthy tissue. Therefore we looked
for a frequency limit that may lead to reinduction and drive the DFT up. Table 5.1 displays
the results of the correlation with the DF assessed optically and the DFT for all therapies.
Only the intra-stage frequency at 70% AF CL was negatively correlated with DFT.
50% AF CL
80% AF CL 100% AF CL 50% AF CL
50% AF CL
interstage
interstage
interstage
interstage
interstage
delay,
delay,
delay,
delay,
delay,
70%AF CL
90%AF CL
100% AF CL 100% AF CL 100% AF CL
intrastage CL intrastage CL intrastage CL intrastage CL intrastage CL

-0.3234

-0.0367

-0.3046

-0.3380

-0.6983

Table 5.1: Correlations between Domination Frequency and Defibrillation Threshold for
Temporal Multi-stage Therapy.
Experiment II and III
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We used the ex vivo rabbit model of AF to address the e↵ects of using multiple shock vectors
independently or in series for Stage 1 on defibrillation efficacy. The probability of success
curves for BPS compared to Stage 1 for both vectors are displayed in Figure 5.7. The longrank test determined that the curves are statistically di↵erent (chi-squared 12.06, p <0.01).
At p50 the lateral vector has the lowest DFT, 3.64 V/cm (CI 2.73-4.58 V/cm) compared
to the BPS DFT at 5.45 (CI 4.55-6.36 V/cm). At p80 there is still an advantage to having
2 shocks but neither vector is more advantageous. Figure 5.8 shows the results of using 2
vectors with a shift in the vector by 60°, 90°, 120°or 270°. The lowest DFT is achieved with
a 60°shift in Stage 1 with a P50 of 2.72 V/cm (CI 1.82-2.72), followed by a 270°shift in Stage
1 with a p50 of 3.64 V/cm (CI 3.64-4.54 V/cm). Using 3 shocks resulted in a p50 of 3.64
(CI 2.72 - 5.45 V/cm), which had the widest range in confidence intervals (data not shown).
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5.4

Discussion

In order to compare defibrillation paradigms it is imperative to have a robust method for
quantifying defibrillation efficacy. In the past we have used the sample mean of the DFT as a
measure of efficacy. Davy et al. evaluated using DFT in a canine model and concluded “that
no unique DFT exists, . . .the relationship between the likelihood of successful defibrillation
and delivered energy is best described by a ‘dose-response’ curve requiring multiple trials
for evaluation” [41]. Therefore we designed a new method to use Weibull survival analysis
to develop dose-response curves with respect to peak voltage and address the probabilistic
nature of defibrillation. By optimizing the therapy in both the temporal and spatial domain,
we found that a 60°shift between the two shocks of Stage 1 improves defibrillation efficacy.
Additionally a short inter-stage delay is more critically important than cycle length of Stage
2. We did find a negative correlation between AF CL and efficacy in this model if Stage
2 and 3 are delivered faster than 90% of the AF CL. Because this model leads to AF CL
that are twice what is seen clinically in humans, it is unclear if this risk persists in larger
models. The ex vivo bath environment has several important limitations. The bath provides
a highly conductive alternative path for the current to take through the mesh electrodes.
The lack of methodology to account for the fraction of current that travels along this path
makes it difficult to interpret the dose-response curves with respect to total energy delivered.
Additionally the charge density from the mesh electrodes is more uniform than that created
with lead-based coils.
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Additionally, with the myocardium exposed we have the flexibility to define shock vectors at
any angle. Traditional lead based defibrillation does not provide the same degree of flexibility
in available shock vectors since there are a fixed number of vessels that can accommodate
shock coils. Additionally, there is some degree of variability in vascular anatomy that would
make controlling for a 60°shift challenging. To test the feasibility of transferring the spatial
advantage to lead-based system we have begun to test the MSE with multiple paths in the
same chronic self-sustaining AF model described above (N=4). At the time of pacemaker
implant we also implanted shock coils (Medtronic 6947, 6937A, or 6935) to the superior vena
cava (SVC), the right atrial appendage (RAA), the proximal coronary sinus (CS), and the
left pulmonary artery (LPA) under fluoroscopic guidance. We used two shock vectors that
transect both the anterior-posterior and lateral orthogonal paths: SVC to CS and RAA to
LPA. Unfortunately, it is extremely difficult to target the left atrium in a lead-based system.
After sustained AF (>24 hours) was achieved with high rate pacing (average DF of 8.15 ±
0.65 Hz), the animals were scheduled for a terminal defibrillation study.
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Figure 5.9: Multi-stage Multi-path Defibrillation Paradigm in Large Animal Model a)
Weibull distributions b) p50 c) p80. Errorbars represent 95-5% CI.
We tested 5 separate therapies: BPS, MSE across only the SVC-CS vector, MSE across the
RAA-LPA vector, a vector shift between the shocks in Stage 1, and a repeated shift in Stage
2 where alternating Stage 2 pulses were delivered across di↵erent vectors to combine the
results of the rabbit study into a multistage, multi-path therapy paradigm. In these studies,
Weibull survival curves for both peak voltage and total energy can be calculated because the
R
current path is limited to within the closed chest. Total energy is defined as: dV dI · dt.
The preliminary results of this pilot study are in the process of being analyzed. Preliminary
results are shown in Figure 5.9. The vector switch in Stage 1 required the lowest peak voltage
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to defibrillate with 50% and 80% success rates. Although these results are based on a small
N, this pilot study suggests that including a multi-path component continues to drive down
the peak voltage required to defibrillate and should be investigated in a larger study.
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Chapter 6
Multifunctional Stretchable
Electronics Quantify the Spatial
Electrophysiology of Cardiac Tissue
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6.1

Introduction

High-density cardiac mapping has been an important experimental and clinical tool for the
identification and the evolution of the understanding of normal conduction and arrhythmia
mechanisms. The first electrode “heart socks” and temporary silicon electrode sheets were
developed in the 1980s for global epicardial electrical mapping. As basic research tools,
many of the first sock devices were handmade designs with recording electrodes mounted
on synthetic fabric, sewn to loosely fit the ventricle [76, 142, 201, 202]. Studies with these
devices were used to investigate local potential heterogeneities in ischemia transition regions [170], to visualize atrial activation patterns including preferential pathways [43], and
to test cardiac resynchronization therapy pacing sites for mechanical resynchronization [80].
However, due to the dynamic contours of the beating heart, it is difficult to achieve uniform quality of contact consistently across the heart with the fabric socks. Additionally,
the handmade assembly creates limitations in spatial coverage, array density, and scalable
manufacturing. Although still used frequently in the research setting, these devices have
not transitioned to clinical applications. As a result, alternative strategies based on serial
mapping with point-contact catheters or imaging techniques that use fluorescence, nuclear
magnetic resonance or ultrasound have emerged to attempt to replicate the spatial coverage and specificity required. Moreover, the heart is a complex electromechanical syncytium
with numerous elements that work in tandem. Much has been gained through studies of
each network in isolation. However, the interplay of pathophysiological remodeling across
the electrical, metabolic, and mechanical machinery of the heart compels the development
of tools that simultaneously probe various states and continuously provide multiparametric
mapping capabilities inclusive but far beyond electrical sensing in a high resolution manner.
This is a challenge with conventional materials, device technologies and imaging modalities but recent developments in material fabrication and innovative circuit design provide a
stretchable electronics platform from which to integrate a range of sensors with the epicardial
surface or transmural wall of the myocardium.
Using this platform, we built multifunctional semiconductor systems in lithographically defined configurations on thin elastic membranes designed to hug the curvilinear contours of the
cardiac geometry or be inserted within the geometry with compatible mechanics so as not to
disrupt contraction. The physical format of the 3D epicardial membrane resembles that of the
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naturally occurring membrane that surrounds the heart, known as the pericardium. These
systems, which we refer to as 3D multifunctional integumentary membranes (3D-MIMs) provide conformal interfaces to all points on the heart, with robust but non-restricting contacts
enabled by the soft elasticity of the membrane itself. A diverse array of sensors and actuators
can be placed in custom orientations across the membrane and tailored to di↵erent shapes
depending on the intended implementation. Planar sheets, epicardial membranes, balloons,
and ultrathin injectable needle-type sensors have all been designed and tested. Examples of
each design are shown in Figure 6.1. We used ex vivo rabbit hearts to demonstrate the utility
of this platform and test the feasibility of a range of sensors to simultaneously interrogate
many cardiac states for research, diagnostic, or therapeutic use.
(a)

(b)

(c)

(d)

Figure 6.1: Diversity in Cardiac Specific Stretchable Electronics Platform. a) sheet, b)
epicardial membrane, c) endocardial balloon, d) transmural needle

6.2

Methods

Design and Fabrication
The cardiac specific devices presented here build upon previous work at the University of
Illinois- Urbana Champaign on soft-contact electronics [96, 98]. The elastomer substrate
and the circuits are designed to stretch, twist, and bend to great extremes while maintaining the integrity of the circuits. The fabrication of the 3D-MIMS begins with the creation
of a thin, 3D elastic membrane shaped to the heart. As shown in Figure 6.2, optical segmentation techniques first capture the full 3D geometry of a heart of interest. For the
experiments presented here, a single representative rabbit geometry [116] was used in place
of patient-specific imaging. A commercial 3D printer (ZPrinter 450, Z-Corporation) then
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renders a solid model of the heart in a proportionally scaled form to serve as a substrate
for mounting ultrathin electronic/optoelectronic sensor systems, separately prefabricated on
planar substrates. The methods for creating these components exploit modern integrated
circuit technologies and achieve spatial resolution far beyond that possible with manually
assembled arrays. The sensors are patterned by photolithography and wet etching. The
3D-MIMs are fabricated using standard planar processing of inorganic semiconductor materials (Si, InGaN or AlInGaP) followed by transfer printing onto substrates coated either
with a bilayer of polyimide (PI) on poly(methyl methacrylate) (PMMA) or poly(ethylene
terephthalate) (PET) on poly(dimethylsiloxane) (PDMS) [97, 100, 101, 6]. Dissolution of the
PMMA or delamination from the PDMS allows release of the devices. Metal layers (Cr/Au)
are vacuum-deposited and patterned to form interconnects, resistors and electrodes. Application and patterning of a polymer encapsulation layer (PI or a photosensitive epoxy, SU8)
on top of the devices completes their fabrication. Transfer printing delivers the resulting
structures to a thin film of a low-modulus silicone elastomer (Ecoflex, Smooth-on). A thin
layer of silicone elastomer is casted and cured on top of the heart model with these multifunctional devices on its surface. The front faces of the device components contact the model
while the back faces bond to the elastomer. Removing the 3D membrane with integrated
device components from the model prepares it for deployment as a type of “instrumented”
artificial pericardium. Figure 6.2 shows a representative 3D-MIM that includes microscale,
inorganic light-emitting diodes (µ-ILEDs) based on indium gallium nitride (InGaN) for optical mapping, silicon (Si) nanomembranes for strain gauges, gold (Au) electrodes for electrical
sensing/stimulation, iridium oxide (IrOx) pads for pH sensors and Au serpentine resistors
for temperature sensors/ heaters. A serpentine connection design removes the rigidity of
the metal wiring, allowing the circuit to stretch with the heart and the substrate on each
contraction. The epicardial devices have secure holes in the substrate to prevent trapping of
fluid between the device and the heart.
The 3D-MIM is engineered with overall dimensions slightly smaller than those of the real
heart, to provide adequate elasticity and mechanical support for robust contact with the epicardium during diastole and systole, but with sufficiently small pressures to avoid disruption
of natural behaviors of the cardiac tissue. The serpentine mesh that interconnects the device
components covers the ventricle and conforms to the contours of the epicardium. Although
this example is designed for research applications on rabbit hearts, the same strategies are
applicable to human hearts, or even other organ systems.
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Figure 6.2: 3D-MIM and Sensors. a) Graphical depiction of the key steps in device design and
fabrication. Scale bar, 2 cm. b) Images of a representative 3D multifunctional integumentary
membrane (3D-MIM) integrated on a Langendor↵-perfused rabbit heart. The white arrows
highlight various function elements in this system. The electronics can cover both anterior
and posterior surfaces of the heart (inset). Scale bars, 6 mm. c) Magnified views of the
functional elements in conformal contact with the epicardium. The images are recorded
from the back side of the devices. Scale bars, 500 microns. [206]
Conversely for the ultra-thin needle-type sensors, Au metal film (150nm thick) was patterned
onto 6 µm thick polyethylene terephthalate needles [184, 102]. The needles were integrated
with three temperature coefficient of resistance sensors, spaced 1 mm apart, each consisting
of a 10 µm wide Au serpentine filament occupying 0.4 mm 0.4 mm. A 4-wire contact configuration reduced errors caused by changes in lead wide resistances, ensuring measurement
of local temperature according to the individual sensing elements. SU-8 (5 µm thick) was
encapsulated over the sensor to provide electrical insulation and a moisture barrier. The
needles were mounted onto 50 µm tungsten guide needles with cellulose for injection into the
transmural wall. After implantation, the guide needle was removed by dissolving the cellulose adhesive, thus leaving only the ultrathin flexible temperature sensors embedded within
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the myocardial tissue. A thin, flexible heat-seal conductive cable (Elform, HST- 9805-210)
serves as a connection to external hardware for data acquisition, power supply and control.
More details on the fabrication process that was developed by our collaborating lab can be
viewed in the corresponding publications.
Animal Experiments
Feasibility experiments in the rabbit model were conducted in accordance with the ethical
guidelines of the National Institutes of Health and with the approval of the Institutional
Animal Care and Use Committee of Washington University in St Louis. Briefly, the animal
is anesthetized with 80mg/kg Sodium Pentobarbitol and 400 U/kg of heparin IV through
the ear vein catheter. When unresponsive to pain, the heart is removed via a thoracotomy
and a cannula is placed in the aorta to allow retrograde perfusion of oxygenated Tyrode’s
solution. The perfusion mimics the electrolyte balance within the animal and provides an
energy substrate for the heart to continue to function normally from an electrical perspective.
The heart is submerged in a perfusion chamber maintained at 37 °C with a pH in the range
of 7.35-7.45. Coronary perfusion is maintained at 60-80 mm Hg with peristaltic pumps.
The optical signals of transmembrane potential (Vm ) rely on the collection of fluorescent
signals from a potentiometric dye (di-4 ANEPPS) with a CMOS camera; when needed to
avoid motion artifacts, an excitation-contraction uncoupler (Blebbistatin) is also added to
the perfusate. 3D-MIM devices with various sensors were deployed after contraction was
arrested and the heart was exposed to a number of conditions including pacing, pinacidilinduced ventricular fibrillation, cold temperatures, ischemia, reperfusion, and focal ablation
with a cautery pen.
The electrical signals are recorded from the Au electrodes on the 3D-MIMs with a 240channel unipolar EG acquisition system (Astrocard, Boston) and a custom-built interface.
Both the optical and electrical signals are collected at a sampling frequency of 1 kHz, aligned
with a trigger TTL pulse and post-processed separately in custom MATLAB software. The
electrical signals acquired from the 3D-MIMs are first filtered with a 60 Hz notch filter internal to the acquisition software, then the electrophysiological parameter of interest (e.g.
activation time) is calculated and aligned to the spatial coordinates of the electrodes based
on the optical background file. The optical signals are binned, filtered and normalized as
previously described in Chapter 2. The electrophysiological parameters are calculated for
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Figure 6.3: Analysis Methodology for OptoElectric Spatial Comparisons. a) Electrical mapping, b) Optical mapping
the complete field of view. To create the spatial maps, the activation times are interpolated
using MATLAB’s internal function for cubic interpolation of scattered data. The optical
map is also sampled at the coordinates of the electrodes and the same interpolation method
is applied to compare the full-resolution optical pattern with the sampled optical map and
the electrical map (Figure 6.3). Data for temperature and strain sensors are acquired with
measurements of resistance of each sensor using a custom-built system based on National
Instruments PXI-6289 board. The resistance of each of the 16 sensors is recorded simultaneously with a 160 mA probe current, a 16-bit A/D converter and a 15 ms sampling period
at each sensor.
To design the mechanical compatibility of the 3D-MIM, we deployed the devices on a leftsided working heart model instead of a Langendor↵ perfused model (N=3 experimental, 3
control). In this model the left atrium is cannulated through an incision in the appendage.
All other outflow ostia (vena cava and pulmonary veins) are tied o↵. The aorta is attached
to a water column that maintains an afterload of 60-80 mm Hg. A modified Krebs perfusate
is used with 20 mg/L albumin to carry more oxygen to the working myocardium and 2 mM
sodium pyruvate to provide a fatty acid energy source. Blebbistatin is not used in these
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experiments. The performance of the cardiac contractions and the health of the heart were
monitored for at least 1 hour with and without the 3D-MIM.
For the ultra-thin needle-type sensor experiments a Langendor↵-perfused left ventricle (LV)
flap preparation was used (N=7 hearts). After the heart was removed the distal left coronary
branches were ligated and the LV free wall was dissected free by opening from apex to base
along the ventricular septum. The LV free wall flap was pinned epicardial side down onto
the silicone floor of the bath. Figure 6.4 illustrates the implant procedure for injecting the
ultrathin temperature sensors into the myocardium. The ultrathin needle-type temperature
sensors were implanted in the left ventricular wall of perfused a rabbit heart from the exposed
endocardial surface. Due to the flexible nature of this device, the sensor was bonded to
a tungsten guide needle (50 µm thick) using cellulose, which is a water-soluble and bioresorbable natural polymer, in order to provide sufficient support for implantation. After
implantation, the guide needle was removed by dissolving cellulose adhesive, thus leaving
only the ultrathin flexible temperature sensors in the myocardial tissue.
Ablation lesions were drawn in close proximity to the implanted temperature sensors. For radiofrequency ablation (RF), a commercially available, non-irrigated 4 mm tip Safire catheter
(St Jude Medical, Saint Paul, MN) was used for 60 seconds at varying powers (3-20W), temperature limited at 60 °C. Cryoablation was performed using an AtriCure system (AtriCure,
West Chester, OH), for 120 seconds at a target temperature of -50°C. Once all endocardial surface area was exhausted, the heart was removed from the perfusion chamber and
incubated in a 1% solution of triphenyltetrazolium chloride (TTC) for 20 minutes at 37C.
Lesions were transected and photographed [57]. TTC-negative regions were classified as
being successfully ablated while regions staining positive for TTC were considered viable.
These images were converted to grayscale and analyzed using custom MATLAB code to assess depth of ablation and percent transmurality of each lesion. Temperature was determined
by monitoring resistance change of implanted sensors while conducting cardiac ablation on
the implantation site. The resistance change was recorded via a digital multimeter (National
instruments; Austin, TX) under 4-wire resistance measurement mode with custom electronics programmed with LabVIEW software allowing simultaneous recording at 4 Hz sampling
rate [184]. Resistance values were converted to temperature based on individual calibration
curves for each sensor. Thermal conductivity was assessed using fabricated TCR sensors by
analyzing thermal transient data while applying 10 mA current for 2 s on sensing elements,
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which generated joule heating [185]. The chronothermographs recorded during RF ablations
were analyzed with custom MATLAB code.

RV

SEPTUM

LV

(a)

(b)

(c)

(d)

Figure 6.4: Implant of Ultra-thin Needle Electrodes

6.3

Results

Mechanical E↵ects of 3D-MIM
A chronological comparison of the pressure waveform at the aorta and electrophysiological
indicators of ischemia during the working heart preparation with and without the 3D-MIMs
on the heart was assessed to aid in the design of the mechanical compatibility of the device.
The results can be seen in Figure 6.5. Signs of ischemia include a decrease in the pressure
waveform, which is an indication of contractility, a decrease in the corrected QT interval of
the far field electrogram and an elevation of the ST segment of the far-field electrogram. The
temporal pattern for the control hearts indicates that the working heart preparation is not
stable across the hour even without the 3D-MIM, however the pressure waveform and the
ST elevation do not seem to indicate that the 3D-MIM is impairing functionality. The QTc
is shortened in the 3D-MIMs group, which does suggest that there may be some impact on
repolarization that would need to be investigated further.
Spatiotemporal Cardiac Measurements and Stimulation of 3D-MIM
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Figure 6.5: Chronological E↵ects of 3D-MIM on Contraction in Working Heart Model. a)
Electrical parameters of ischemia. b) example pressure waveforms and electrocardiograms
with and without the 3D-MIM[206]
To demonstrate the various functional modes of operation we conducted high-precision mapping of epicardial electrical activity. A single 3D-MIM can accommodate some range in specific sizes and shapes associated with a single type of animal model, due to its soft, elastic
construction. The device here incorporates 68 Au electrodes (1 mm2 surface area and spacing
of 3.5 mm), distributed across both the anterior and posterior surfaces of the epicardium.
The electrochemical impedances of individual electrodes are 2 k⌦ at a frequency of 1 kHz,
measured in phosphate-bu↵ered saline. In the current design iteration, these devices achieve
a spatial resolution of 5 mm with an average signal to noise ratio of >40 dB across both
pharmaceutically arrested and beating rabbit hearts. The transparency of the membrane
allows simultaneous optical mapping through voltage-dependent fluorescence, as a means
for validating the electrical measurements. Signals were acquired from four hearts under a
variety of conditions: normal sinus rhythm, and paced at a range of frequencies and from a
range of electrode pairs to increase the variability of the propagation patterns in the spatial
activation maps. The surface electrograms captured various key morphologies associated
with the QRS and T waves (Figure 6.6). Representative maps and correlations between
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electrical and optical activation times appear in panel c and b, respectively. The overall linear correlations between optical and electrical activation times were 0.957 for sinus data and
0.943 for paced data. Additionally, activation recovery interval and action potential duration values were correlated across recording methods. The results show a strong correlation
and similar spatial patterns as seen in Figure 6.7. These studies indicate that this configuration of measurement electrodes can replicate patterns of activation to a resolution that
captures the spatial variations observed optically. Figure 6.6 presents a 3D map derived
from signals recorded from the anterior and posterior surfaces of the heart. Unlike optical mapping where motion artifacts dramatically impact the measurement quality requiring
static heart geometries, electrophysiological mapping with 3D-MIMs can be applied under
normal beating condition. The integrated sensors move synchronously with the underlying
cardiac tissue. Although it is practically difficult to avoid relative lateral motion between
the sensors and the epicardium during beating cycles, due to the engineered geometries of
3D-MIMs, the displacement can be minimized to be less than the characteristic sizes of the
sensors and to have negligible impact to the signal quality. This feature is necessary for
extending the mapping capabilities beyond laboratory studies and implementing in clinical
electrophysiology.
A 3D-MIM with arrays of temperature sensors illustrates capabilities in monitoring spatial
distributions of cardiac temperature. The temperature sensor elements use designs established previously, consisting of serpentine traces of gold (20 µm wide, 50 µm thick) in which
changes in resistance correlate to changes in temperature. The temperature sensors exhibit
linear responses over physiological range, with a measurement precision of 23 mK when
sampled at 2 Hz in typical hospital settings. Figure 6.8 shows a 3D-MIM with 16 integrated temperature sensors during use on a beating heart. The sensors are calibrated in
a temperature-controlled water bath before the animal experiments, exhibiting average responses of 1.23 ± 0.05 ⌦/°C over 16 sensors. In one experiment, the temperature of the
heart was changed by altering the temperature of the perfusion. The measured epicardial
temperature gradually decreased by 7°C during cooling of the perfusate, with a uniform
distribution of temperature across the heart. The heart rate, determined from the far-field
electrocardiogram, decreased with decreasing temperature and recovered to the original value
as the temperature returned to physiological levels, indicating that temperature controlled
the rate of myocardial metabolism. In a second experiment, a cautery pen was used to
acutely burn a small region of the epicardium, simulating clinical ablation. The associated
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Figure 6.6: High-Density Electrical Mapping: Activation. a) Representative optical and
electrical signals acquired simultaneously. Scale bar, 7 mm. b) Top: schematic illustration
of activation time definition. Bottom: correlation of electrical and optical activation times. c)
Interpolated spatial activation maps determined from the electrical and optical measurements
for a paced heart and sinus rhythm. d) 3D mapping of electrical signaling from both the
anterior and posterior surfaces of the heart. Scale bar, 7 mm. [206]
temperature map (Figure 6.8) shows localized elevation of temperature near the point of
ablation. Such information can be used as feedback for clinical control of ablation time and
size of a↵ected area. In combination with electrical sensors, such a device could provide the
real-time relation between temperature and excitation.
Transmural Spatiotemporal Temperature During Cardiac Ablation with Ultrathin Needles
The three temperature sensing moieties on the ultrathin needle-type temperature sensors
are embedded within the transmural wall such that the proximal temperature sensor (Sensor 3) is located just below the endocardial tissue surface and the implant depth of distal
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(a)

(b)

(c)

Figure 6.7: High-Density Electrical Mapping: Repolarization. a) Definitions of activation
recovery interval and action potential duration. b) Correlation between electrical and optical
parameters. c) Example spatial patterns from electrical and optical parameters [206]
temperature sensor is approximately 3 mm. The sensor provides real-time chronothermographs at di↵erent tissue depths during ablations (Figure 6.9). Of note, the extremely thin
geometry and high degree of mechanical flexibility of the device allow great biomechanical
compatibility, minimizing the risk of tissue damage (see publication for Supporting Video 1).
The temperature change was monitored while conducting both cryo-ablation and RF ablation to demonstrate performance at a range of temperature values relevant to ablation. The
chronothermograph was monitored at three tissue depths to characterize the distribution of
thermal energy across the wall for a successful lesion.
For both cryo and low power RF ablation, the greatest and fastest temperature change was
observed by the sensor located proximal to the ablation source, while those located deeper in
the myocardial tissue showed progressively less and slower change as shown in (Figure 6.9).
The thermographs of both ablation methods showed distinct phases, which may correspond
to mechanistic changes in lesion formation. The temperature profiles from cryoablation
show definitive freezing and thawing periods across all 3 sensors, while the RF ablation
temperature profiles have a distinct inflection point. Mechanistically, RF ablation creates
the desired tissue damage in two ways. At first the electrical current directly heats the tissue
through resistive heating. The degree of resistive heating drops o↵ with distance from the
current source. The second mechanism is passive conductive heating transferring through
the tissue[139]. The inflection point in the RF temperature profiles likely represents the
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Figure 6.8: Application of Additional 3D-MIM Sensors. a) Temperature monitoring during
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corresponds to one temperature sensor. Scale bar, 1 cm. b)Temperature map and recordings
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transition from resistive to conductive heating. The transition from resistive to conductive
heating was identified by calculating the first inflection point after the start of the ablation.
The second derivative of the signal was estimated using a numerical computing method
for noisy data [83]. Both the timing and the temperature at this inflection point were
recorded. The temperature and timing of the maximum temperature change were also
extracted from the profile. Two additional parameters were defined to characterize the
profile morphology: the ratio of time before the inflection point to the time the maximum
temperature was achieved and the ratio of the temperature increase before the inflection point
and the maximal temperature. These values were statistically compared across groups and
sensor depth using 2-way unbalanced ANOVA method. Statistical significance was defined
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Figure 6.9: Ultra-thin Needle Electrodes and Chronothermographs Recorded During Cryo
and Radiofrequency Ablation. a) Ultra-thin needle sensor. Thermographic monitoring during both b) cryoablation and c) 5W radiofrequency by transversally implanted ultrathin and
flexible temperature sensor. The sensor closest to the tissue surface and ablation source was
sensor 3 (blue solid line) and the one furthest from the source was sensor 1 (black solid line),

as p=0.05. A significant change in thermal conductivity was not observed after either cryo
or RF ablation (results not shown).
A total of 20 experimental RF lesions were assessed to correlate chronothermographs with lesion depth. The range of ablation powers and variety in the ventricular geometry resulted in
a distribution of lesion transmurality as shown in Figure 6.10. The lesions were grouped into
fully transmural (N=11) and non-transmural (N=9) lesions. A representative post-processing
example of a nontransmural lesion and a transmural lesion is displayed in Figure 6.10. The
shaded region highlights the lesion as defined by the custom threshold program. The corresponding temperature profiles for all lesions were assessed in detail to extract parameters
that may aid in the real-time identification of successful lesion attempts. A representative
example of a chronothermograph recorded during a 5W RF ablation and the definitions of
the parameters used to characterize the shape of the thermograph profile are shown in Figure
6.11. The first inflection point is identified in orange. The maximum temperature change is
identified in green. Four parameters were evaluated: maximum temperature change, time to
inflection point, ratio of temperature change at inflection point to total temperature change,
and ratio of time to inflection point to time to maximum change. Each parameter was statistically compared by location within the myocardial wall and across transmurality groups.
The two parameters with statistically di↵erent results across the transmural groups were the
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Figure 6.10: Distribution of Ablation Transmurality for Ultra-thin Needle Experiments.
Representative examples of TTC-stained lesion classified as non-transmural a) or transmural
b) by custom processing. c) Distribution of transmurality for n=20 lesions included in this
study
maximum temperature change (p=0.0039) and the ratio of time in phase 1 of the temperature change (i.e. resistive heating) to the time when the maximum temperature was reached
(p=0.0328). In both cases the transmural lesions were larger across all temperature sensor
locations. In accordance with the analytical data (see publication for work by collaborating
lab), the middle sensor on the needle-like devices observed the greatest di↵erences between
transmural and non-transmural lesions for all parameters except maximum temperature and
may be the best sensor for lesion characterization. We envision real-time monitoring of
the mid-myocardial temperature profile to provide feedback for increased time spent in the
resistive heating phase and thus, better lesion formation. Ideally, constant power or novel
current delivery strategies would be titrated while observing the temperature profile to ensure that the observed profile remained in the linear (resistive) phase for as long as possible.
Several strategies have been used to assess the thermal distribution during RF ablation on
bench-top studies [30], however the dimensions and mechanical properties of these ultrathin
needle type sensors provide the first technique that could be employed in vivo without restricting the contraction of the heart. Additionally, this platform could be used to mount a
variety of sensors including resistivity sensors to further characterize the dynamic changes
of mid-myocardial tissue during ablation and provide valuable feedback to the clinicians.
Strain Sensors on Epicardial Surface
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Figure 6.11: Parameters for Possible Real-Time Transmurality Predictions. Comparison of
chronothermograph parameters for non-transmural and transmural lesions and across sensor
locations assessed by a) ratio of temperature change in phase 1 (indicated in e)) to maximum temperature change; b) maximum temperature; c) ratio of time duration in phase
1 to time maximum temperature was achieved; and d) time spent in phase 1. e) Representative chronothermograph (blue) and second derivative (gray) from which parameters
were extracted. Orange identifies the inflection point and green identifies the maximum
temperature. f) Di↵erences across transmural group for each parameter and sensor location.
In addition to electrical and chemical evaluation, mechanical characteristics can be determined. Strain sensors based on piezoresistive e↵ects in nanomembranes of Si allow monitoring of the mechanics of contractions of the heart during a variety of propagation states.
Careful mechanical design of the serpentine interconnect structures allows accurate measurement in spite of the fact that typical epicardial strains [133] greatly exceed the fracture
threshold of Si, as described in previously reported small-scale 2D devices [97]. In the present
design, the 3D-MIM strain sensors include three p-doped Si piezoresistors in a rosette configuration. Two of the piezoresistors, with longitudinal axes perpendicular to each other, are
aligned to the <110>crystalline directions of the Si, o↵ering an e↵ective longitudinal gauge
factor of 0.33 and e↵ective transverse gauge factor of nearly 0.06 for each piezoresistor. The
piezoresistor aligned to the <100>crystalline direction exhibits relatively small change in resistance under strain, due to the intrinsic sensitivity associated with the crystalline direction
as well as the overall device geometry. The piezoresistors aligned to the <110>directions
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provide maximum sensitivity for characterization of mechanical rhythms of the heart while
the piezoresistor aligned to the<100>direction can be used to calibrate for e↵ects of temperature. Experiments revealed the mechanical behaviors during sinus rhythm, ventricular
pacing and pharmacologically induced ventricular fibrillation (VF) with Pinacidil (30 µM
bulk dose). The use of Pinacidil significantly reduces the action potential duration and subsequently increases the vulnerability to reentrant arrhythmias when stimulated with 50 Hz
AC burst pacing. Bath electrodes simultaneously recorded a far-field ECG to establish the
temporal correlation between the electrical and mechanical behaviour. Figure 6.8 shows the
response of a representative piezoresistor aligned to the <110>direction. The measurements
reveal mechanical rhythms of the cardiac cycles, with a frequency consistent with ECG deflections. During VF condition, both the strain gauges and ECG show that the waveform
lost normal rhythm and displayed a random pattern typical for VF.
Optical Spectroscopy with 3D-MIM Device
The final 3D-MIM demonstration exploits arrays of µ-ILEDs to illustrate the capacity for
advanced semiconductor integration and optical mapping/stimulation. Nine ultrathin (3
µm), microscale (300 x 300 mm2 ) LEDs based on aluminium indium gallium phosphide
(AlInGaP) with peak emission wavelengths of 670 nm served as local light sources for the
excitation of voltage-sensitive dyes. Changes in fluorescence associated with these dyes
allowed measurement of the cardiac action potential. Figure 6.8 compares signals obtained
with an external light source (Prizmatix, 630 nm) and with the integrated µ-ILEDs. In spite
of their small sizes, the LEDs enable recording of clear action potentials, with waveform
shapes consistent with external light. The signal-to-noise ratio of the µ-ILED-excited action
potentials is lower than the externally excited action potentials due to a necessary decrease
in light intensity to minimize the power delivered to the device. The results demonstrate
the future possibility of an in vivo optical mapping using either externally applied dyes or
internal fluorescent indicators and/or stimulation system in a 3D integration format.

6.4

Discussion

The results presented here suggest routes for integrating active electronic materials and sensors in organ-specific designs, with potential utility in both biomedical research and clinical
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applications. With attention to materials, engineering mechanics and functional devices,
these systems can establish conformal interfaces with the epicardium or within the transmural wall, and perform a variety of high-density physiological multiparametric mapping
and stimulation. The use of transfer printing and the reported scheme for integration onto
the printed 3D heart structure allows diverse sensor/actuator devices on a single platform.
Separate electrical connection, with a single trigger channel to synchronize the timing, eliminates e↵ects of crosstalk. The devices can provide local information on the metabolic,
excitable, ionic, contractile and thermal state for investigations of both the spatial and temporal responses to a variety of insults, diseases and therapies. The devices could be used
to identify critical regions that indicate the origin of pathophysiological conditions such as
arrhythmias, ischemia or heart failure. With future development, these membranes can be
implemented as near-continuous monitors of cardiac performance, providing clinicians with
a set of internal eyes guarding patients’ progression into or from disease states by tracking
improvement following therapeutic intervention. Additionally, these regions could be used
to guide therapeutic interventions.
The heart is a complex functional syncytium with a series of elements working in unison
to reliably perform and respond to conditions of stress. The combined functional behavior
on the organ level and the interaction between each subsystem is necessary to complete our
understanding of disease states of the heart. AF is an excellent example of the complex
network and feedback loops across systems inherent in cardiac disease states and illustrates
the need for simultaneous sensing. AF is strongly associated with self-propagating electrical
and structural remodeling [10]. Electrically, this is marked by changes in the conduction
velocity, the action potential duration and the refractory period; however, there are many
additional parameters that may contribute mechanistically to these changes. AF is often
associated with atrial dilation on the cellular and the macro scale; changes in wall stress,
intra-atrial pressure and activation of stretch receptors may all activate downstream cascades
[192]. Additionally, AF is marked by severe metabolic changes. Studies have shown increases
in oxygen consumption, decreases in atrial reserve flow, mitochondrial deletion and glycogen
accumulation [171]. Together these changes significantly impact the energetic state of the
atria and alter calcium handling, leading to both electrical and mechanical consequences
[92]. Electrophysiological, metabolic, and mechanical changes have distinct time courses
and spatial dependences, which may help separate cause from consequence and identify
those changes that are reversible. A multiparametric array can locally probe these changes
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simultaneously. These devices could be used to identify critical anatomical regions that
indicate the origin of pathophysiological conditions such as arrhythmias, ischemia, or heart
failure.
Light emitting diodes of a variety of wavelengths can be employed for optical spectroscopy of
internal fluorophores and added fluorescent dyes. To date the UIUC group has created arrays
of stretchable LEDs ranging from 450 to 670 nm in wavelength. With full spatial control over
powering the LEDs, these devices can interrogate regional di↵erences in fluorescence with
targeted excitation. By pairing custom LEDs with stretchable silicon-based photodiodes [96]
or miniature digital camera components [204] researchers can use this technique for localized
diagnostics of intrinsic fluorescent indicators like NADH, which has been demonstrated as
an attractive biomarker in ex vivo studies [14].
In addition to the numerous diagnostic applications of these devices, there are also sensing
and actuating capabilities that make them a relevant therapeutic tool. The same LED arrays can be used in spatially targeted optogenetics or the release of light-activated drugs. A
protocol was recently published outlining the feasible use of these LEDs in a device designed
for optogenetic studies in neuroscience [125]. The wavelengths are already tailored for excitation of light sensitive channel Rhodopsin. The LEDs can also be paired with photodiodes
to include feedback on the area that is receiving illumination. Using stretchable membranes
in the place of fiber optics could provide an internal light source that does not impede physical behavior, a significant hurdle in in vivo optogenetic studies and eventual transition to
clinical use of any therapy that relies on light. Furthermore, incorporating these sensors in
a number of clinical procedures could provide clinicians with much-needed feedback on the
instantaneous e↵ect of therapy, such as the needle-type temperature sensors for ablation.
If sensors were to remain on the patient’s heart after the procedure, the device could alert
the physician when a line of block recovers. The time course of recovery may help explain
the mechanism of arrhythmia recurrence after ablation procedures and guide new ablation
techniques that could circumvent this occurrence.
Another clinical therapy that might benefit from the addition of such a device is the use of
stimulators and defibrillators. Therapeutic electrical stimulation paradigms have long been
restricted to 1 or 2 electrode sites. CRT was a sizable step forward with the introduction of
simultaneous pacing at two separate sites [107]. However, not all patients respond equally to
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CRT in its current form [16]. These devices o↵er a platform for access to an enormous increase
in pacing sites and a shift from low definition to high definition electrical therapies.The square
electrodes can be fabricated using platinum instead of gold for targeted pacing applications.
Bipolar pacing has been achieved through these devices in the ex vivo rabbit heart. New
fractal structural designs can be implemented to build electrodes with greater surface area
to deliver high voltage shocks without sacrificing the mechanical stretch (see Appendix B).
With a combination of sensing and shocking electrodes, a device could be conceived for
high definition therapy, targeting only the spatially vulnerable regions as identified by the
sensors instead of limiting the shock to a single vector. A defibrillation protocol that takes full
advantage of the spatial coverage of the electrodes can be implemented to target arrhythmias
with a potential decrease in peak voltage required to successfully defibrillate. Additional
sensors including pH or ionic sensors can be added to instantaneously indicate myocardial
injury due to high voltage shocks or reduce the number of inappropriate shocks.

6.5

Future Directions

To increase the resolution and numbers of sensors, it may be necessary to incorporate transistors into the device to allow multiplexed addressing. Remaining challenges for use as
a chronic implant include means for power supply, control/communication and encapsulation. The wired connections must be replaced with full duplex wireless communication.
Work has begun to incorporate RF transmitters [125] into similarly fabricated devices. Additionally, fatigue testing has to be performed to establish the lifetime of the serpentine
wired circuit, which needs to withstand the stress of a heart beating 30 million times per
year. Future devices need evenly spaced sensors encompassing the entire heart surface. The
complex shape of the atria, pulmonary veins, and great vessels make the development of
atrial-specific devices difficult; however, the medical imaging techniques that provided the
ventricular geometry can also be employed for the atria. Transitioning to in vivo feasibility studies would also require the development of a minimally-invasive deployment strategy.
Previous experience with minimally invasive implantation methodologies used for ventricular
assist devices, valves and pacemakers/defibrillators will be the basis for such future development, but significant improvements will be needed for deployment of high-definition future
devices. Continuing work on the substrate chemistry and material properties will also open
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doors for new applications. Energy requirements are a concern for electronically implanted
devices, including pacemakers and defibrillators that rely on battery power for operation.
Recently, piezoelectric energy harvesting and storage have been developed through flexible
and integrated systems that use the natural motion of the beating heart as an energy source.
Harvesting power directly from natural processes of the body is an attractive method to
reduce battery size and eliminate the need to replace them [40]. In addition to energy harvesting, transient electronics is an emerging new area in material science that has numerous
cardiac applications, such as the temporary monitoring of transplanted tissue constructs
to ensure proper integration. Transient circuits are built with magnesium, tungsten, zinc,
and iron, all of which dissolve in physiological fluids and can be patterned onto stretchable
membranes in a similar manner to the sensors and actuators mentioned previously [39]. The
dissolving rates can be tuned by the addition of di↵erent metals and current circuits can
remain stable and then disappear within a few hours to 20 days.
With future development, these membranes can be implemented as near-continuous monitors
of cardiac function and provide necessary interventions as well as enhance current technology.
Implantable defibrillators would benefit from comprehensive monitoring, where traditional
low resolution electrical monitoring can lead to improper identification of arrhythmias and
inappropriate, painful shocks to patients. Additionally, ablation therapy of atrial fibrillation
relies on multielectrode basket catheters to locate ectopic foci or reentrant wavefronts with
limited endocardial contact. Form-fitting, comprehensive diagnostic catheters could reduce
the time to determine the electrical activation pattern reducing procedure time and improving patient outcomes. Combining the exciting new advances and the recent demonstrations
in cardiac applications, customizable stretchable substrates for multi-parametric sensors and
actuators have the potential to greatly increase the amount of data available to clinicians
and researchers studying pathophysiological disease states of the heart.
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Chapter 7
Conclusions
“We can only see a short distance ahead, but we can see plenty there that needs to be
done.” - Alan Turing
“We shall not cease from exploration, and the end of all our exploring will be to arrive
where we started and know the place for the first time.” - T. S. Eliot
Heart rhythm disorders are the leading cause of morbidity and mortality in the developed
world. Atrial fibrillation (AF), in particular, is becoming a massive and increasing burden
on the health care system. Unfortunately, current therapeutic options fall short of providing
relief for these patients in a consistent and reliable manner. With this dissertation, I have
taken a two-tiered approach to addressing the limitations of AF therapy and diverging from
the traditional electrotherapy paradigms. In order to develop therapies that are rooted in
biophysical mechanisms or at least are tailored by physiological feedback, we need to develop
methods to better di↵erentiate individual episodes of AF, as well as design therapies that
can better target individualized patterns. Chapter 3 and 4 are dedicated to characterizing
the spatiotemporal dynamics of AF in two di↵erent species and trying to discern some
organization out of the chaotic signals. By analyzing the spatiotemporal dynamics of AF
propagation, I have arrived at two important conclusions. The first is that the complex atrial
geometry should not be approximated as a 2D shell or even a shell with uniform thickness.
The anatomical variation of the atria a↵ects driver location, stability, and disruption in
a manner that is not yet predictable due to its level of complexity. With these projects, I
began to investigate how the anatomy harbors a three-dimensional substrate. The ventricular
transmural wall is a tightly controlled structure, critical to function. Since the atria serve
a di↵erent mechanical purpose there seems to be less order over the formation of the wall
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structures, leading to areas of discrete preferential transmural paths that are not uniformly
distributed throughout the atria. However, this is a significant area to expand upon. We
have begun a collaboration with Dr. Christine Hendon’s laboratory to use optical coherence
tomography to tease out fiber orientation and stitch together a 3D map of this orientation.
I think this will be a vast improvement over the small sampling of fiber orientation patterns
investigated in Chapter 4. Additionally, I think it will be important to develop a method
to register the functional maps to the anatomical maps to discern the interaction between
the variations in structure and the electrical substrate. In the studies presented here, I was
hesitant to calculate the regional incidence of AF drivers since I thought that information
should not be extrapolated from tens of animal hearts to clinical AF. However, I think if we
had an anatomical map of thickness and fiber orientation that we could register directly to
the driver location, it would be beneficial to look for regional correlations. The AF models
used in this study are limited without structurally remodeling but they lay a good foundation
before introducing the additional level of complexity resulting from pathological conduction
abnormalities and the insulation of fibrosis.
My second main conclusion was that even in a controlled animal model, there was a spectrum
of dissociation between animals. Although global parameters like dominant frequency and
regularity index are well conserved across the transmural wall, dissociation and the role of
transmural conductance are exposed with a spatiotemporal characterization of wavefront
and PS dynamics in an acute model of AF that was mostly driven by short-lived meandering
rotors. If we could make a di↵erentiation along this spectrum clinically, this may provide
an opportunity to distinguish a sub population of patients that are easier to target. Of
course it would be beneficial to repeat the transillumination study in human atria, especially
in the tissue of patients who su↵er from prolonged atrial fibrillation to confirm that the
spectrum exists outside of the animal models. Additionally, it remains unclear what role the
dyssynchrony across the wall plays with respect to new targeted ablation approaches. I think
an important next step would be to attempt to disrupt the patterns by targeting the pattern
on one side of the wall. In order to complete this study, the dynamic parameter algorithms
need to be adapted for quick extraction from the data. The processing would need to be
performed in a near-real-time sense so that the experimenter could respond appropriately
with an ablation lesion.
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In Chapter 4, I began to add more optical planes through the atria to approach a 3D imaging strategy by alternating the direction of illumination. I think that with more e↵ort and
creative use of new fluorescent dye properties and alternating excitation wavelengths one
could parcel the transmural wall into more planes optically and perhaps visualize out of
plane rotation, if it exists. If I were to repeat these studies I would alternate the illumination between red and green light from a single side in addition to switching between the
contralateral and ipsilateral direction. I might also consider adding simultaneous calcium
imaging. Calcium dynamics play an important role in driving AF and it would be beneficial
to simultaneously investigate the interaction between voltage and calcium in this model with
both the endocardium and epicardium exposed.
There is a great deal of work to be done to bridge the characterization studies of the early
chapters with the serial defibrillation paradigms discussed in Chapter 5. I think the temporal
optimization studies helped to determine that it is important for Stage 2 to be tightly coupled
in time to Stage 1. However, the first shock of Stage 2 can come too early, when all the tissue
is refractory, which is detrimental to the therapeutic efficacy. The spatial studies included
in this dissertation confirm the advantage of multi-path serial defibrillation with respect to
efficacy. Surprisingly, a more acute shift decreased the threshold to a greater degree than an
orthogonal shift. Understanding the mechanism of the optimal vector is a crucial next step to
these studies. Ideally, I wanted to use the optical maps of the pressure-loaded atria model to
look at the angle of incidence between propagating wavefronts and the shock vectors to begin
to probe the spatial interaction patterns with the applied electrical field. I believe this is the
ideal experimental preparation to look for the impact of di↵erent shock vectors compared
to the flat atrial preps because the atria are intact and in a physiological confirmation
when the shock is delivered. However, the experiment did not permit this analysis because
of the superposition of ventricular and atrial signals. It was difficult to ensure that the
ventricular wavefront from under the atria was sufficiently removed. I tried many things
to experimentally block the ventricular signal including trying to ablate the atrioventricular
node with an RF catheter and a cryocatheter. I tried injecting ethanol and formalin into the
AV node to damage it. I tried using a dye or a physical material inside the volume of the
atria to make the tissue less transparent and block the camera from the ventricles without
consistent success. I did implement an algorithm for wavefront identification and primary
conduction angle estimation for the isolated AF preps but was not able to apply it to this
dataset. Therefore, I think there is a lot of work that could be done to tease out why a vector
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shift decreased the defibrillation threshold, especially if this trend is confirmed in the in
vivo canine model that is currently being conducted. Additionally, if the shifted probability
of success curve is reproducible in the canine model for either Stage 1 rotation or Stage
2, there are some coupling parameters that would need to be optimized. To date we have
continued to couple the Stage 2 dynamics with the Stage 3 dynamics in an e↵ort to simplify
the degrees of freedom; however, it may not be the most efficacious approach. The Labview
code is written to be easily adapted to di↵erent spatial strategies. The hardware currently
can dynamically shift between 6 bipolar vectors from a single current source. The relays
have a hardware delay of <15ms, providing a great deal of flexibility in the shock timing.
If we could add a second current source I think it would be very interesting to investigate
overlapping shocks in time across separate vectors instead of discrete spatial shocks with a
quiescent delay. I believe that the vulnerability within the cycle length of an arrhythmia
is a spatial and temporal phenomenon, and we have yet to determine the best approach to
identify and target the applied energy in both domains.
Traditionally defibrillation strategies have been guided by shock-induced electrical responses.
However, it is important to remember that the electrical machinery in the heart does not
function in isolation. There is a complex network of feedback loops between the metabolic,
electrical, and mechanical states of the heart. All of which are a↵ected by electrotherapy.
Although we conducted many feasibility tests on a variety of high density multi-parametric
sensors on the stretchable electronics platform, we did not yet use the information as a
marker for myocardial damage during defibrillation. I think one of the best applications of
this technology is to provide the real-time, high definition feedback on the shock-response
beyond just the electrical information we can gain from optical mapping. This will greatly
improve our physiological understanding of how the myocardial tissue responds energetically
and mechanically to high voltage shocks. The information could be used to help design
new paradigms that are truly rooted in biophysical mechanisms. As a step towards this
goal, we started to design potassium sensitive electrodes to measure spatial maps of elevated extracellular potassium. We used a local and global ischemia-reperfusion model in
a Langendor↵-perfused rabbit heart to induce potassium release in our preliminary studies
and monitored the oxygen consumption of the heart with an in-flow oxygen electrode at the
inlet and outlet of the perfusion system (Strathkelvin) to correlate with the timing of spikes
in potassium levels. Figure 7.1 displays the results from one of these preliminary studies. Although we were able to capture dynamics in the potassium concentration, the electrodes are
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not yet stable in time. We are working on surface modifications to the potassium-sensitive
membrane to remove the drift and improve sensitivity. I think this is an excellent first sensor to use to look at the spatial tissue response to high voltage shocks. Additionally, in its
current form, the 3D MIM devices are designed to fit the ventricle. This was our first target
because the shape is more stable and easier to conform to without deforming. Significant
e↵ort is required to design a device capable of conforming to the atria, if these devices are
going to be used to provide high definition shocking vectors to the atria. By combining a
spatial analysis of the arrhythmia drivers, the energy delivered and the resulting damage I
hope we can enhance the biophysical understanding of AF electrical cardioversion and design an ideal targeted energy delivery protocol to improve upon all limitations of current
electrotherapy.
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Figure 7.1: Preliminary Study with Stretchable Potassium Sensors. a) An array of 8 K+
sensitive electrodes sutured across posterior surface of the heart, crossing tissue that is fed
by both the right and left coronary arteries. The blue dye highlights the tissue that was
a↵ected when the left branch was occluded for “local ischemia” b) Temporal trace from one
K+ sensor on the left side of the heart and simultaneous global outflow oxygen concentration
measurements to confirm ischemic conditions during 3 di↵erent conditions: local left sided
ischemia-reperfusion, global ischemia-reperfusion and a repeated local left sided ischemiareperfusion cycle. c) Action potential shortening confirms the ischemic condition used to
test the sensors.
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Appendix A
Quantifying Spatial Heterogeneity of
Cardiac Electrophysiology
A.1

Introduction

Although the heart is often referred to as a functional syncytium, it is a well-coordinated
dynamic system of individual cells with diverse electrophysiological properties. The threedimensional variations within the tissue properties are organized in such a fashion as to
produce a single electrical circuit and a synchronous mechanical contraction when it is properly functioning. The dynamic nature allows it to uniformly respond to neural stimulation
to adjust the rate to meet the circulatory demand. Due to the intricate spatial design,
spatial pattens and disruptions to electrophysiological gradients cannot be neglected when
investigating the cause and the e↵ects of irregular rhythms.
Irregular propagation can be initiated at the spatial boundaries of electrophysiological properties within the tissue. The charge density is altered at sharp gradients and the path of current can be diverted. This idea is validated by computational models that have demonstrated
that di↵erences in the duration of the electrical recovery and the resistance to conduction
between cells contribute to the conditions necessary for conduction block and reentrant arrhythmia [183]. Under the right conditions where the di↵erence in electrical properties at
the boundary is sufficient, the propagating wavefront results in unidirectional block at the
boundary, increasing the vulnerability to an arrhythmia. The length of the cellular refractory
period and how the cells are spatially dispersed is also critical for generating the entrance
block that silences premature beats.
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Pronounced structural and functional remodeling during arrhythmias has been extensively
studied on the cellular, tissue, and intact heart level. We have discussed many of the changes
associated with AF throughout this dissertation and each cardiac pathology is associated
with its own course of remodeling. The changes in ion channel expression have profound
e↵ects on the temporal behavior of the action potential, a↵ecting both depolarization and
repolarization. Studies have also shown that the electrophysiology changes caused by some
arrhythmias hinder or eliminate the rate adaption of the repolarization phase [191]. Temporal changes are often used as an investigative parameter to characterize arrhythmogenic
conditions. Due to the complex nature of these alterations in ion channel and connexin expression it is unlikely to be a uniform change across the tissue. Therefore remodeling is likely
to result in an increase in spatial heterogeneity or a transition to a disordered heterogeneity
of the electrical properties with more harsh boundaries. This change in the spatial pattern
may contribute to arrhythmogenic changes in addition to the temporal changes in the action
potentials that are easily quantified.
Measures of variance capture some degree of these heterogeneous changes but decouple it
from spatial location and therefore miss the critical changes in spatial patterns. High resolution mapping techniques o↵er the ability to visualize the spatial activation and repolarization
patterns of isolated cardiac tissue. Despite the clear need to compare the pathological heterogeneity to that of healthy tissue and the compelling hypothesis that spatial dispersion of
electrophysiological properties contributes to improper conduction within the heart, measuring cardiac heterogeneity remains largely an elusively qualitative observation. The definition
of heterogeneity does not lend itself to being easily quantified, simply meaning a quality of
being nonuniform. Much of the literature dedicated to developing strategies for quantifying
spatial heterogeneity comes from the field of geostatistics to extract features from landscape
and stream studies [110]. These strategies have only recently been applied to medical imaging for the purpose of identifying anomalies in various fields including oncology in the lungs,
brain and epidermal tissue [152, 168, 81]. A clear method or set of techniques that reliably
and accurately quantify the spatial heterogeneity would help to improve the understanding
of the cause and consequence of electrophysiological heterogeneity and its role in arrhythmia.
This study aims to apply several di↵erent statistical strategies ranging from texture analysis
to orthogonal regression to identify the limitations and advantages of numerically representing the spatial heterogeneity of a map of high density simultaneous cardiac recordings.
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A.2
A.2.1

Datasets
Synthetic Data

Synthetic data was used to create a framework with a controlled amount of spatial noise for
initial testing and di↵erentiating the efficacy of all methodologies. Intensity maps with a
mean of 0.5 were created in a 100 by 100 array as an initial condition. Two di↵erent cases
were considered a uniform gradient from 0 to 1 or a homogenous substrate. Controlling
for a constant mean, 10% of the pixels were changed to a di↵erent intensity in a random
spatial pattern for each permutation. The intensity of the noise was limited to ±10% o↵
the mean, ± 25% o↵ the mean and the full range from 0 to 1. For the uniform gradient
the standard deviation was also maintained by moving 10% of the current pixels to new
arbitrary locations. Each heterogeneity strategy was then tested on the maps from 0-10
permutations to establish limitations and identify the ideal parameters to extract from each
technique.Figure A.1 displays the increasing permutations of noise on the gradient template.

Figure A.1: Synthetic Data with Controlled Increases in Heterogeneity. a) random noise 0
to 1 1 perm. mu=0.5, sigma=0.29 b) 5 perm. mu=0.5, sigma=0.29 c) 10 perm. mu=0.5,
sigma=0.29 d) random noise +/- 10% o↵ mean 1 perm mu=0.5, sigma=0.28 e) 5 perm. mu=
0.5, sigma=0.24 f) 10 perm. mu=0.5, sigma=0.18
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A.2.2

Experimental Data

After promising techniques were identified using the control data, they were applied to
experimentally collected data. A representative experiment that optically mapped cardiac
tissue from a Control group (N=5) and an Experimental inflammation model (N=5) was
used as a test dataset. The optical mapping system used has been described in detail in
Chapter 2. Briefly, a voltage sensitive dye is used to collect fractional fluorescence changes
that correspond to changes in membrane potential with a 100 x 100 pixel CMOS sensor. The
tissue was externally paced at di↵erent cycle lengths ranging from 350ms to 150ms to test
the hypothesis that spatial heterogeneity does not vary with the pacing rate. Some rates
were excluded from this study if they produced alternans, complicating the application of
the spatial processing. Spatial variation in action potential duration (APD) values was used
as the target parameter. The APD was defined as the distance from the upstroke to 90% of
the repolarization back to baseline (APD90). In some cases the APD50, the distance from
the upstroke to 50% of the repolarization phase, was used to corroborate the findings. The
data was first filtered to exclude any points beyond a physiologically relevant range of 60 to
300ms before the heterogeneity methods were applied.

A.3

Methods

All methods were implemented used custom MATLAB software.

A.3.1

Texture Analysis: Haralick Features

Texture analysis uses tone to classify the spatial dependencies of a pictorial image. First,
the data must be converted to a 2D gray level intensity array with values ranging from 0 to
1. The synthetic data was built to be an intensity map of these values but the experimental
data was normalized by the 99th percentile for each pixel, using each dog as its own control
or normalizing all the dogs by the same average 99th percentile value. A co-occurrence
matrix is created to portray the distribution of pairs of pixels. Each element of the matrix
Pij represents the relative frequency of co-occurrence of gray levels with intensity levels i
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and j separated by a given displacement. The displacement and consequent matrix has a
directionality and magnitude, which requires multiple matrices to be developed for a single
image. For this study 50 matrices were created with a displacement of 1-50 pixels in four
directions: 0°, 45°, 90°, 135°. The four directions were then averaged to ensure rotational
invariance, forming 50 individual matrices per image. A variety of statistical parameters
calculated in the spatial domain and first described by Robert Haralick can be extracted
from each matrix [75]. This study focused on the correlation (A.1), contrast (A.2), energy
(A.3), and homogeneity (A.4) parameters as defined below. The values from the matrices
created with a distance of 10-50 were then averaged to ignore nearest- neighbor distribution,
resulting in one final parameter for each image. This analysis was conducted using the
functions provided by MATLAB for creating a gray-level co-occurrence matrix (GLCM) and
calculating the Haralick features in the Statistics Toolbox.
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A.3.2

Texture Analysis: Run Length Matrix

The run-length matrix method also requires a 2D gray level intensity array from 0 to 1. A
run length is a measure of the number of consecutive pixels of the same intensity calculated
along four displacement vectors: 0°, 45°, 90°, 135°. These runs are then tallied for each
intensity to create a matrix where each element P(i,j) corresponds to the relative frequency
of a run of intensity i with length j. Four matrices are calculated from each image and
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the 95th percentile for the run length was extracted for each direction and averaged as the
measure of heterogeneity.

A.3.3

Inhomogeneity Index: Maximum Di↵erence Phase Map

The inhomogeneity index calculated from a maximum di↵erence phase map is one of the
only techniques in the literature developed specifically for the cardiac application [106]. Each
element of the phase map is created by determining the maximum di↵erence between every
group of four neighboring locations. A histogram is created and the inhomogeneity index, a
parameter independent of the average, is extracted from the distribution using the 5th, 50th,
and 95th percentile values (A.5). This method has been applied previously to conduction
velocity measurements of rabbit atria to attempt to predict reentry vulnerability.

I=

A.3.4

P5

P95

(A.5)

P50

Variogram

A variogram is a tool often used to express spatial variation and roughness. The equation
for calculating the variogram is shown in (A.6), where z is the electrophysiological parameter
and x and y represent the lag vector. This method also has a directionality associated with
it and must be repeated for multiple angles in order to achieve rotational invariance using
the same 4 displacement vector angles. For this study an angle tolerance was not included
in the lag vector. To infer this function from the observed data an approximation was used
as shown in (A.7). The variogram function computed over a lag distance of 0-50 pixels was
fit to a linear model because a sill was never reached. The R-squared value and slope were
used as a measure of goodness-of-fit and heterogeneity.

2 ( x, y) = E[Z(x +

x, y +
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y)

Z(x, y))2 ]

(A.6)

( x, y) =

A.3.5

X
1
2N ( x, y) i,j✏S( x,

(zi

zj )2

(A.7)

y)

Orthogonal Regression

This method fits a 2D plane through a 3D cloud of points to minimize the orthogonal distance
from the points to the plane using principal component analysis. It was applied directly
to the data without any prior transformations. For the synthetic data the intensity map
was multiplied by 300 to produce physiologically relevant values. The normal vector to the
plane is described by the principal component analysis coefficients of the electrophysiological
parameter values and the basis of the plane is spatial location of the parameter on the
Cartesian map. The mean squared error of the regression analysis is used as a measure of
heterogeneity.

A.4

Results

Trends with respect to the number of permutations are displayed in Figure A.2 for a select few
methods. Quantifying orthogonal regression with mean squared error (MSE) values displays
a fairly linear positive correlation for both the homogenous plane and the gradient datasets.
However this parameter saturates with fewer permutations of noise for the homogenous plane
dataset. The data is also sensitive to the relative location of the “electrodes” to each other.
Additionally this method is sensitive to the intensity of noise introduced, which is a synthetic
indicator of increased heterogeneity.
The Haralick parameters do not respond to noise in a consistent manner for both the homogeneous plane and the uniform gradient. The Homogeneity and Energy parameters both
decrease from 1 with increased heterogeneity in a linear fashion for the homogeneous case
but the energy values stay stable for the uniform gradient case regardless of the noise introduced. The Homogeneity parameter still decreases but starts from a much lower baseline and
is much less sensitive to each permutation of more spatial noise. The di↵erences between the
Homogeneity parameter with respect to distance can be used to quantitatively di↵erentiate
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Figure A.2: Synthetic Analysis of Heterogeneity Methods. Trends with respect to permutations for select methods applied to the homogeneous and gradient starting conditions.

a gradient. Each direction can also be assessed independently to identify the direction of the
gradient. The Contrast parameter increases with increased heterogeneity but the maximum
value is unclear from this data so it may be difficult to assess absolute heterogeneity.
The run length matrix approach produced consistent results for all the tested cases with
only slight variations due to noise intensity. Complete homogeneity approaches 100 and
the value decreases with increases in heterogeneity. The baseline value for a homogeneous
plane is much larger than the gradient but the relationship evens out as more permutations
of noise are introduced. This approach is more sensitive to changes in heterogeneity since
an introduction of 10% random noise drops the 95th percentile to 30% of the baseline for
the homogeneous plane and near 50% of the baseline for the uniform gradient. The run
length parameter then stabilizes after 5 permutations of spatial noise. This may be a good
parameter to identify slight changes in the degree of heterogeneity.
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The other approaches produce less promising trends. The slope of the linear fit for the
variogram produces a fairly linear relationship, but the values are extremely low and the
relationship does not hold for the gradient. Although the inhomogeneity index is the most
consistent between the uniform gradient and homogeneous plane, there is no observable trend
with respect to the permutations of noise. The 50th percentile lags behind the increases in
the 5th and 95th percentile changes with respect to permutations, resulting in the observed
spike at 3 permutations. There is also no discernible di↵erence from 4 to 10 permutations.
Based on the synthetic results, the Haralick Homogeneity parameter, run length matrix and
orthogonal regression approaches were applied to the experimental datasets. The results
for all the tested datasets are displayed in Figure A.3. It is important to note that an
increased MSE and a decreased Haralick Homogeneity or Run-length Matrix parameter
refer to increased heterogeneity. All methods revealed the same trend that the heterogeneity
is increased across all pacing cycle lengths for the experimental condition but the degree of
increased heterogeneity varies per method.

Control

Control

Experimental

Control

Experimental

Experimental

Figure A.3: Heterogeneity Methods Applied to Experimental Data. Averages for each approach to quantifying heterogeneity (N=5 for each group)
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A.5

Discussion

The analysis with the synthetically created data identified several parameters as monotonic
indicators of increasing spatial heterogeneity. Unfortunately there was no one parameter that
captured all conditions without being influenced by the starting distribution or noise intensity. This may cloud the interpretation of each individual parameter such that a collection of
methods might be the ideal approach. The run length matrix was a sensitive approach that
picked up small changes in heterogeneity and may be a good starting approach. However,
small changes to already heterogeneous maps may be lost using this approach. The fact
that the Haralick parameters do not uniformly respond to a gradient and a planar map is
concerning due to the frequent presence of both these spatial patterns in cardiac tissue. Still
the correlation parameter is a measure of linear dependence and could be used to identify
maps in which the homogeneity parameter fails due to the presence of a gradient. The regression analysis is also a promising approach that responds to the di↵erence in magnitude
at the borders. Using these three approaches together may help to identify spatial changes
in heterogeneity within an animal.

A.6

Future Directions

Average values for all the parameters associated with a directional vector were used to
create rotational invariance. However in the case of the gradient, this may mask some of the
patterns. It may be worth a second look to identify di↵erent parameters for the promising
methods that better capture the relationship between the parameter and the lag distance or
direction. Although these techniques add spatial information in a controlled setting, it is not
clear whether they can be e↵ectively applied to a group of experimental optical maps. In this
study there was no clear relationship established across cycle length or experimental group
that was upheld by all the approaches. Due to anatomical variation between individuals
and the heterogeneity innate in the normal structure of the heart, it is unlikely that the
field of view examined between two dogs produces a similar baseline parameter for any of
these approaches. This unavoidable disparity may account for a significant amount of the
variation observed in the data when the mean values were compared. It is much more
important from this early stage that the values calculated for the approaches are congruent
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with the subjective classification of more or less heterogeneous. In most cases this seemed to
be the case for the real data. It is possible that changes in heterogeneity could be assessed
successfully compared to a chosen baseline condition.
The results were sensitive to the normalization process and care must be taken to establish
if each dog should serve as its own control or if one normalization value is needed in order to
be able to compare across dogs. Despite these shortcomings in interpreting the data across
multiple dogs, this study does present some promising new ways to approach quantifying
the spatial data produced from high resolution mapping of cardiac tissue. When comparing
two independent maps, the approaches outlined here can successfully discriminate between
levels of heterogeneity.
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Appendix B
Material and Fractal Designs for 3D
Multifunctional Integumentary
Membranes with Capabilities in High
Definition Cardiac Electrotherapy
This chapter appears in the following original publication:
Xu L, Gutbrod SR, Ma Y, Petrossians A, Liu Y, Webb RC, Fan JA, Yang Z, Xu R,
Whalen JJ, Weiland JD, Huang Y, Efimov IR, Rogers JA. Material and Fractal Designs for
3D Multifunctional Integumentary Membranes with Capabilities in Cardiac Electrotherapy.
Adv. Mater. 2015; 27: 1731-1737.

B.1

Introduction

Physical constraints limit the nature of the interfaces between cardiac structures and the
electrodes used to deliver electrotherapy. A trade-o↵ exists between spatial control of the
electrode location with respect to the local anatomy and large simultaneous coverage of the
tissue. An radio frequency (RF) catheter provides precise access to anatomical regions but
can only make a single point of contact and burn a small mass of tissue at a time. Defibrillation vectors simultaneously excite a large mass of tissue but the flexibility of their
position is limited with respect to the anatomy. Additionally, no existing clinical method
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can provide simultaneous electrotherapy with high density spatiotemporal mapping of physiological parameters for feedback control. Defibrillation strategies have remained relatively
stagnant in the way in which energy is delivered. The high voltage shocks that are used
in conventional procedures can be extremely painful and require a great deal of energy to
be stored in the batteries of such devices. A promising direction for advanced low energy
cardiac electrotherapy couples feedback-controlled, targeted defibrillation techniques with
greatly reduced voltage and energy requirements [112, 90, 119, 38]. Multifunctional, conformal platforms of electrodes that can integrate over large areas of cardiac structures provide
the opportunity to advance beyond traditional implantable lead-based delivery paths.
Emerging classes of materials and mechanics concepts in the field of stretchable electronics
create new opportunities for integrating high performance electronics with the human body
and individual organs. Devices described in Chapter 6, referred to as 3D multifunctional
integumentary membranes (3D-MIM), provide conformal electronic platforms that interface
with the full 3D geometry of the epicardium. 3D imaging and printing techniques enable
organ-specific geometric designs with an instrumented interface. High performance electronic
materials, interconnect structures, and sensors mount on this platform to yield various spatiotemporal mapping and stimulation capabilities. The results presented in this appendix
expand on these concepts to demonstrate 3D-MIM devices configured for high definition cardiac electrotherapy. Here, fractal geometries yield compliant, large area, low impedance electrodes for electrical stimulation in designs that do not compromise the physical stretchability
or the low e↵ective modulus of the overall system. Advanced electrode materials, including nanotextured platinum-iridium (Pt-Ir) alloys and poly(3,4-ethylenedioxythiophene):poly(styrene sulfonate) (PEDOT:PSS), integrate naturally to enable low impedance interfaces
that are well suited both for delivering electrical pulses and for sensing intrinsic electrophysiology. These constructs yield versatile platforms for cardiac electrotherapy. Experiments on
ex vivo Langendor↵-perfused rabbit hearts demonstrate the operational capabilities of these
systems.
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B.2

Fabrication

The devices reported here are compromised of an array of 8 electrodes distributed around
the circumference of the heart (see Figure
(a)

(b)

Figure B.1: Representative Device Integrated on Rabbit Heart and Illustration of Functional
Components
Figure B.1 also shows the materials components and illustrates a general integration scheme
for functional elements of the device. A silicone elastomer (Ecoflex, Smooth-on) with low
elastic modulus (60 kPa) serves as the mechanical support for the active components. This
non-conductive substrate may also help contain the electrotherapy to within the boundaries
of the membrane, which could potentially reduce pain associated with high-voltage shocks
and improve the efficiency of defibrillation. A co-integrated array of resistive temperature
sensors based on Au traces (15 µm in width and 70 nm in thickness) are integrated as a
placeholder for sensors that could be used to monitor myocardial damage following defibrillation. Thin layers of Au (300 nm) and Ti (5 nm) serve as interconnects as well as conductive
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surfaces for electrode deposition and processing. Polyimide (PI) layers (1.2 µm) provide electrical insulation. Low-impedance coatings of nanotextured Pt-Ir alloys or PEDOT:PSS can
be electrodeposited to yield high quality electrical interfaces.
Fractal design concepts for the electrodes enable large area coverage and high filling fraction
for electrically active surfaces, suitable for generating electric fields across cardiac tissue,
but without compromising stretchability and compliance [54]. Here, the pattern for each
electrode exploits a 2nd order iteration of the Greek cross fractal motif, with serpentine
traces that fill a rectangular area of 14.5 mm x 2.5 mm. Serpentines with widths of 100
µm result in a filling fraction of 44%, thereby providing 14 mm2 of geometrical surface area
for each electrode. By comparison to previously reported 3D-MIM electrodes, the present
configuration increases the surface area by a factor of 14 and increases the overall dimension
(defined by the area of the perimeter of the electrode structure) by a factor of 36. The Greek
cross involves a high degree of geometrical connectivity, to reduce the electrical resistance and
provide a high degree of tolerance to defects. The unique layouts of these fractal geometries
increase the ratio of the electrode-insulation edge length to the geometric surface area of
the electrode, when compared to a conventional electrode of equivalent geometric area. It
is well understood that current at an electrochemical electrode interface is preferentially
distributed at the electrode-insulation edges [7, 140, 36]. This observation suggests that
a fractal electrode of equivalent geometric area to a conventional electrode design should
transfer current more efficiently from the electrode to the tissue. These improvements are
particularly beneficial to the development of low power systems.
The mechanics of these structures are also critically important. Finite element analysis
(FEA) illustrates the response of the fractal electrodes to applied strains, throughout a
range associated with 3D integration and operation on the surface of a beating heart. The
e↵ective modulus of the fractal electrode element is 120 kPa, and it can accommodate 15%
stretching in either the vertical or horizontal direction before reaching a regime of plastic
deformation. By comparison, the intrinsic modulus and yield strain of the constituent metals
are 100 GPa and 0.3%, respectively. The overall mechanical behavior of the integrated device
must meet two requirements: i) sufficient stretchability for the device to allow deformations
associated with contraction and relaxation of the heart muscle, and ii) minimal force exerted
by the device on structures of the epicardial surface. FEA in combination with uniaxial
and biaxial stretching experiments reveals the geometry change, strain distribution, and
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(a)

(b)

(c)

(d)

Figure B.2: Finite Element Analysis of Mechanical Properties of Fractal Electrode Patterns

e↵ective modulus of the device, as parameters that determine the ability to meet these
two requirements. Figure B.2 displays the device geometry and strain distribution in the
undeformed state, with 20% uniaxial stretching and with 15% biaxial stretching, respectively.
The uniaxial stretch is in the horizontal direction, corresponding to the atrioventricular
plane, which makes the largest contribution to total heart volume change associated with
cardiac cycles[31]. The resulting strain is accommodated by deformation of the soft elastomer
substrate and buckling of the serpentine features. The maximum principal strain obtained
by FEA is less than 0.3%, which is within the elastic regime for the metal and is far less
than the fracture strain for all constituent materials (Ti, Au, Pt-Ir, polymer). These results
suggest that the device can withstand the mounting process as well as the contraction and
relaxation of the heart muscles, which result in 10-15’% of tensile deformation.
The second requirement demands minimal constraint on the heart, which is equivalent to
minimizing the e↵ective modulus of the device to reduce the average pressure that it exerts
on the heart. Figure B.2 shows the linear relationship between the stress and strain for the
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elastomer membrane and the 3D-MIM. The e↵ective modulus is dominated by the silicone
membrane (150 µm in thickness, with modulus 60 kPa). The modulus for the 3D-MIM is only
slightly larger, 71 kPa (horizontal stretching) and 74 kPa (vertical stretching). The calculated
average pressure associated with integration of the device on the heart in its diastolic state
(145% of the contracted volume) is 273 Pa, which is similar to the pericardial pressure under
normal physiological states and well below the values associated with pericardial constraint
[84].
These results indicate that the device is unlikely to cause restrictive impact on the intrinsic
cardiac cycles, consistent with all of our experimental observations. Reducing the electrochemical impedance associated with the interface between the electrodes and the cardiac
tissue improves the signal-to-noise ratio (SNR) for recording biopotentials and lowers the
power consumption for electrical stimulation [36]. Lowering the impedance also enables reductions in electrode size without compromising charge capacity, thereby allowing improved
current focusing and reduced probability of pain or other side e↵ects caused by aberrant current, high-voltage, and high-energy electrical shocks. The large area fractal electrodes dramatically reduce the impedance compared to previous designs. Pt-Ir alloys with nanoscale
surface textures and PEDOT:PSS films represent two attractive options that are compatible
with the platforms and fabrication procedures reported here. The former exploits recently
reported electrochemical deposition methods [144] to yield electrodes with enhanced mechanical and electrical properties compared to more conventional alternatives such as Pt, Pt
black, or standard Pt-Ir alloys. We implemented this technology as a surface modification
to the previously described fractal electrodes.

B.3

Methods

The animal study was approved by the Institutional Animal Care and Use Committee of
Washington University School of Medicine. The heart was obtained from a New Zealand
white rabbit, anesthetized with an intravenous injection of 80 mg /kg of sodium pentobarbital and 400 USP units/ kg of heparin before the heart was surgical explanted.
The heart was then transferred to a tissue bath that maintained the temperature (37
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±1 °C) and pH (7.4 ± 0.05) to mimic physiological conditions. The heart was retrogradely perfused under a constant pressure of 60-80 mm Hg with oxygenated Tyrode’s solution (95%O2 , 5%CO2 , N aCl128.2 ⇥ 10 3 , CaCl2 1.3 ⇥ 10 3 , KCl4.7 ⇥ 10 3 , M gCl2 1.05 ⇥
10 3 , N aH2 P O4 1.19 ⇥ 10 3 , N aHCO3 20.0 ⇥ 10 3 , glucose11.1 ⇥ 10 3 M ). The heart was
mechanically uncoupled with 15 ⇥ 10 6 M Blebbistatin (Cayman Chemical, Ann Arbor, MI)
and perfused with a bolus injection of di-4 ANEPPS (Life Technologies, Grand Island, NY,
USA). The 3D-MIM was placed over the heart, positioned with 4 electrodes across the anterior surface and 4 electrodes on the posterior surface. The electrodes were connected in
pairs to a custom defibrillator (Cardialen, Inc, St Louis, MO, USA) that delivered 50-100 V
biphasic truncated exponential pulses (phase 1 duration 6 ms, phase 2 duration 4 ms, phase
2 voltage was half the peak amplitude and opposite polarity voltage of phase 1). Optical action potentials were recorded before, during, and after delivery of the shock with two CMOS
cameras (SciMedia Ltd, Costa Mesa, Ca, USA) with 520 nm excitation light through a long
pass emission filter with a 650 nm cuto↵. The data were then processed with custom Matlab
software. The VEP was determined by evaluating the sign of the optical action potential
derivative from the time of the shock until 10 ms past the shock.

B.4

Results

Animal experiments on Langendor↵-perfused rabbit hearts demonstrate the multifunctional
operation of the devices. Epicardial electrograms recorded with a PEDOT:PSS electrode
display clear signals. o simulate defibrillation therapy, 50 V electrical shocks were applied
through each pair of electrodes (with Pt coated surfaces) integrated on the epicardium to
form vectors that traverse the ventricles. Optically imaged action potentials from the epicardium demonstrate an immediate tissue response to the applied electrotherapy. The video
in the Supporting Information, shows the potential during a sinus beat followed by a shock
induced beat to illustrate e↵ective capture with a single vector. Figure B.3 compares the
activation pattern of the sinus beat with the shock-induced activation. The varying spatial
response in activation time confirms e↵ective capture. The virtual electrode pattern (VEP)
induced by high voltage shocks is an important feature that determines the mechanism of
successful electrotherapy. Figure 4 c illustrates this characteristic pattern following a 50 V
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shock delivered from the electrode highlighted in white. This simple demonstration establishes feasibility of creating stretchable thin film electrodes that can carry high voltage and
large current shocks to the cardiac tissue. Repeated high-voltage shocks have the potential
to induce corrosive degradation of the thin metal layers used in these electrodes. Further investigation will be necessary for chronic operation of this type of high-voltage electrotherapy
but this could be a possible device to deliver the spatially tuned electrotherapy paradigms
proposed in Chapter 5.
(a)

(b)

(c)

Figure B.3: Successful Shock Delivery through Fractal Electrodes

B.5

Conclusions

In summary, advanced designs and materials approaches provide capabilities for high definition cardiac electrotherapy in an advanced 3D-MIM platform. Concepts in fractal geometry
allow large area, conformal electrodes suitable for delivering cardiac electrical stimulation,
and for sensing cardiac electrical activity. Surface coating materials improve the electrochemical characteristics of the electrodes, in ways that are naturally compatible with the
platform and its fabrication. Integrated arrays of sensors can be used to precisely monitor
the electrotherapy and other forms of intervention. Animal experiments demonstrate the
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multifunctional operation of the devices. These results suggest routes for developing advanced tools with utility in both fundamental research and clinical application of cardiac
electrotherapy.
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Appendix C
Protocols and Analysis Code
C.1

Guide to Optical Mapping of Rabbit Heart

General Set-up
1. Make solutions: 1 Liter of stock solution prepared in advance and stored at 4 °C
Tyrode’s stock I (25X):
NaCl: 187.3 g
CaCl2 : 4.78g
KCl: 8.76g
M gCl2 : 5.335g
N aH2 P O4 : 4.105g

Tyrode’s stock II (25X):
N aHCO3 : 42.005g

Combine 80 mL of each stock with 4g of Glucose, fill to 2L with Ultra-Pure Water.

2. Calibrate pH probe

3. Oxygenate the solution with 10psi 95 : 5%O2 /CO2 (adjust to maintain pH). Maintain
pH=7.35±0.05, temperature 37±0.5°C in the tissue bath.
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4.
5.
6.
7.
8.
9.

Prepare cannula
Calibrate pressure and oxygen sensor
Place filter in perfusion line before aortic cannula
Prepare camera, choose appropriate filter (650nm for di4), focus the camera.
Connect triggers or acquisition cables if needed.
Prepare small beaker of Tyrode’s for the heart

Rabbit Euthanasia
1. 80/390 ml/kg of Fatal Plus + 0.4mL/kg Heparin
2. Mix well and attach butterfly needle.
3. Trim ear hair, place clip, clean with alcohol and scratch ear to desensitize.
4. Insert butterfly needle and push drug slowly. Clear line to be sure entire volume is delivered.
5. Confirm unresponsiveness to pain, remove from restrainer
6. Locate xyphoid process, cut into skin here.
7. Cut down until the diaphragm is exposed, puncture the diaphragm and remove it from
chest wall to expose the heart.
8. Cut along the ribs and spread with hemostat.
9. Scoop the heart and cut the aorta above and below the heart, continue cutting to release
the heart. Place in small beaker to transport.
10. Hang heart on cannula and secure with suture.
11. Release pressure in filling pericardium with a small incision.
12. Clean the fat, lungs, etc. carefully, do not cut myocardium
13. When sufficiently clean move heart to recirculating chamber

Optical Mapping
1. Allow heart to adjust to temperature in tissue bath, add needles to check ECG. Turn o↵
lights.
2. Dilute 0.2mL of stock BB in 1 mL and add slowly to bubble trap. Continue this until
beating stops (1-2mL total BB stock).
3. Add 20-30 µL of di-4 through bubble trap.
4. Adjust light and focus until sample monitor >30.
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5. Continue with experimental protocol.

Clean-Up
1. Remove all fluid from the perfusion lines. REMOVE FILTER AND CHAMBER BEFORE NEXT STEP.
2. Run alcohol through line and collect it. (must be put in hazardous waste bin for pickup)
3. Run DI water through the line.
4. Remove filters and lenses and place cover back on camera.

C.2

Labview code for controlling digital relay switches

This labview program was designed to control a front-end series of relay-gates between the
Cardialen defibrillator and the subject. It was designed in Labview 2012 with a compactRIO
ADC with an Analog Input and a Digital Output module (National Instruments). The
software is designed to receive a constantly wait for a trigger to signal that the shock is
going to be delivered in 10 ms. Upon receiving the trigger, the compactRIO will deliver a
series of signals to turn on and o↵ the relay gates in a manner defined by the user. In the
current design, the user can choose 1) Rotate Shock 1 based on the AF CL with no rotation
in Shock 2, 2) Rotate Shock 2 based on the AF CL with no rotation in Shock 1, or 3) No
rotation with the whole therapy delivered to either Vector 1 or Vector 2. Additional vector
options are easily added by adding more frames to the sequence structures. The code will
alert the user when a trigger is received and highlights the vectors that are turned on with
virtual LEDs.
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Figure C.1: Front Panel for Vector Relay Control

Figure C.2: Block Diagram for Vector Relay Control
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Sellers. Mechanism of blebbistatin inhibition of myosin ii. Journal of Biological Chemistry, 279(34):35557–35563, 2004.
[105] Valentin I Krinsky and Igor R Efimov. Vortices with linear cores in mathematical
models of excitable media. Physica A: Statistical Mechanics and its Applications,
188(1):55–60, 1992.
[106] WJ Lammers, MJ Schalij, CJ Kirchhof, and MAURITS A Allessie. Quantification of
spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias.
American Journal of Physiology-Heart and Circulatory Physiology, 259(4):H1254–
H1263, 1990.
[107] JJ Lattuca, TJ Cohen, and MM Mower. Biventricular pacing to improve cardiac
hemodynamics. In Clinical Research, volume 38, pages A882–A882. SLACK INC 6900
GROVE RD, THOROFARE, NJ 08086, 1990.
[108] Jacob I Laughner, Fu Siong Ng, Matthew S Sulkin, R Martin Arthur, and Igor R
Efimov. Processing and analysis of cardiac optical mapping data obtained with potentiometric dyes. American Journal of Physiology-Heart and Circulatory Physiology,
303(7):H753–H765, 2012.
[109] Thomas Lewis. The mechanism and graphic registration of the heart beat. PB Hoeber,
1920.
[110] Habin Li and James F Reynolds. A simulation experiment to quantify spatial heterogeneity in categorical maps. Ecology, pages 2446–2455, 1994.
153

[111] Li Li, Vladimir Nikolski, Don W Wallick, Igor R Efimov, and Yuanna Cheng. Mechanisms of enhanced shock-induced arrhythmogenesis in the rabbit heart with healed
myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology, 289(3):H1054–H1068, 2005.
[112] Wenwen Li, Crystal M Ripplinger, Qing Lou, and Igor R Efimov. Multiple monophasic
shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic
infarction. Heart Rhythm, 6(7):1020–1027, 2009.
[113] Yongqin Li, Giuseppe Ristagno, Tao Yu, Joe Bisera, Max Harry Weil, and Wanchun
Tang. A comparison of defibrillation efficacy between di↵erent impedance compensation techniques in high impedance porcine model. Resuscitation, 80(11):1312–1317,
2009.
[114] Han S Lim, Stephan Zellerho↵, Nicolas Derval, Arnaud Denis, Seigo Yamashita, Benjamin Berte, Saagar Mahida, Darren Hooks, Nora Aljefairi, Ashok J Shah, et al. Noninvasive mapping to guide atrial fibrillation ablation. Cardiac Electrophysiology Clinics,
2014.
[115] Qing Lou, Vadim V Fedorov, Alexey V Glukhov, Nader Moazami, Vladimir G Fast,
and Igor R Efimov. Transmural heterogeneity and remodeling of ventricular excitationcontraction coupling in human heart failure. Circulation, 123(17):1881–1890, 2011.
[116] Qing Lou, Wenwen Li, and Igor R Efimov. The role of dynamic instability and wavelength in arrhythmia maintenance as revealed by panoramic imaging with blebbistatin
vs. 2, 3-butanedione monoxime. American Journal of Physiology-Heart and Circulatory
Physiology, 302(1):H262–H269, 2012.
[117] BERNARD Lown. Electrical reversion of cardiac arrhythmias. British heart journal,
29(4):469, 1967.
[118] Bernard Lown, Robert Kleiger, and Gerald Wol↵. The technique of cardioversion.
American heart journal, 67(2):282–284, 1964.
[119] Stefan Luther, Flavio H Fenton, Bruce G Kornreich, Amgad Squires, Philip Bittihn,
Daniel Hornung, Markus Zabel, James Flanders, Andrea Gladuli, Luis Campoy, et al.
Low-energy control of electrical turbulence in the heart. Nature, 475(7355):235–239,
2011.
[120] RH Lyons, A Farah, GK Moe, and JA Abildskov. Atrial tachycardia, flutter, and
fibrillation. Circulation, 20(3):451–458, 1959.
[121] Luca Mainardi, Leif Sornmo, and Sergio Cerutti. Understanding atrial fibrillation: the
signal processing contribution. Morgan &amp; Claypool Publishers, 2008.
154

[122] Raphael P Martins, Kuljeet Kaur, Elliot Hwang, Rafael J Ramirez, B Cicero Willis,
David Filgueiras-Rama, Steven R Ennis, Yoshio Takemoto, Daniela Ponce-Balbuena,
Manuel Zarzoso, et al. Dominant frequency increase rate predicts transition from
paroxysmal to long-term persistent atrial fibrillation. Circulation, 129(14):1472–1482,
2014.
[123] Arvydas Matiukas, Bogdan G Mitrea, Maochun Qin, Arkady M Pertsov, Alexander G
Shvedko, Mark D Warren, Alexey V Zaitsev, Joseph P Wuskell, James Watras, Leslie M
Loew, et al. Near-infrared voltage-sensitive fluorescent dyes optimized for optical mapping in blood-perfused myocardium. Heart Rhythm, 4(11):1441–1451, 2007.
[124] Alfred Goldsborough Mayor. Rhythmical pulsation in scyphomedusae. Number 47.
Carnegie Institution of Washington, 1906.
[125] Jordan G McCall, Tae-il Kim, Gunchul Shin, Xian Huang, Yei Hwan Jung, Ream AlHasani, Fiorenzo G Omenetto, Michael R Bruchas, and John A Rogers. Fabrication
and application of flexible, multimodal light-emitting devices for wireless optogenetics.
Nature protocols, 8(12):2413–2428, 2013.
[126] John A McWilliam. Fibrillar contraction of the heart. The Journal of physiology,
8(5):296–310, 1887.
[127] George Ralph Mines. On dynamic equilibrium in the heart. The Journal of physiology,
46(4-5):349–383, 1913.
[128] M Mirowski, Morton M Mower, William S Staewen, Bernard Tabatznik, and Albert I
Mendelo↵. Standby automatic defibrillator: an approach to prevention of sudden
coronary death. Archives of internal medicine, 126(1):158–161, 1970.
[129] M Mirowski, Philip R Reid, Morton M Mower, Levi Watkins, Vincent L Gott, James F
Schauble, Alois Langer, MS Heilman, Steve A Kolenik, Robert E Fischell, et al. Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator
in human beings. The New England journal of medicine, 303(6):322, 1980.
[130] Andrew Robert John Mitchell, Philip Anthony Roworth Spurrell, Lana Elizabeth
Boodhoo, and Neil Sulke. Long-term care of the patient with the atrial defibrillator. American heart journal, 147(2):210–217, 2004.
[131] Gordon K Moe, Werner C Rheinboldt, and JA Abildskov. A computer model of atrial
fibrillation. American heart journal, 67(2):200–220, 1964.
[132] George B Moody and Roger G Mark. A new method for detecting atrial fibrillation
using rr intervals. Computers in Cardiology, 10:227–230, 1983.

155

[133] Christopher C Moore, Carlos H Lugo-Olivieri, Elliot R McVeigh, and Elias A Zerhouni. Three-dimensional systolic strain patterns in the normal human left ventricle:
Characterization with tagged mr imaging 1. Radiology, 214(2):453–466, 2000.
[134] MARTIN Morad and G Salama. Optical probes of membrane potential in heart muscle.
The Journal of physiology, 292(1):267–295, 1979.
[135] KA Mowrey, Y Cheng, PJ Tchou, and IR Efimov. Kinetics of defibrillation shockinduced response: design implications for the optimal defibrillation waveform. Europace, 4(1):27–39, 2002.
[136] Siddhartha Mukherjee. The emperor of all maladies: a biography of cancer. Simon
and Schuster, 2010.
[137] Francis D Murgatroyd and AJ Camm. Atrial fibrillation: the last challenge in interventional electrophysiology. British heart journal, 74(3):209, 1995.
[138] Sanjiv M Narayan, David E Krummen, Kalyanam Shivkumar, Paul Clopton, WouterJan Rappel, and John M Miller. Treatment of atrial fibrillation by the ablation of
localized sources: Confirm (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. Journal of the American College of
Cardiology, 60(7):628–636, 2012.
[139] Sunil Nath, JOHN DiMARCO, and David E Haines. Basic aspects of radiofrequency
catheter ablation. Journal of cardiovascular electrophysiology, 5(10):863–876, 1994.
[140] John Newman. Resistance for flow of current to a disk. Journal of the electrochemical
society, 113(5):501–502, 1966.
[141] Kunihiro Nishida, Georghia Michael, Dobromir Dobrev, and Stanley Nattel. Animal
models for atrial fibrillation: clinical insights and scientific opportunities. Europace,
12(2):160–172, 2010.
[142] THOMAS PAUL, JEFFREY P MOAK, CODY MORRIS, and ARTHUR GARSON.
Epicardial mapping: how to measure local activation? Pacing and Clinical Electrophysiology, 13(3):285–292, 1990.
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